Teleflex (TFX) 10-K 24 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Feb. 14, 2014	Jun. 30, 2013
Document Information [Line Items]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Trading Symbol	'TFX	'	'
Entity Registrant Name	'TELEFLEX INC	'	'
Entity Central Index Key	'0000096943	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Current Reporting Status	'No	'	'
Entity Voluntary Filers	'Yes	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	41,216,674	'
Entity Public Float	'	'	$2,334,281,638

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net revenues	$1,696,271	$1,551,009	$1,492,528
Cost of goods sold	857,326	802,784	783,750
Gross profit	838,945	748,225	708,778
Selling, general and administrative expenses	502,187	454,489	423,909
Research and development expenses	65,045	56,278	48,712
Goodwill impairment	'	332,128	'
Restructuring and other impairment charges	38,452	3,037	6,005
Net (gain) loss on sales of businesses and assets	'	-332	582
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	233,261	-97,375	229,570
Interest expense	56,905	69,565	70,317
Interest income	-624	-1,571	-1,260
Loss on extinguishments of debt	1,250	'	15,413
Income (loss) from continuing operations before taxes	175,730	-165,369	145,100
Taxes on income (loss) from continuing operations	23,547	16,413	25,778
Income (loss) from continuing operations	152,183	-181,782	119,322
Operating (loss) income from discontinued operations (including gain on disposal of $2,205 and $270,630 for 2012 and 2011, respectively)	-2,205	-9,207	292,683
Taxes (benefit) on income (loss) from discontinued operations	-1,770	-1,887	87,038
Income (loss) from discontinued operations	-435	-7,320	205,645
Net income (loss)	151,748	-189,102	324,967
Less: Income from continuing operations attributable to noncontrolling interest	867	955	1,021
Income from discontinued operations attributable to noncontrolling interest	'	'	617
Net income (loss) attributable to common shareholders	150,881	-190,057	323,329
Basic:	'	'	'
Income (loss) from continuing operations	$3.68	($4.47)	$2.92
Income (loss) from discontinued operations	($0.01)	($0.18)	$5.06
Net income (loss)	$3.67	($4.65)	$7.98
Diluted:	'	'	'
Income (loss) from continuing operations	$3.46	($4.47)	$2.90
Income (loss) from discontinued operations	($0.01)	($0.18)	$5.02
Net income (loss)	$3.45	($4.65)	$7.92
Dividends per share	$1.36	$1.36	$1.36
Weighted average common shares outstanding:	'	'	'
Basic	41,105	40,859	40,501
Diluted	43,693	40,859	40,801
Amounts attributable to common shareholders:	'	'	'
Income (loss) from continuing operations, net of tax	151,316	-182,737	118,301
Income (loss) from discontinued operations, net of tax	-435	-7,320	205,028
Net income (loss) attributable to common shareholders	$150,881	($190,057)	$323,329

CONSOLIDATED_STATEMENTS_OF_INC1

CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012		Dec. 31, 2011
Gain (loss) on disposal of discontinued operations	$2,205	[1]	$270,630	[1]
[1]	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the cargo systems and cargo container businesses.

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net income (loss)	$151,748	($189,102)	$324,967
Other comprehensive income (loss), net of tax:	'	'	'
Foreign currency translation, net of tax	-9,637	13,071	-77,073
Pension and other postretirement benefits plans adjustment, net of tax	30,220	7,291	-38,802
Derivatives qualifying as hedges, net of tax	381	6,876	8,005
Other comprehensive income (loss), net of tax	20,964	27,238	-107,870
Comprehensive income (loss)	172,712	-161,864	217,097
Less: comprehensive income attributable to noncontrolling interest	638	888	1,241
Comprehensive income (loss) attributable to common shareholders	172,074	-162,752	215,856
Defined Benefit Pension and Other Postretirement Plans	'	'	'
Other comprehensive income (loss), net of tax:	'	'	'
Foreign currency translation	-177	-168	-57
Prior service cost recognized in net periodic cost, net of tax of $(9),$(8) and $(9)	-12	-12	-15
Transition obligation recognized in net periodic cost, net of tax of $2, $35 and $42	3	62	68
Unamortized gain (loss) arising during the period, net of tax of $14,638, $2,399 and $28,779	25,641	2,796	-50,359
Net loss recognized in net periodic cost, net of tax of $2,446, $2,537 and $1,399	4,765	4,621	2,488
Settlement, net of tax of $40 and $(2)	'	66	-3
Curtailment, net of tax of $(44)	'	-74	'
Divestiture of businesses, net of tax of $4,865	'	'	9,076
Comprehensive Income Derivatives Qualifying As Hedges	'	'	'
Other comprehensive income (loss), net of tax:	'	'	'
Unrealized gain (loss) on derivatives arising during the period, net of tax $265, $102 and $(830)	-549	515	-1,920
Reclassification adjustment on derivatives included in net income, net of tax of $(46), $3,832 and $5,757	930	6,361	9,990
Discontinued operations, net of tax of $(39)	'	'	-65
Foreign Currency	'	'	'
Other comprehensive income (loss), net of tax:	'	'	'
Foreign currency translation	-9,637	13,071	-53,386
Foreign currency translation divestiture of businesses	'	'	($23,687)

CONSOLIDATED_STATEMENTS_OF_COM1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Foreign Currency	'	'	'
Foreign currency translation, tax	$8,086	$1,210	($161)
Defined Benefit Pension and Other Postretirement Plans	'	'	'
Prior service cost recognized in net periodic cost, tax	-9	-8	-9
Transition obligation recognized in net periodic cost, tax	2	35	42
Unamortized gain arising during the period, tax	14,638	2,399	28,779
Net loss recognized in net periodic cost, tax	2,446	2,537	1,399
Settlement, tax	'	40	-2
Curtailment, tax	'	-44	'
Divestiture of businesses, tax	'	'	4,865
Foreign currency translation, tax	66	-58	-20
Comprehensive Income Derivatives Qualifying As Hedges	'	'	'
Unrealized gain (loss) on derivatives arising during the period, tax	265	102	-830
Reclassification adjustment on derivatives included in net income, tax	-46	3,832	5,757
Discontinued operations, tax	'	'	($39)

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$431,984	$337,039
Accounts receivable, net	295,290	297,976
Inventories, net	333,621	323,347
Prepaid expenses and other current assets	39,810	28,712
Prepaid taxes	36,504	27,160
Deferred tax assets	52,917	51,025
Assets held for sale	10,428	7,963
Total current assets	1,200,554	1,073,222
Property, plant and equipment, net	325,900	297,945
Goodwill	1,354,203	1,238,452
Intangibles assets, net	1,255,597	1,058,792
Investments in affiliates	1,715	2,066
Deferred tax assets	943	1,347
Other assets	70,095	61,863
Total assets	4,209,007	3,733,687
Current liabilities	'	'
Notes payable	356,287	4,700
Accounts payable	71,967	75,165
Accrued expenses	74,868	65,064
Current portion of contingent consideration	4,131	23,693
Payroll and benefit-related liabilities	73,090	74,586
Accrued interest	8,725	9,418
Income taxes payable	23,821	16,895
Other current liabilities	22,231	5,779
Total current liabilities	635,120	275,300
Long-term borrowings	930,000	965,280
Deferred tax liabilities	514,715	418,874
Pension and postretirement benefit liabilities	109,498	170,946
Noncurrent liability for uncertain tax positions	55,152	61,979
Other liabilities	48,506	59,771
Total liabilities	2,292,991	1,952,150
Commitments and contingencies (See Note 15)	'	'
Common shareholders’ equity	'	'
Common shares, $1 par value Issued: 2013 — 43,243 shares; 2012 — 43,102 shares	43,243	43,102
Additional paid-in capital	409,338	394,384
Retained earnings	1,696,424	1,601,460
Accumulated other comprehensive loss	-110,855	-132,048
Shareholders Equity Before Treasury Stock, Total	2,038,150	1,906,898
Less: Treasury stock, at cost	124,623	127,948
Total common shareholders’ equity	1,913,527	1,778,950
Noncontrolling interest	2,489	2,587
Total equity	1,916,016	1,781,537
Total liabilities and equity	$4,209,007	$3,733,687

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Common shares, par value	$1	$1
Common shares, shares Issued	43,243,000	43,102,000

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash Flows from Operating Activities of Continuing Operations:	'	'	'
Net income (loss)	$151,748	($189,102)	$324,967
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'	'
Loss (income) from discontinued operations	435	7,320	-205,645
Depreciation expense	42,368	36,204	40,336
Amortization expense of intangible assets	50,608	44,264	42,634
Amortization expense of deferred financing costs and debt discount	14,959	14,416	13,526
Loss on extinguishments of debt	1,250	'	15,413
Changes in contingent consideration	-12,642	263	274
Impairment of long-lived assets	3,460	'	'
In-process research and development impairment	7,381	'	'
Interest rate swap buyout	'	'	-11,695
Stock-based compensation	11,871	8,623	4,532
Net (gain) loss on sales of businesses and assets	'	-332	582
Impairment of investments in affiliates	'	'	2,499
Goodwill impairment	'	332,128	'
Deferred income taxes, net	-8,925	-39,178	-14,067
Other	-8,700	-3,776	-2,701
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:	'	'	'
Accounts receivable	-1,294	-2,932	-43,561
Inventories	-8,931	-1,970	-33,819
Prepaid expenses and other current assets	-5,926	9,595	-8,473
Accounts payable and accrued expenses	-684	-1,412	-1,636
Income taxes receivable and payable, net	-7,107	-20,258	-28,809
Net cash provided by operating activities from continuing operations	229,871	193,853	94,357
Cash Flows from Investing Activities of Continuing Operations:	'	'	'
Expenditures for property, plant and equipment	-63,580	-65,394	-44,582
Payments for businesses and intangibles acquired, net of cash acquired	-309,008	-369,444	-24,623
Proceeds from sales of businesses and assets, net of cash sold	'	66,660	376,025
Investments in affiliates	-50	-80	-150
Net cash (used in) provided by investing activities from continuing operations	-372,638	-368,258	306,670
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Proceeds from long-term borrowings	680,000	'	515,000
Repayment of long-term borrowings	-375,000	'	-455,800
Debt extinguishment, issuance and amendment fees	-6,400	'	-18,518
Decrease in notes payable and current borrowings	'	-706	-24,714
Proceeds from stock compensation plans	7,609	9,003	34,009
Payments to noncontrolling interest shareholders	-736	'	'
Payments for contingent consideration	-16,958	-17,596	-5,947
Dividends	-55,917	-55,589	-55,136
Net cash provided by (used in) financing activities from continuing operations	232,598	-64,888	-11,106
Cash Flows from Discontinued Operations:	'	'	'
Net cash (used in) provided by operating activities	-3,327	-7,799	121
Net cash used in investing activities	'	-2,351	-2,875
Net cash used in discontinued operations	-3,327	-10,150	-2,754
Effect of exchange rate changes on cash and cash equivalents	8,441	2,394	-11,531
Net increase (decrease) in cash and cash equivalents	94,945	-247,049	375,636
Cash and cash equivalents at the beginning of the year	337,039	584,088	208,452
Cash and cash equivalents at the end of the year	431,984	337,039	584,088
Supplemental Cash Flow Information:	'	'	'
Cash interest paid	43,581	46,683	45,336
Income taxes paid, net of refunds	$43,975	$74,908	$67,419

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $)	Total	Common Stock	Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income	Treasury Stock	Noncontrolling Interest
In Thousands, except Share data
Beginning Balance at Dec. 31, 2010	$1,787,278	$42,245	$349,156	$1,578,913	($51,880)	($135,058)	$3,902
Beginning Balance (in shares) at Dec. 31, 2010	'	42,245,000	'	'	'	2,250,000	'
Net income (loss)	324,967	'	'	323,329	'	'	1,638
Cash dividends ($1.36 per share)	-55,136	'	'	-55,136	'	'	'
Other comprehensive loss	-107,870	'	'	'	-107,473	'	-397
Disposition of noncontrolling interest	-2,830	'	'	'	'	'	-2,830
Distributions to noncontrolling interest shareholders	-118	'	'	'	'	'	-118
Shares issued under compensation plans	36,355	678	31,848	'	'	3,829	'
Shares issued under compensation plans, shares	'	678,000	'	'	'	-63,000	'
Deferred compensation	137	'	-39	'	'	176	'
Deferred compensation, shares	'	'	'	'	'	-4,000	'
Ending Balance at Dec. 31, 2011	1,982,783	42,923	380,965	1,847,106	-159,353	-131,053	2,195
Ending Balance (in shares) at Dec. 31, 2011	'	42,923,000	'	'	'	2,183,000	'
Net income (loss)	-189,102	'	'	-190,057	'	'	955
Cash dividends ($1.36 per share)	-55,589	'	'	-55,589	'	'	'
Other comprehensive loss	27,238	'	'	'	27,305	'	-67
Distributions to noncontrolling interest shareholders	-496	'	'	'	'	'	-496
Shares issued under compensation plans	16,597	179	13,429	'	'	2,989	'
Shares issued under compensation plans, shares	'	179,000	'	'	'	-49,000	'
Deferred compensation	106	'	-10	'	'	116	'
Deferred compensation, shares	'	'	'	'	'	-4,000	'
Ending Balance at Dec. 31, 2012	1,781,537	43,102	394,384	1,601,460	-132,048	-127,948	2,587
Ending Balance (in shares) at Dec. 31, 2012	'	43,102,000	'	'	'	2,130,000	'
Net income (loss)	151,748	'	'	150,881	'	'	867
Cash dividends ($1.36 per share)	-55,917	'	'	-55,917	'	'	'
Other comprehensive loss	20,964	'	'	'	21,193	'	-229
Distributions to noncontrolling interest shareholders	-736	'	'	'	'	'	-736
Shares issued under compensation plans	18,374	141	14,963	'	'	3,270	'
Shares issued under compensation plans, shares	'	141,000	'	'	'	-65,000	'
Deferred compensation	46	'	-9	'	'	55	'
Deferred compensation, shares	'	'	'	'	'	-1,000	'
Ending Balance at Dec. 31, 2013	$1,916,016	$43,243	$409,338	$1,696,424	($110,855)	($124,623)	$2,489
Ending Balance (in shares) at Dec. 31, 2013	'	43,243,000	'	'	'	2,064,000	'

CONSOLIDATED_STATEMENTS_OF_CHA1

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Dividends per common share	$1.36	$1.36	$1.36

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies	'
	Note 1 — Summary of significant accounting policies
	Consolidation: The consolidated financial statements include the accounts of Teleflex Incorporated and its subsidiaries (the “Company”). Intercompany transactions are eliminated in consolidation. Investments in affiliates over which the Company has significant influence but not a controlling equity interest, including variable interest entities where the Company is not the primary beneficiary, are carried on the equity basis. Investments in affiliates over which the Company does not have significant influence are accounted for using the cost method of accounting. These consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and include management’s estimates and assumptions that affect the recorded amounts.
	In June 2013, the Company revised its Consolidated Statement of Cash Flows to reflect contingent consideration payments related to businesses acquired as a cash outflow from financing activities of continuing operations, thereby correcting a presentation error in previous filings.  Since 2011, these payments were reflected as a cash outflow from investing activities of continuing operations. The Company also revised the Consolidated Statements of Cash Flows, as well as the Condensed Consolidating Statements of Cash Flows included in Note 17, for the twelve months ended December 31, 2012 and 2011 to reclassify $17.6 million and $5.9 million, respectively, as cash outflows from financing activities to reflect this correction. The changes do not affect the Company’s consolidated balance sheets, statements of operations and comprehensive income or statements of changes in stockholders’ equity. Moreover the reclassifications resulting from the change were not considered material to any previously issued financial statements.
	We made certain other revisions to the 2012 and 2011 guarantor financial information presented in the 2012 and 2011 Form 10-Ks to correct errors identified in the current year.  Refer to Note 17 to the consolidated financial statements for additional details.
	Other assets in the consolidated balance sheet as of December 31, 2013 include $17.6 million of receivables outstanding greater than one year.
	Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and cash equivalents: All highly liquid debt instruments with an original maturity of three months or less are classified as cash equivalents. The carrying value of cash equivalents approximates their current market value.
	Accounts receivable: Accounts receivable represents amounts due from customers related to the sale of products and provision of services. An allowance for doubtful accounts is maintained and represents the Company’s estimate of the amount of uncollectible receivables. The allowance is provided at such time as management believes reasonable doubt exists that such balances will be collected within a reasonable period of time. The allowance is based on the Company’s historical experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. The allowance for doubtful accounts was $10.7 million and $7.8 million as of December 31, 2013 and 2012, respectively. See Note 9 to the consolidated financial statements for information on the Company’s concentration of credit risk. In addition, we maintain a reserve for returns and allowances based on the Company’s historical experience. The reserve for returns and allowances was $3.3 million and $2.9 million as of December 31, 2013 and 2012, respectively.
	Inventories:  Inventories are valued at the lower of cost or market. The cost of the Company’s inventories is determined using the average cost method. Elements of cost in inventory include raw materials, direct labor, and manufacturing overhead. In estimating market value, the Company evaluates inventory for excess and obsolete quantities based on estimated usage and sales.
	Property, plant and equipment: Property, plant and equipment are stated at cost, net of accumulated depreciation. Costs incurred to develop internal-use computer software during the application development stage generally are capitalized. Costs of enhancements to internal-use computer software are capitalized, provided that these enhancements result in additional functionality. Other additions and those improvements which increase the capacity or lengthen the useful lives of the assets are also capitalized. With minor exceptions, composite useful lives for property, plant and equipment, which are depreciated on a straight-line basis are as follows: land improvements — 5 years; buildings — 30 years; machinery and equipment — 3 to 10 years; computer equipment and software — 3 to 10 years. Leasehold improvements are depreciated over the remaining lease periods. Repairs and maintenance costs are expensed as incurred.
	Goodwill and other intangible assets: Goodwill and other intangible assets with indefinite lives are not amortized but are tested for impairment annually during the fourth quarter or more frequently if events or changes in circumstances indicate that an impairment may exist. Impairment losses, if any, are included in income from operations. The goodwill impairment test is applied to each of the Company’s reporting units with goodwill. For purposes of this assessment, a reporting unit is an operating segment, or a business one level below that operating segment (a component) if discrete financial information is prepared and regularly reviewed by segment management. However, separate components are aggregated as a single reporting unit if they have similar economic characteristics.
	In applying the goodwill impairment test, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors may include, but are not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategies and financial performance. If, after completing such assessment, it is determined more likely than not that the fair value of a reporting unit is less than its carrying value, the Company proceeds to a two-step quantitative impairment test. Alternatively, the Company may proceed directly to testing goodwill for impairment through the two-step impairment test without conducting the qualitative analysis. In the fourth quarter 2013, the Company elected to forgo the qualitative assessment and test all reporting units with goodwill through the two-step quantitative impairment test.
	The first step of the two-step impairment test is to quantitatively compare the fair value of a reporting unit, including goodwill, to its carrying value. In performing the first step, the Company calculates the fair value of the reporting unit using equal weighting of two methods; one which estimates the discounted cash flows (“DCF”) of the reporting unit based on projected earnings in the future (the Income Approach) and one which is based on sales of similar assets in actual transactions (the Market Approach). If the reporting unit fair value exceeds the carrying value, there is no impairment. If the reporting unit carrying value exceeds the fair value, the Company would perform the second step of the goodwill impairment test, in which the Company would recognize an impairment loss if the carrying value of goodwill exceeds its implied fair value. The implied fair value of goodwill is determined by deducting the fair value of a reporting unit's identifiable assets and liabilities from the fair value of the reporting unit as a whole, as if that reporting unit had just been acquired and the fair value of the individual assets acquired and liabilities assumed initially were being determined. The Company performed the goodwill impairment test during the fourth quarter 2013, and for each reporting unit whose assets include goodwill, the fair value of each of the reporting units exceeded the carrying value.  As a result, no impairment in the carrying value of any of the Company’s reporting units was evident.
	The Company’s intangible assets consist of customer lists, intellectual property, distribution rights and trade names. The Company tests its indefinite-lived intangible assets for impairment annually, and more frequently if events or changes in circumstances indicate that an impairment may exist. Similar to the goodwill impairment test process, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If, after completing such qualitative assessment, the Company determines it is more likely than not that the fair value of the indefinite-lived intangible asset is greater than its carrying amount, the asset is not impaired. If the Company concludes it is more likely than not that the fair value of the indefinite-lived intangible assets is less than the carrying value, the Company then proceeds to a quantitative impairment test, which consists of a comparison of the fair value of the intangible assets to their carrying amounts. Alternatively, the Company may elect to forgo the qualitative analysis and proceed directly to testing the indefinite-lived intangible asset for impairment through the quantitative impairment test. The Company recorded IPR&D impairment charges of $7.4 million in 2013 upon the decision to abandon certain of the IPR&D projects. See Note 4 to the consolidated financial statements for further information related to these charges. No other impairment charge was evident for indefinite-lived intangible assets as a result of the fourth quarter 2013 impairment assessment.
	Intangible assets consisting of intellectual property, customer lists, distribution rights and certain tradenames are being amortized over their estimated useful lives, which are as follows: intellectual property, 3 to 20 years; customer lists, 5 to 30 years; distribution rights, 3 to 22 years; tradenames, 1 to 30 years. The weighted average amortization period is approximately 16 years. The Company periodically evaluates the reasonableness of the useful lives of these assets.
	Long-lived assets: We assess the remaining useful life and recoverability of long-lived assets whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. Such evaluation is based on various analyses, including undiscounted cash flow and profitability projections that incorporate, as applicable, the impact on the existing business.  Therefore, the evaluation involves significant management judgment. Any impairment loss, if indicated, is measured as the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset.
	Foreign currency translation: Assets and liabilities of subsidiaries with non-United States dollar denominated functional currencies are translated into United States dollars at the rates of exchange at the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the year. The translation adjustments are reported as a component of accumulated other comprehensive income.
	Derivative financial instruments: The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in interest rates and foreign currency exchange rates. All instruments are entered into for other than trading purposes. All derivatives are recognized on the balance sheet at fair value. Changes in the fair value of derivatives are recorded in earnings or other comprehensive income, based on whether the instrument is designated as part of a hedge transaction and, if so, the type of hedge transaction. Gains or losses on derivative instruments reported in other comprehensive income are reclassified to earnings in the period in which earnings are affected by the underlying hedged item. The ineffective portion of all hedges is recognized in current period earnings. If the hedging relationship ceases to be highly effective or it becomes probable that an expected transaction will no longer occur, gains or losses on the derivative are recorded in current period earnings.
	Share-based compensation: The Company estimates the fair value of share-based awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods. Share-based compensation expense related to stock options is measured using a Black-Scholes option pricing model that takes into account highly subjective and complex assumptions. The expected life of options granted is derived from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that options granted are expected to be outstanding. Expected volatility is based on a blend of historical volatility and implied volatility derived from publicly traded options to purchase the Company’s common stock, which the Company believes is more reflective of the market conditions and a better indicator of expected volatility than would be the case if the Company only used historical volatility. The risk-free interest rate is the implied yield currently available on United States Treasury zero-coupon issues with a remaining term equal to the expected life of the option.
	Share-based compensation expense for 2013, 2012 and 2011 was $11.9 million, $8.6 million and $4.5 million, respectively, and is included in selling, general and administrative expenses. The total income tax benefit recognized for share-based compensation arrangements for 2013, 2012 and 2011 was $3.8 million, $2.7 million and $2.5 million, respectively. The higher share-based compensation expense in 2013 is primarily due to the increase in the market price of the Company’s common stock.  The lower share-based compensation expense for 2011 is primarily due to stock option and restricted share forfeitures of approximately $3 million related to the separation of the Company’s former chief executive officer.
	As of December 31, 2013, unamortized share-based compensation cost related to non-vested stock options, net of expected forfeitures, was $4.4 million, which is expected to be recognized over a weighted-average period of 1.92 years. Unamortized share-based compensation cost related to non-vested shares (restricted stock), net of expected forfeitures, was $9.2 million, which is expected to be recognized over a weighted-average period of 1.81 years.
	Share-based compensation expense recognized during a period is based on the value of the portion of stock-based awards that is ultimately expected to vest during the period less estimated forfeitures. Forfeitures are required to be estimated at the time of grant. To minimize fluctuations in share-based compensation expense, management reviews and revises the estimate of forfeitures for all share-based awards on a quarterly basis based on management’s expectation of the awards that will ultimately vest. The Company issued 148,191, 178,690 and 175,291 of non-vested shares (restricted stock) in 2013, 2012 and 2011, respectively, the majority of which vest on the third anniversary of the grant date (cliff vesting).
	Income taxes: The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized to reflect the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases, and to reflect operating loss and tax credit carryforwards. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Provision has been made for income taxes on unremitted earnings of subsidiaries and affiliates, except for subsidiaries in which earnings are deemed to be permanently reinvested.
	Significant judgment is required in determining income tax provisions and in evaluating tax positions. The Company establishes additional provisions for income taxes when, despite the belief that tax positions are supportable, there remain certain positions that do not meet the minimum probability threshold, which is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of its provision for income taxes. Interest accrued related to unrecognized tax benefits and income tax related penalties are both included in taxes on income from continuing operations. The Company periodically assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, the current tax liability and deferred taxes in the period in which the facts that give rise to an adjustment become known.
	Pensions and other postretirement benefits: The Company provides a range of benefits to eligible employees and retired employees, including pensions and postretirement healthcare. The Company records annual amounts relating to these plans based on calculations which include various actuarial assumptions such as discount rates, expected rates of return on plan assets, compensation increases, turnover rates and healthcare cost trend rates. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends when appropriate. The effect of the modifications is generally amortized over future periods.
	Restructuring costs: Restructuring costs, which include termination benefits, facility closure costs, contract termination costs and other restructuring costs are recorded at estimated fair value. Key assumptions in calculating the restructuring costs include the terms and payments that may be negotiated to terminate certain contractual obligations and the timing of reductions in force.
	Revenue recognition: The Company recognizes revenues from product sales, including sales to distributors, or services provided when the following revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectability is reasonably assured. This generally occurs when products are shipped, when services are rendered or upon customers’ acceptance. Revenues are net of estimated returns and other allowances. The Company’s estimated returns and allowances are calculated based on historical experience and current trends.
	The Company’s normal policy is to accept returns only in cases in which the product is defective and covered under the Company’s standard warranty provisions. However, in the limited cases where an arrangement provides a right of return to the customer, including a distributor, the Company believes it has the ability to reasonably estimate the amount of returns based on its substantial historical experience with respect to these arrangements. The Company accrues any costs or losses that may be expected in connection with any returns in accordance with FASB Accounting Standards Codification (“ASC”) Topic 450, “Contingencies.” Revenues and cost of goods sold are reduced to reflect estimated returns.
	Allowances related to customer incentive programs, which include discounts or rebates, are estimated and provided for in the period that the related sales are recorded. These allowances are recorded as a reduction of revenue.
	The Company offers rebates to certain distributors and reserves an estimate for the rebates as a reduction of revenues at the time of sale. In estimating rebates, the Company considers the lag time between the point of sale and the payment of the distributor’s rebate claim, distributor-specific trend analyses, contractual commitments, including stated rebate rates, historical experience and other relevant information. The Company adjusts reserves to reflect differences between estimated and actual experience, and record such adjustment as a reduction of sales in the period of adjustment.  The reserve for estimated rebates was $7.8 million and $19.5 million at December 31, 2013 and 2012, respectively. The decrease in accrued rebates in 2013 as compared to 2012 was primarily due to the continued migration to a common global ERP platform, specifically, the integration of our LMA and Arrow businesses, which resulted in reduced processing lag time (from monthly to daily payments in many instances).  There were no significant changes in estimates recorded during the year.  We expect the reserve as of December 31, 2013 to be paid within 90 days subsequent to year-end.

New_Accounting_Standards

New Accounting Standards	12 Months Ended
	Dec. 31, 2013
New Accounting Standards	'
	Note 2 — New accounting standards
	Recently issued not yet effective
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has assessed these recently issued standards that are not yet effective and believes the new standards will not have a material impact on the Company’s results of operations, cash flows or financial position.
	Recently adopted
	In February 2013, the FASB issued an amendment to its accounting guidance on reporting amounts reclassified out of accumulated other comprehensive income. The guidance requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items on the face of the statement where net income is presented, or in the notes to the financial statements, if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about the effect of the reclassifications. The guidance was effective prospectively for reporting periods beginning after December 15, 2012. Refer to Note 11 to the consolidated financial statements for new disclosures resulting from the adoption of this amendment.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2013
Acquisitions	'
	Note 3 — Acquisitions
	The Company made the following acquisitions during 2013, all of which were accounted for as business combinations:
	·	On December 2, 2013, the Company acquired Vidacare Corporation, a provider of intraosseous, or inside the bone, access devices. This acquisition complements the vascular access and specialty product portfolio in the Company’s Critical Care product group.
	·	On June 11, 2013, the Company acquired the assets of Ultimate Medical Pty. Ltd. and its affiliates (“Ultimate”), a supplier of airway management devices with a related portfolio of patented products. This acquisition complements the anesthesia products in the Company’s Critical Care product group.
	·	On June 6, 2013, the Company acquired Eon Surgical, Ltd. (“Eon”), a developer of a minimally invasive microlaparoscopy surgical platform technology designed to enhance a surgeon’s ability to perform scarless surgery while producing better patient outcomes. This technology complements the product portfolio of the Company’s Surgical Care product group.
	The total fair value of consideration for the 2013 acquisitions is estimated at $307.0 million. Transaction expenses associated with these acquisitions, which are included in selling, general and administrative expenses on the consolidated statements of income (loss) were $3.8 million for the twelve months ended December 31, 2013. For the twelve month period ended December 31, 2013, the Company has recorded revenue and operating profit of $9.7 million and $2.8 million, respectively related to the businesses acquired in 2013. The results of operations of the acquired businesses and assets are included in the consolidated statements of income (loss) from their respective acquisition dates. Pro forma information is not presented as the operations of the acquired businesses are not significant to the overall operations of the Company.
	In connection with the Ultimate and Eon acquisitions, during the second quarter 2013, the Company recorded a liability and related restructuring and impairment charge of $2.8 million related to post-closing obligations associated with the acquired businesses. In the fourth quarter 2013, the Company reversed approximately $0.8 million of this liability in conjunction with the settlement of this obligation, which was paid in the first quarter 2014.
	The following table presents the preliminary fair values determination of the assets acquired and liabilities assumed in the acquisitions that occurred during 2013:
			(Dollars in millions)
	Assets
	Current assets		$	21
	Property, plant and equipment			1.4
	Intangible assets:
	Intellectual property			159.5
	Tradenames			26.5
	In-process research and development			19.9
	Customer lists			49.6
	Goodwill			123.3
	Total assets acquired			401.2
	Less:
	Current liabilities			5.4
	Deferred tax liabilities			88.8
	Liabilities assumed			94.2
	Net assets acquired		$	307
	The Company is continuing to evaluate the 2013 acquisitions. Further adjustments may be necessary as a result of the Company’s assessment of additional information related to the fair values of assets acquired and liabilities assumed, primarily related to deferred tax assets and liabilities and goodwill.
	Among the acquired assets, intellectual property has useful lives ranging from 10 to 18 years, customer lists have useful lives ranging from 16 to 27 years and finite tradenames have useful lives ranging from 1 to 30 years. IPR&D has an indefinite life and is not amortized until development of the related project is completed, at which time the IPR&D becomes an amortizable asset. If the related project is not completed in a timely manner, the Company may incur an impairment charge related to the IPR&D, calculated as the excess of the asset’s carrying value over its fair value. The goodwill resulting from the acquisitions primarily reflects the expected revenue growth attributable to anticipated increased market penetration from acquired and future products and customers. Goodwill and the step-up in basis of the intangible assets in connection with stock acquisitions are not deductible for tax purposes.
	The Company made the following acquisitions during 2012, all of which were accounted for as business combinations:
	·	On October 23, 2012, the Company acquired substantially all of the assets of LMA International N.V. (“LMA”), a global provider of laryngeal masks whose products are used in anesthesia and emergency care. On October 23, 2012, in a separate transaction, the Company also acquired the LMA branded laryngeal mask supraglottic airway business and certain other products in the United Kingdom, Ireland and Channel Islands from the shareholders of Intravent Direct Limited and affiliates. These acquisitions complement the anesthesia product portfolio in the Company’s Critical Care product group.
	·	On June 22, 2012, the Company acquired Hotspur Technologies Inc., a developer of catheter-based technologies designed to restore blood flow in patients with obstructed vessels. The acquired business complements the dialysis access product line in the Company’s Cardiac Care product group.
	·	On May 22, 2012, the Company acquired Semprus BioSciences Corp., a biomedical company that developed a long-lasting, covalently bonded, non-leaching polymer designed to reduce infections and thrombus related complications. While the Company will explore opportunities to apply this technology to a broad array of its product offerings, the initial focus for the technology is on vascular devices within the Company’s Critical Care product group. During 2013, the Company experienced unexpected difficulties with respect to the development of the Semprus technology, which the Company is currently attempting to resolve through further research and testing.  Failure to resolve these issues may result in a reduction of the expected future cash flows related to the Semprus technology and could result in recognition of impairment charges with respect to the related assets, which could be material.  As of December 31, 2013, the Company has recorded net assets in the amount of approximately $42 million related to this investment.
	·	On May 3, 2012, the Company acquired substantially all of the assets of Axiom Technology Partners, LLC (“Axiom”), constituting its EFx laparoscopic fascial closure system, which is designed for the closure of abdominal trocar defects through which access ports and instruments were used during laparoscopic surgeries. The acquired business complements the surgical closure product line in the Company’s Surgical Care product group.
	·	On April 5, 2012, the Company acquired the EZ-Blocker product line, a single-use catheter used to perform lung isolation and one-lung ventilation. The acquisition of this product line complements the anesthesia product portfolio in the Company’s Critical Care product group.
	In connection with the acquisitions, the Company agreed to pay contingent consideration based on the achievement of specified objectives, including the receipt of regulatory approvals and achievement of sales targets. The aggregate fair value of consideration for the 2012 acquisitions, based on the estimated fair values at the respective acquisition dates, was estimated at $422.2 million, which included the initial payments of $367.9 million in cash and the estimated fair value of the contingent consideration of $55.8 million, partially offset by a $1.5 million favorable working capital adjustment. The Company recorded $227.5 million of intangible assets and $153.0 million of goodwill related to these acquisitions. As of December 31, 2013, the Company has made aggregate contingent consideration payments of $27 million related to these acquisitions. The range of remaining undiscounted contingent consideration the Company could be required to pay is zero to $62 million. For further information on contingent consideration, see Note 10 to the consolidated financial statements.

Restructuring_and_other_impair

Restructuring and other impairment charges	12 Months Ended
	Dec. 31, 2013
Restructuring and other impairment charges	'
	Note 4 — Restructuring and other impairment charges
	The amounts recognized in restructuring and other impairment charges for the twelve months ended December 31, 2013, 2012 and 2011 consisted of the following:
			2013				2012				2011
			(Dollars in thousands)
	LMA restructuring program		$	12,152			$	2,515			$	—
	2013 restructuring charges			10,230				—				—
	2012 restructuring charges			4,229				2,459				—
	2011 restructuring program			770				—				3,047
	2007 Arrow integration program			230				(1,937	)			461
	In-process research and development impairment			7,381				—				—
	Long-lived asset impairment			3,460				—				—
	Investments in affiliates impairment			—				—				2,497
	Restructuring and other impairment charges		$	38,452			$	3,037			$	6,005
	LMA Restructuring Program
	In connection with the acquisition of LMA in 2012, the Company formulated a plan related to the integration of LMA and the Company’s businesses. The integration plan focuses on the closure of LMA corporate functions and the consolidation of manufacturing, sales, marketing, and distribution functions in North America, Europe and Asia.
	The charges associated with this restructuring program that are included in restructuring and other impairment charges for the twelve months ended December 31, 2013 and 2012 were as follows:
			2013				2012
			(Dollars in thousands)
	Termination benefits		$	3,282			$	2,229
	Facility closure costs			788				—
	Contract termination costs			7,906				274
	Other restructuring costs			176				12
			$	12,152			$	2,515
	A reconciliation of the changes in accrued liabilities associated with the LMA restructuring program from the inception of the program through December 31, 2013 is set forth in the following table:
			Termination							Contract			Other			Total
			benefits							Termination			Restructuring
						Facility Closure Costs				Costs			Costs
			(Dollars in thousands)
	Balance at December 31, 2011		$	—		$	—			$	—		$	—		$	—
	Subsequent accruals			2,229			—				274			12			2,515
	Cash payments			(488	)		—				—			—			(488	)
				3			—				3			—			6
	Foreign currency translation
	Balance at December 31, 2012			1,744			—				277			12			2,033
	Subsequent accruals			3,282			788				7,906			176			12,152
	Cash payments			(4,461	)		(362	)			(4,560	)		(164	)		(9,547	)
	Foreign currency translation			(13	)		1				63			(8	)		43
	Balance at December 31, 2013		$	552		$	427			$	3,686		$	16		$	4,681
	Aside from nominal facility closure costs anticipated in 2014, the Company does not expect to incur additional costs associated with this program. The Company expects to complete this project in 2014.
	2013 Restructuring Charges
	In 2013, the Company initiated programs to consolidate certain administrative and manufacturing facilities in North America and warehouse facilities in Europe and terminate certain European distributor agreements in an effort to reduce costs. The Company estimates that it will incur an aggregate of up to approximately $11 million in restructuring and other impairment charges over the term of this restructuring program. Of this amount, $5 million relates to employee termination costs, $3 million relates to termination of certain distributor agreements and $3 million relates to facility closures costs and other actions. The charges associated with this restructuring program that are included in restructuring and other impairment charges for the twelve months ending December 31, 2013 were as follows:
			2013
			(Dollars in thousands)
	Termination benefits		$	4,787
	Contract termination costs			3,326
	Other restructuring costs			2,117
			$	10,230
	As of December 31, 2013, the Company has a reserve of $4.2 million in connection with these projects. The Company expects to complete this program in 2015.
	2012 Restructuring Charges
	In 2012, the Company identified opportunities to improve its supply chain strategy by consolidating its three North American warehouses into one centralized warehouse, lower costs and improve operating efficiencies through the termination of certain distributor agreements in Europe, the closure of certain North American facilities and workforce reductions. The charges associated with this restructuring program that are included in restructuring and other impairment charges for the twelve months ending December 31, 2013 and 2012 were as follows:
			2013				2012
			(Dollars in thousands)
	Termination benefits		$	2,993			$	1,681
	Facility closure costs			935				—
	Contract termination costs			296				758
	Other restructuring costs			5				20
			$	4,229			$	2,459
	The Company expects to complete the projects over a one year period and does not anticipate incurring additional costs associated with this program.
	2011 Restructuring Program
	In 2011, the Company initiated a restructuring program at three facilities to consolidate operations and reduce costs. In connection with this program, the Company recorded contract termination costs of approximately $2.6 million associated with a lease termination, as the Company had vacated 50% of the premises during 2011. In addition, the Company recorded approximately $0.4 million for employee termination benefits in connection with workforce consolidations. In the fourth quarter 2013, the Company recorded an additional $0.8 million in contract termination costs and has completely exited the leased facility. This program was completed in 2013.
	2007 Arrow Integration Program
	In connection with the Company’s acquisition of Arrow International, Inc. (“Arrow”), the Company implemented a program in 2007 to integrate Arrow’s businesses into the Company’s other businesses. The aspects of this program that affected Teleflex employees and facilities (such aspects being referred to as the “2007 Arrow integration program”) were charged to earnings and classified as restructuring and impairment charges.
	The charges associated with the 2007 Arrow integration program that were included in restructuring and other impairment charges for the years ended December 31, 2013, 2012, and 2011 were $0.2 million, $(1.9) million and $0.5 million, respectively. The net credit recorded during the year ended December 31, 2012 was primarily the result of the reversal of contract termination costs related to a settlement of a dispute involving the termination of a European distributor agreement that was established in connection with the acquisition of Arrow. This program was completed in 2013.
Impairment Charges
The Company incurred the following asset impairment charges during 2013, 2012 and 2011. These asset impairments were measured at fair value using significant unobservable inputs that are categorized as Level 3 under the fair value hierarchy, which is described in Note 10 to the consolidated financial statements.
·	During the fourth quarter 2013, the Company recorded a $2.9 million IPR&D charge upon the decision to abandon a research and development project associated with the Company’s vascular business.
·	During the third quarter 2013, the Company recorded $3.5 million in impairment charges related to assets held for sale that had a carrying value in excess of their appraised fair value.
·	During the first quarter 2013, the Company recorded a $4.5 million IPR&D charge pertaining to a research and development project associated with the Axiom acquisition because technological feasibility had not yet been achieved and the Company determined that the subject technology had no future alternative use.
·	During 2011, the Company recognized impairment charges of $2.5 million related to the decline in value of its investments in affiliates that are considered to be other than temporary. In making this determination, the Company considered multiple factors, including its intent and ability to hold investments, operating losses of investees that demonstrate an inability to recover the carrying value of the investments, the investee’s liquidity and cash position and market acceptance of the investee’s products and services.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2013
Inventories	'
	Note 5 — Inventories
	Inventories at December 31, 2013 and 2012 consisted of the following:
		2013			2012
		(Dollars in thousands)
	Raw materials	$	70,209		$	84,636
	Work-in-process		53,672			47,440
	Finished goods		242,113			222,974
			365,994			355,050
	Less: Inventory reserves		(32,373	)		(31,703	)
	Inventories, net	$	333,621		$	323,347

Property_Plant_and_Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment	'
	Note 6 — Property, plant and equipment
	The major classes of property, plant and equipment, at cost, at December 31, 2013 and 2012 are as follows:
		2013			2012
		(Dollars in thousands)
	Land, buildings and leasehold improvements	$	199,741		$	201,155
	Machinery and equipment		322,060			313,325
	Computer equipment and software		102,527			70,618
	Construction in progress		55,092			41,424
			679,420			626,522
	Less: Accumulated depreciation		(353,520	)		(328,577	)
	Property, plant and equipment, net	$	325,900		$	297,945

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2013
Goodwill and Other Intangible Assets	'
	Note 7 — Goodwill and other intangible assets
	Changes in the carrying amount of goodwill, by reporting segment, for the twelve months ended December 31, 2013 and 2012 are as follows:
			Americas			EMEA			Asia			Total
			Segment			Segment			Segment
			(Dollars in thousands)
	Balance as of December 31, 2012
	Goodwill		$	1,077,829		$	353,282		$	139,469		$	1,570,580
	Accumulated impairment losses			(332,128	)		—			—			(332,128	)
				745,701			353,282			139,469			1,238,452
	Goodwill related to acquisitions			99,125			19,922			4,237			123,284
	Translation adjustment			(833	)		2,217			(8,917	)		(7,533	)
	Balance as of December 31, 2013
	Goodwill			1,176,121			375,421			134,789			1,686,331
	Accumulated impairment losses			(332,128	)		—			—			(332,128	)
			$	843,993		$	375,421		$	134,789		$	1,354,203
			Americas			EMEA			Asia			OEM			Total
			Segment			Segment			Segment			Segment
			(Dollars in thousands)
	Goodwill balance as of December 31, 2011		$	1,005,021		$	283,362		$	121,983		$	28,176		$	1,438,542
	Goodwill impairment charges			(332,128	)		—			—			—			(332,128	)
	Goodwill related to acquisitions			78,875			69,723			15,384			—			163,982
	Goodwill related to dispositions			—			—			—			(28,176	)		(28,176	)
	Purchase accounting adjustments(1)			(8,878	)		—			(2,126	)		—			(11,004	)
	Translation adjustment			2,132			876			4,228			—			7,236
	Transfer of goodwill			679			(679	)		—			—			—
	Balance as of December 31, 2012
	Goodwill			1,077,829			353,282			139,469			—			1,570,580
	Accumulated impairment losses			(332,128	)		—			—			—			(332,128	)
			$	745,701		$	353,282		$	139,469		$	—		$	1,238,452
	-1	Purchase accounting adjustments related to the finalization of the purchase price allocation of uncertain tax positions and deferred taxes for the LMA acquisition. The purchase accounting adjustments were completed in 2013, however, in accordance with ASC Topic 805, “Business Combinations,” the Company retrospectively adjusted the December 31, 2012 balance sheet, as well as the Condensed Consolidating Balance Sheet included in Note 17, for these adjustments as the acquisition occurred in 2012.
	In the first quarter 2012, due to a change in the Company’s reporting structure, the Company performed goodwill impairment tests and determined that three of the reporting units in the North America segment were impaired. The Company recorded goodwill impairment charges of $220 million in the Vascular reporting unit, $107 million in the Anesthesia/Respiratory reporting unit and $5 million in the Cardiac reporting unit. The goodwill impairment charges were determined based upon the amount by which the goodwill carrying values exceed its fair value. The fair value of the goodwill was measured using significant unobservable inputs that are categorized as Level 3 under the fair value hierarchy, which is described under Note 10 to the consolidated financial statements.
	Intangible assets at December 31, 2013 and 2012 consisted of the following:
			Gross Carrying Amount						Accumulated Amortization
			2013			2012			2013			2012
			(Dollars in thousands)
	Customer lists		$	628,020		$	580,151		$	(168,223	)	$	(141,520	)
	In-process research and development			68,786			53,157			—			—
	Intellectual property			435,869			276,458			(118,086	)		(95,967	)
	Distribution rights			16,797			16,567			(14,592	)		(13,880	)
	Trade names			407,879			384,131			(1,148	)		(305	)
	Noncompete agreements			337			—			(42	)		—
			$	1,557,688		$	1,310,464		$	(302,091	)	$	(251,672	)
	Trade names of $371.6 million and in-process research and development of $68.8 million are considered indefinite lived. Acquired in-process research and development is indefinite-lived until the completion of the associated efforts, at which point amortization of the carrying value of the technology will commence.
	Amortization expense related to intangible assets was $50.6 million, $44.3 million, and $42.6 million for 2013, 2012 and 2011, respectively. Estimated annual amortization expense for each of the five succeeding years is as follows:
			(Dollars in thousands)
	2014		$	59,100
	2015			53,300
	2016			52,900
	2017			52,400
	2018			51,900

Borrowings

Borrowings	12 Months Ended
	Dec. 31, 2013
Borrowings	'
	Note 8 — Borrowings
	The components of long-term debt at December 31, 2013 and 2012 are as follows:
			2013			2012
			(Dollars in thousands)
	Senior Credit Facility:
	Revolving credit facility, at a rate of 1.92% at December 31, 2013, due 7/16/2018		$	680,000		$	—
	Term loan facility, at a rate of 2.75% at December 31, 2012			—			375,000
	3.875% Convertible Senior Subordinated Notes			400,000			400,000
	6.875% Senior Subordinated Notes due 2019			250,000			250,000
				1,330,000			1,025,000
	Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes			(48,413	)		(59,720	)
				1,281,587			965,280
	Current portion of borrowings			(351,587	)		—
			$	930,000		$	965,280
	Senior Credit Facility
	On July 16, 2013, the Company replaced its $775 million senior credit facility comprised of a $375 million term loan and a $400 million revolving credit facility with a new $850 million senior credit facility consisting solely of a revolving credit facility. In connection with this transaction, the Company incurred transaction fees of $6.4 million, which were recorded as a deferred asset and are being amortized over the term of the facility. Additionally, during the third quarter of 2013, in connection with the early repayment of its $375 million term loan, the Company recognized expense of approximately $1.3 million resulting from the write-off of unamortized debt issuance costs. The Company borrowed $382.0 million at the inception of the new $850 million senior credit facility. During the fourth quarter 2013, the Company borrowed an additional $298.0 million under the senior credit facility to fund the purchase of the Vidacare business.  See Note 3 to the consolidated financial statements.
	The new $850 million senior credit facility bears interest at an applicable rate elected by the Company generally equal to either the “base rate” (the greater of either the federal funds effective rate plus 0.5%, the prime rate or one month LIBOR plus 1.0%) plus an applicable margin of 0.25% to 1.00%, or a “LIBOR rate” for the period corresponding to the applicable interest period of the borrowings plus an applicable margin of 1.25% to 2.00%. As of December 31, 2013, the interest rate on the $850 million senior credit facility was 1.92% (comprised of the LIBOR rate of 0.17% plus a margin of 1.75%). The obligations under the senior credit facility are guaranteed (subject to certain exceptions) by substantially all of the material domestic subsidiaries of the Company and (subject to certain exceptions and limitations) secured by a pledge on substantially all of the equity interests owned by the Company and each guarantor.
	Convertible Notes
	On August 9, 2010, the Company issued $400.0 million of 3.875% Convertible Senior Subordinated Notes (the “Convertible Notes”). The Company pays interest on the Convertible Notes semi-annually on February 1 and August 1 of each year at a rate of 3.875% per year. The Convertible Notes mature on August 1, 2017. The Convertible Notes are the Company’s unsecured senior subordinated obligations and are (i) not guaranteed by any of the Company’s subsidiaries; (ii) subordinated in right of payment to all of the Company’s existing and future senior indebtedness; and (iii) junior to the Company’s existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.
	The Convertible Notes are convertible at the option of the holder upon the occurrence of any of the following circumstances (i) during any fiscal quarter, if the last reported sales price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter exceeds 130% of the conversion price on each applicable trading day; or (ii) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Notes is less than 98% of the product of the last reported sale price of the common stock and the applicable conversion rate on each trading day during the measurement period; or (iii) upon the occurrence of specified corporate events; or (iv) at any time on or after May 1, 2017 up to and including July 28, 2017. The Convertible Notes are convertible at a conversion rate of 16.3084 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to a conversion price of approximately $61.32. The conversion rate is subject to adjustment upon certain events. Upon conversion, the Company’s conversion obligation may be satisfied, at the Company’s option, in shares of common stock, cash or a combination of cash and shares of common stock. The Company has elected a net-settlement method to satisfy its conversion obligation. Under the net-settlement method, the Company may settle the $1,000 principal amount of the Convertible Notes in cash and settle the excess conversion value in shares, plus cash in lieu of fractional shares.
	During the fourth quarter 2013, the Company’s closing stock price exceeded the 130% threshold described in clause (i) above; accordingly the Convertible Notes were classified as a current liability as of December 31, 2013. The determination of whether or not the Convertible Notes are convertible as described above is made each quarter until maturity or conversion.  Consequently, the Convertible Notes may not be convertible in one or more future quarters, in which case the Convertible Notes would again be classified as long-term debt, unless one of the other conversion events described above were to occur. While the Company believes it has sufficient liquidity to repay the principal amounts due through a combination of utilizing our existing cash on hand and accessing our credit facility, our use of these funds could adversely affect our results of operations and liquidity.
	In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions with two counterparties pursuant to which it purchased call options for $88.0 million ($56.0 million net of tax) in private transactions. The call options enable the Company to receive, in effect for no additional consideration, shares of the Company’s common stock and/or cash from counterparties equal to the amounts of common stock and/or cash related to the excess value over the conversion price that it would pay to the holders of the Convertible Notes upon conversion. These call options will terminate upon the earlier of July 28, 2017 or the first day all of the related Convertible Notes are no longer outstanding due to conversion or otherwise.
	The Company also entered into privately negotiated warrant transactions with the same counterparties generally relating to the same number of shares of common stock with each of the option counterparties. Under certain circumstances, the Company may be required under the terms of the warrant transactions to issue up to 7,981,422 shares of common stock (subject to adjustments). The warrants have been divided into components that expire ratably over a 180 day period commencing November 1, 2017. The strike price of the warrants is approximately $74.65 per share of common stock, subject to customary anti-dilution adjustments. Proceeds received from the issuance of the warrants totaled approximately $59.4 million.
	The convertible note hedge and warrant transactions described above are intended to reduce the potential dilution with respect to the Company’s common stock and/or reduce the Company’s exposure to potential cash payments that the Company may be required to make upon conversion of the Convertible Notes by, in effect, increasing the conversion price, from the Company’s economic standpoint, to $74.65 per share. However, the warrant transactions could have a dilutive effect with respect to the common stock or, if the Company so elects, obligate the Company to make cash payments to the extent that the market price per share of common stock exceeds $74.65 per share on any expiration date of the warrants.
	The Company allocated the proceeds of the Convertible Notes between the liability and equity components of the debt. The initial $316.3 million liability component was determined based on the fair value of a similar debt instrument excluding the conversion feature. The initial $83.7 million ($53.3 million net of tax) equity component represented the difference between the fair value or carrying value of $316.3 million of the debt and the $400.0 million of proceeds. The related debt discount of $83.7 million will be amortized under the interest method over the remaining life of the Convertible Notes, which, at December 31, 2013, is approximately 3.6 years. An effective interest rate of 7.814% was used to calculate the debt discount on the Convertible Notes. The following table provides interest expense amounts related to the Convertible Notes for the periods presented:
	(in millions)		Year Ended			Year Ended			Year Ended
			December 31, 2013			December 31, 2012			December 31, 2011
	Interest cost related to contractual interest coupon		$	15.5		$	15.5		$	15.5
	Interest cost related to amortization of the discount		$	11.3		$	10.5		$	9.7
	The following table provides the carrying value of the Convertible Notes as of December 31, 2013 and 2012:
	(in millions)		December 31, 2013			December 31, 2012
	Principal amount of the Convertible Notes		$	400		$	400
	Unamortized discount			(48.4	)		(59.7	)
	Net carrying amount		$	351.6		$	340.3
	6.875% Senior Subordinated Notes
	On June 13, 2011, the Company issued $250.0 million of 6.875% Senior Subordinated Notes due 2019 (the “Notes”). The Company pays interest on the Notes semi-annually on June 1 and December 1. The Notes will mature on June 1, 2019, unless earlier redeemed or purchased by the Company at the holder’s option under specified circumstances following a Change of Control or Asset Sale (each as defined in the Indenture) or upon the Company’s election to exercise its optional redemption rights, as described below. The Company incurred transaction fees of approximately $3.7 million, including underwriters’ discounts and commissions in connection with the public offering of the Notes. The Company used $125 million of the proceeds to repay term loan borrowings under its senior credit facility and recorded a $0.8 million write-off of unamortized debt issuance costs as a loss on extinguishment of debt in the second quarter 2011.
	The Notes constitute the Company’s general unsecured senior subordinated obligations and are subordinated in right of payment to all of the Company’s existing and future senior indebtedness, including the Company’s indebtedness under its senior credit facilities, and will be equal in right of payment with all of the Company’s existing and future senior subordinated indebtedness, including the Company’s 3.875% Convertible Senior Subordinated Notes. The obligations under the Notes are guaranteed, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is a guarantor or other obligor under the Company’s senior credit facilities and by certain of the Company’s other domestic subsidiaries. The guarantees are full and unconditional, subject to certain customary automatic release provisions. The guarantees of the Notes will be subordinated in right of payment to all of the existing and future senior indebtedness of such Guarantors and will be equal in right of payment with all of the future senior subordinated indebtedness of such Guarantors. The Notes and the guarantees will be junior to the existing and future secured indebtedness of the Company and the Guarantors to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all of the existing and future indebtedness and other liabilities of the Company’s non-guarantor subsidiaries.
	At any time on or after June 1, 2015, the Company may redeem some or all of the Notes at a redemption price of 103.438% of the principal amount of the Notes subject to redemption, declining to 100% of the principal amount on June 1, 2017, plus accrued and unpaid interest. In addition, at any time prior to June 1, 2015, the Company may, on one or more occasions, redeem some or all of the Notes at a redemption price equal to 100% of the principal amount of the Notes redeemed plus a “make-whole” premium and any accrued and unpaid interest. The “make-whole” premium is the greater of (i) 1.0% of the principal amount of the Notes subject to redemption or (ii) the excess, if any, over the principal amount of the notes of the present value, on the redemption date, of the sum of (a) the June 1, 2015 optional redemption price, plus (b) all required interest payments on the Notes through June 1, 2015 (other than accrued and unpaid interest to the redemption date), calculated based on a specified Treasury rate for the period most closely corresponding to the period from the redemption date to June 1, 2015, plus 50 basis points. In addition, at any time prior to June 1, 2014, the Company may redeem up to 35% of the aggregate principal amount of the Notes, using the proceeds of certain specified Company equity offerings, at a redemption price equal to 106.875% of the principal amount of the Notes redeemed, plus accrued and unpaid interest.
	Interest Rate Swap
	In 2011, the Company terminated its interest rate swap agreement that, at the date of termination, had a notional amount of $350 million. The interest rate swap was designated as a cash flow hedge against the previously outstanding term loan under the Company’s senior credit facility. At the date of termination, the interest rate swap was in a liability position resulting in a cash payment by the Company to the counterparties of approximately $14.8 million, which included $3.1 million of accrued interest. The cash flows from the termination of the interest rate swap have been reported as an operating activity in the consolidated statements of cash flows. As of December 31, 2012, all unrealized losses within accumulated other comprehensive income (“AOCI”) associated with this interest rate swap were reclassified into earnings.
	Fair Value of Long-Term Debt
	The carrying amount of long-term debt reported in the consolidated balance sheet as of December 31, 2013 is $1,281.6 million. The Company uses a discounted cash flow technique that incorporates a market interest yield curve with adjustments for duration, optionality, and risk profile to determine the fair value of its debt. The Company’s implied credit rating is a factor in determining the market interest yield curve. The following table provides the fair value of the Company’s debt by fair value hierarchy level (see Note 10 to the consolidated financial statements further information) as of December 31, 2013 and 2012:
			Fair value of debt
			December 31, 2013			December 31, 2012
				(Dollars in thousands)
	Level 1		$	899,390		$	782,377
	Level 2			644,012			382,634
	Total		$	1,543,402		$	1,165,011
	Securitization Program
	The Company has an accounts receivable securitization facility under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of Teleflex. Accordingly, the assets of the SPE are not available to satisfy the obligations of Teleflex or any of its subsidiaries. The SPE then sells undivided interests in those receivables to an asset backed commercial paper conduit for consideration of up to $50.0 million. As of December 31, 2013, the maximum amount available for borrowing under this facility was $43.9 million. This facility is utilized from time to time for increased flexibility in funding short term working capital requirements. The agreement governing the accounts receivable securitization facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this facility may give rise to the right of its counterparty to terminate this facility. As of December 31, 2013 and 2012, the Company had $4.7 million of outstanding borrowings under its accounts receivable securitization facility.
	Debt Maturities
	As of December 31, 2013, the aggregate amounts of long-term debt, demand loans and debt under the Company’s securitization program that will mature during each of the next four fiscal years and thereafter were as follows:
			(Dollars in thousands)
	2014(1)		$	404,700
	2015			—
	2016			—
	2017			—
	2018 and thereafter			930,000
	-1	The Convertible Senior Subordinated Notes are included in amounts that will mature in 2014 due to the trigger of the conversion feature, which is described in more detail in the “Convertible Notes” section above.

Financial_instruments

Financial instruments	12 Months Ended
	Dec. 31, 2013
Financial Instruments	'
	Note 9 — Financial instruments
	The Company uses derivative instruments for risk management purposes. Forward rate contracts are used to manage foreign currency transaction exposure. These derivative instruments are designated as cash flow hedges and are recorded on the balance sheet at fair market value. The effective portion of the gains or losses on derivatives is reported as a component of other comprehensive income and thereafter is recognized in the statement of income (loss) in the period or periods during which the hedged transaction affects earnings. Gains and losses on the derivatives representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. As of December 31, 2013, the Company had no open forward rate contracts. See Note 10 to the consolidated financial statements.
	The following table presents the balance sheet location and fair values of derivative instruments designated as hedging instruments in the consolidated balance sheet as of December 31, 2013 and 2012:
		December 31, 2013			December 31, 2012
		Fair Value			Fair Value
		(Dollars in thousands)
	Asset derivatives:
	Foreign currency exchange contracts
	Other assets – current	$	—		$	1,279
	Total asset derivatives	$	—		$	1,279
	Liability derivatives:
	Foreign currency exchange contracts
	Derivative liabilities – current	$	—		$	598
	Total liability derivatives	$	—		$	598
	The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (“OCI”) for the years ended December 31, 2013, 2012 and 2011:
		After Tax Gain/(Loss)
		Recognized in OCI
		2013			2012			2011
		(Dollars in thousands)
	Interest rate swap	$	—		$	7,032		$	8,330
	Foreign currency exchange contracts		381			(156	)		(325	)
	Total	$	381		$	6,876		$	8,005
	See Note 11 to the consolidated financial statements for information on the location and amount of gains and losses attributable to derivatives that were reclassified from accumulated other comprehensive income (“AOCI”) to expense (income), net of tax.
	For the years ended December 31, 2013, 2012 and 2011, there was no ineffectiveness related to the Company’s derivatives.
	During 2012, the Company entered into forward exchange contracts for Singapore dollars and US dollars in anticipation of the acquisition of substantially all of the assets of LMA. In accordance with applicable accounting guidance, a forecasted transaction is not eligible for hedge accounting if the forecasted transaction involves a business combination. Therefore, gains and losses relating to this arrangement were recognized as incurred. The Company realized a pre-tax loss of $7.6 million upon settlement of the forward exchange contracts. See Note 3 to the consolidated financial statements for additional information on the LMA acquisition.
	In 2011, the Company terminated its interest rate swap covering a notional amount of $350 million designated as a hedge against the variability of the cash flows in the interest payments under the Company’s term loan. As of December 31, 2012, all unrealized losses within AOCI associated with this interest rate swap had been reclassified into earnings. See Note 8 to the consolidated financial statements for additional information on the termination of the interest rate swap.
	Concentration of Credit Risk
	Concentration of credit risk with respect to trade accounts receivable is generally limited due to the Company’s large number of customers and their diversity across many geographic areas. A portion of the Company’s trade accounts receivable outside the United States, however, include sales to government-owned or supported healthcare systems in several countries which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries’ economies.
	In the ordinary course of business, the Company grants non-interest bearing trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all of its customer relationships, (ii) performs ongoing credit evaluations of its customers’ financial condition, (iii) monitors the payment history and aging of its customers’ receivables, and (iv) monitors open orders against an individual customer’s outstanding receivable balance.
	An allowance for doubtful accounts is maintained for accounts receivable based on the Company’s historical collection experience and expected collectability of the accounts receivable, considering the period an account is outstanding, the financial position of the customer and information provided by credit rating services. The adequacy of this allowance is reviewed each reporting period and adjusted as necessary.
	In light of the disruptions in global economic markets, the Company instituted enhanced measures, within countries where the Company has collectability concerns, to facilitate customer-by-customer risk assessment when estimating the allowance for doubtful accounts. Such measures included, among others, monthly credit control committee meetings, at which customer credit risks are identified after review of, among other things, accounts that exceed specified credit limits, payment delinquencies and other customer issues. In addition, for some of the Company’s non-government customers, the Company instituted measures designed to reduce its risk exposures, including issuing dunning letters, reducing credit limits, requiring that payments accompany orders and instituting legal action with respect to delinquent accounts. With respect to government customers, the Company evaluates receivables for potential collection risks associated with the availability of government funding and reimbursement practices.
	Some of the Company’s customers, particularly in Europe, have extended or delayed payments for products and services already provided. Collectability concerns regarding the Company’s accounts receivable from these customers, for the most part in Greece, Italy, Spain and Portugal resulted in an increase in the allowance for doubtful accounts related to these countries. If the financial condition of these customers or the healthcare systems in these countries deteriorate such that the ability of an increasing number of customers to make payments is uncertain, additional allowances may be required in future periods. The aggregate net current and long-term accounts receivables for Spain, Italy, Greece and Portugal and the percentage of the Company’s total net current and long-term accounts receivables represented by the net current and long-term accounts receivables in those countries at December 31, 2013 and 2012 are as follows:
		December 31, 2013			December 31, 2012
		(Dollars in thousands)
	Current and long-term accounts receivable (net of allowances of $7.9 million and $6.3 million in 2013 and 2012, respectively) in Spain, Italy, Greece and Portugal	$	97,852		$	101,009
	Percentage of total net current and long-term accounts receivables		31	%		34	%
	For the years ended December 31, 2013, 2012 and 2011, net revenues to customers in Spain, Italy, Greece and Portugal were $142.6 million, $132.5 million and $138.4 million, respectively.

Fair_Value_Measurement

Fair Value Measurement	12 Months Ended
	Dec. 31, 2013
Fair Value Measurement	'
	Note 10 — Fair value measurement
	Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes a three-level hierarchy, which maximizes the use of observable inputs and minimizes the use of unobservable inputs used in measuring fair value. The levels within the hierarchy are as follows:
	Level 1 inputs — quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
	Level 2 inputs — inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 2 inputs include:
	1	Quoted prices for similar assets or liabilities in active markets.
	2	Quoted prices for identical or similar assets or liabilities in markets that are not active.
	3	Inputs other than quoted prices that are observable for the asset or liability.
	4	Inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	Level 3 inputs — unobservable inputs for the asset or liability. Unobservable inputs may be used to measure fair value only when observable inputs are not available. Unobservable inputs reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability in achieving the fair value measurement objective of an exit price perspective. An exit price is the price that would be received to sell an asset or paid to transfer a liability.
	The following tables provide information regarding the financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2013 and 2012:
		Total carrying				Quoted prices in				Significant		Significant
		value at				active markets				other		unobservable
		December 31,				(Level 1)				observable		inputs (Level 3)
		2013								inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	6,150			$	6,150			$	—	$	—
	Contingent consideration liabilities		20,313				—				—		20,313
		Total carrying				Quoted prices in				Significant		Significant
		value at				active markets				other		unobservable
		December 31,				(Level 1)				observable		inputs (Level 3)
		2012								inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	4,785			$	4,785			$	—	$	—
	Derivative assets		1,279				—				1,279		—
	Derivative liabilities		598				—				598		—
	Contingent consideration liabilities		51,196				—				—		51,196
	There were no transfers of financial assets or liabilities carried at fair value among Level 1, Level 2 or Level 3 within the valuation hierarchy during the twelve months ended December 31, 2013 or 2012.
	The following table provides information regarding changes in Level 3 financial liabilities related to contingent consideration in connection with various Company acquisitions, including those described in Note 3 to the consolidated financial statements during the twelve months ended December 31, 2013 and 2012:
			Contingent consideration
			2013				2012
			(Dollars in thousands)
	Beginning balance – January 1		$	51,196			$	9,676
	Initial estimate upon acquisition			—				58,895
	Payment			(18,880	)			(18,426	)
	Revaluations			(11,982	)			1,055
	Translation adjustment			(21	)			(4	)
	Ending balance – December 31		$	20,313			$	51,196
	The Company reduced contingent consideration liabilities and selling, general and administrative expense by $12.3 million for the year ended December 31, 2013 after determining that certain conditions for the payment of certain contingent consideration would not be satisfied.
	See Note 8 to the consolidated financial statements for a discussion of the fair value of the Company’s long-term debt.
	Valuation Techniques Used to Determine Fair Value
	The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to satisfy benefit obligations under Company benefit plans and other arrangements. The investment assets of the trust are valued using quoted market prices.
	The Company’s financial assets and liabilities valued based upon Level 2 inputs are comprised of foreign currency forward contracts. The Company uses forward rate contracts to manage currency transaction exposure. The fair value of the foreign currency forward contracts represents the amount required to enter into offsetting contracts with similar remaining maturities based on quoted market prices. The Company has taken into account the creditworthiness of the counterparties in measuring fair value. See Note 9 to the consolidated financial statements for additional information.
	The Company’s financial liabilities valued based upon Level 3 inputs are comprised of contingent consideration arrangements pertaining to the Company’s acquisitions. The Company accounts for contingent consideration in accordance with applicable accounting guidance pertaining to business combinations. In connection with several of its acquisitions, the Company agreed to pay contingent consideration upon the achievement of specified objectives, including receipt of regulatory approvals, achievement of sales targets and, in some instances, the passage of time (collectively, “milestone payments”), and therefore recorded contingent consideration liabilities at the time of the acquisitions. The Company is required to reevaluate the fair value of contingent consideration each reporting period based on new developments and record changes in fair value until such consideration is satisfied through payment upon the achievement of the specified objectives or is no longer payable due to failure to achieve the specified objectives.
	It is estimated that milestone payments will occur in 2014 and may extend until 2018 or later. As of December 31, 2013, the range of undiscounted amounts the Company could be required to pay for contingent consideration arrangements is between zero and $77 million. The Company determines the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the valuation hierarchy. The fair value of the contingent consideration liability associated with future milestone payments is based on several factors including:
	·	estimated cash flows projected from the success of market launches;
	·	the estimated time and resources needed to complete the development of acquired technologies;
	·	the uncertainty of obtaining regulatory approvals within the required time periods; and
	·	the risk adjusted discount rate for fair value measurement.
	The following table provides information regarding the valuation techniques and inputs used in determining the fair value of the contingent consideration liabilities categorized as Level 3 measurements:
			Valuation Technique		Unobservable Input		Range (Weighted Average)
	Contingent consideration		Discounted cash flow		Discount rate			1% - 10% (6%)
					Probability of payment			0 - 100% (31%)
	As of December 31, 2013, of the $20.3 million of total recorded liabilities for contingent consideration, the Company has recorded approximately $4.1 million in Current portion of contingent consideration and the remaining $16.2 million in Other liabilities.

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2013
Shareholders' Equity	'
	Note 11 — Shareholders’ equity
	The authorized capital of the Company is comprised of 200 million common shares, $1 par value, and 500,000 preference shares. No preference shares have been outstanding during the last three years.
	In 2007, the Company’s Board of Directors authorized the repurchase of up to $300 million of outstanding Company common stock. Repurchases of Company stock under the Board authorization may be made from time to time in the open market and may include privately-negotiated transactions as market conditions warrant and subject to regulatory considerations. The stock repurchase program has no expiration date and the Company’s ability to execute on the program will depend on, among other factors, cash requirements for acquisitions, cash generation from operations, debt repayment obligations, market conditions and regulatory requirements. In addition, under the Company’s senior credit agreements, the Company is subject to certain restrictions relating to its ability to repurchase shares in the event the Company’s consolidated leverage ratio (generally, the ratio of Consolidated Total Indebtedness to Consolidated EBITDA, as defined in the senior credit agreements) exceeds certain levels, which may limit the Company’s ability to repurchase shares under this Board authorization. Through December 31, 2013, no shares have been purchased under this Board authorization.
	Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased for dilutive securities. The difference between basic and diluted weighted average common shares results from the assumption that dilutive stock options were exercised. The following table provides a reconciliation of basic to diluted weighted average shares outstanding:
			2013		2012				2011
			(Shares in thousands)
	Basic		41,105			40,859				40,501
	Dilutive effect of share based awards		410			—				287
	Dilutive effect of 3.875% Convertible Notes and warrants		2,178			—				13
	Diluted		43,693			40,859				40,801
	Weighted average shares that were antidilutive and therefore not included in the calculation of earnings per share were approximately 7.7 million, 9.0 million and 8.8 million for the twelve months ended December 31, 2013, 2012 and 2011, respectively.
	Under the terms of the Convertible Notes the Company elected the net settlement method to satisfy its conversion obligation.  Under the net-settlement method, the Company may settle the principal amount of the Convertible Notes in cash and settle the excess conversion value in shares, plus cash in lieu of fractional shares. The excess conversion shares are included in the dilutive net income per share calculation using the treasury stock method during a fiscal quarter following an immediately preceding fiscal quarter in which the last reported sales price of our common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of such preceding fiscal quarter is above the applicable conversion price of the Convertible Notes, or $61.32 per share; the impact of conversion may be dilutive. In these periods, under the treasury stock method, we calculate the number of shares issuable under the terms of these notes based on the average market price of the stock during the period, and include that number in the total diluted shares outstanding for the period.
	In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge and warrant agreements. The convertible note hedge economically reduces the dilutive impact of the Convertible Notes. However, because the Company separately analyzes the impact of the convertible note hedge and the impact of the warrant agreements on diluted weighted average shares outstanding, the purchases of the convertible note hedges are excluded because their impact would be anti-dilutive. The anti-dilutive shares associated with the convertible note hedges are 1.6 million, 0.3 million for the twelve month periods ended December 31, 2013 and 2012, respectively. The anti-dilutive shares associated with the convertible note hedges for the twelve month period ended December 31, 2011 are nominal. The treasury stock method is applied when the warrants are in-the-money, assuming the proceeds from the exercise of the warrants are used to repurchase shares based on the average stock price during the period. The strike price of the warrants is approximately $74.65 per share of common stock. Shares issuable upon exercise of the warrants that were included in the total diluted shares outstanding were 0.6 million for the twelve month period ended December 31, 2013. The warrants had no dilutive impact for the twelve month periods ended December 31, 2012 and 2011. For additional information regarding the convertible notes and convertible note hedge and warrant agreements, see Note 8 to the consolidated financial statements.
	The following tables provide information relating to the changes in accumulated other comprehensive income (loss), net of tax, for the twelve months ended December 31, 2013 and 2012:
			Cash Flow				Pension and				Foreign			Accumulated
			Hedges				Other				Currency			Other
							Postretirement				Translation			Comprehensive
							Benefit Plans				Adjustment			Income (Loss)
			(Dollars in thousands)
	Balance at December 31, 2011		$	(7,257	)		$	(134,548	)		$	(17,548	)	$	(159,353	)
	Other comprehensive income before reclassifications			515				2,628				13,138			16,281
	Amounts reclassified from accumulated other comprehensive income			6,361				4,663				—			11,024
	Net current-period other comprehensive income			6,876				7,291				13,138			27,305
	Balance at December 31, 2012			(381	)			(127,257	)			(4,410	)		(132,048	)
	Other comprehensive income (loss) before reclassifications			(549	)			25,464				(9,408	)		15,507
	Amounts reclassified from accumulated other comprehensive income			930				4,756				—			5,686
	Net current-period other comprehensive income (loss)			381				30,220				(9,408	)		21,193
	Balance at December 31, 2013		$	—			$	(97,037	)		$	(13,818	)	$	(110,855	)
	The following table provides information relating to the reclassifications of losses/(gain) in accumulated other comprehensive income into expense/(income), net of tax, for the twelve months ended December 31, 2013 and 2012:
			December 31,				December 31,
			2013				2012
			(Dollars in thousands)
	Gains and losses on cash flow hedges:
	Interest Rate Contracts:
	Interest expense		$	—			$	11,057
	Foreign Currency Exchange Contracts:
	Net Revenue			—				34
	Cost of goods sold			884				(898	)
	Total before tax			884				10,193
	Tax expense (benefit)			46				(3,832	)
	Net of tax		$	930			$	6,361
	Amortization of pension and other postretirement benefits items (1):
	Actuarial losses		$	7,211			$	7,158
	Prior-service costs			(21	)			(20	)
	Transition obligation			5				97
	Curtailment charge			—				(118	)
	Settlement charge			—				106
	Total before tax			7,195				7,223
	Tax benefit			(2,439	)			(2,560	)
	Net of tax		$	4,756			$	4,663
	Total reclassifications, net of tax		$	5,686			$	11,024
	-1	These accumulated other comprehensive income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 14 to the consolidated financial statements for additional information).

Stock_Compensation_Plans

Stock Compensation Plans	12 Months Ended
	Dec. 31, 2013
Stock Compensation Plans	'
	Note 12 — Stock compensation plans
	The Company has two stock-based compensation plans under which equity-based awards may be made. The Company’s 2000 Stock Compensation Plan (the “2000 plan”) provides for the granting of incentive and non-qualified stock options and restricted stock units to directors, officers and key employees. Under the 2000 plan, the Company is authorized to issue up to 4 million shares of common stock, but no more than 800,000 of those shares may be issued as restricted stock. Options granted under the 2000 plan have an exercise price equal to the average of the high and low sales prices of the Company’s common stock on the date of the grant, rounded to the nearest $0.25. Generally, options granted under the 2000 plan are exercisable three to five years after the date of the grant and expire no more than ten years from the grant date. Outstanding restricted stock units generally vest in one to three years. In 2013, the Company granted incentive and non-qualified options to purchase 29,875 shares of common stock and granted restricted stock units representing 8,092 shares of common stock under the 2000 plan. The unrecognized compensation expense for these awards as of the grant date was $1.0 million, which will be recognized over the vesting period of the awards. As of December 31, 2013, 760,979 shares were available for future grants under the 2000 plan.
	The Company’s 2008 Stock Incentive Plan (the “2008 plan”) provides for the granting of various types of equity-based awards to directors, officers and key employees. These awards include incentive and non-qualified stock options, stock appreciation rights, stock awards and other stock-based awards. Under the 2008 plan, the Company is authorized to issue up to 2.5 million shares of common stock, but grants of awards other than stock options and stock appreciation rights may not exceed 875,000 shares. Options granted under the 2008 plan have an exercise price equal to the closing price of the Company’s common stock on the date of grant. In 2013, the Company granted incentive and non-qualified options to purchase 387,609 shares of common stock and granted restricted stock units representing 140,099 shares of common stock under the 2008 plan. The unrecognized compensation expense for these awards as of the grant date was $16.1 million, which will be recognized over the vesting period of the awards. As of December 31, 2013, 839,542 shares were available for future grants under the 2008 plan.
	The fair value for options granted in 2013, 2012 and 2011 was estimated at the date of grant using a multiple point Black-Scholes option pricing model. The following weighted-average assumptions were used:
		2013		2012				2011
	Risk-free interest rate	0.75%			0.81	%			1.92	%
	Expected life of option	4.87 yrs.			4.85 yrs.				4.70 yrs.
	Expected dividend yield	1.73%			2.28	%			2.34	%
	Expected volatility	24.65%			28.46	%			26.82	%
	The fair value for non-vested shares granted in 2013, 2012 and 2011 was estimated at the date of grant based on the market price for the underlying stock on the grant date discounted for the risk free interest rate and the present value of expected dividends over the vesting period. The following weighted-average assumptions were used:
		2013		2012				2011
	Risk-free interest rate	0.36%			0.37	%			1.04	%
	Expected dividend yield	1.71%			2.24	%			2.34	%
	The Company applied a simplified method to establish the beginning balance of the additional paid-in capital pool (“APIC Pool”) related to the tax effects of employee stock-based compensation and to determine the subsequent impact on the APIC Pool and consolidated statements of cash flows of the tax effects of employee stock-based compensation awards that are outstanding.
	The following table summarizes the option activity during 2013:
		Shares				Weighted				Weighted				Aggregate
		Subject to				Average				Average				Intrinsic
		Options				Exercise				Remaining				Value
						Price				Contractual
										Life In Years
														(Dollars in thousands)
	Outstanding, beginning of the year		1,084,193			$	58.43
	Granted		417,484				79.37
	Exercised		(157,545	)			57.16
	Forfeited or expired		(64,652	)			65.79
	Outstanding, end of the year		1,279,480				65.05				7.1			$	36,900
	Exercisable, end of the year		652,431			$	59.31				5.7			$	22,543
	The weighted average grant date fair value was $14.30, $11.78 and $11.45 for options granted during 2013, 2012 and 2011, respectively. The total intrinsic value of options exercised was $4.1 million, $2.7 million and $6.9 million during 2013, 2012 and 2011, respectively. New shares of the Company’s common stock is issued upon exercises of options.
	The Company recorded $4.4 million of expense related to the portion of the shares underlying options that vested during 2013, which is included in selling, general and administrative expenses.
	The following table summarizes the non-vested restricted stock unit activity during 2013:
		Number of				Weighted				Weighted		Aggregate
		Non-Vested				Average				Average		Intrinsic
		Shares				Grant-Date				Remaining		Value
						Fair Value				Contractual
										Life In Years
												(Dollars in thousands)
	Outstanding, beginning of the year		364,788			$	55.77
	Granted		148,191				75.6
	Vested		(99,666	)			63.01
	Forfeited		(59,956	)			59.87
	Outstanding, end of the year		353,357				62.49			1.3		$	33,166
	The weighted average grant-date fair value for non-vested restricted stock units granted during 2013, 2012 and 2011 was $75.60, $56.95 and $54.33, respectively. The Company reissues shares of treasury stock to satisfy non-vested restricted stock units upon vesting of the award.
	The Company recorded $7.5 million of expense related to the portion of the restricted stock units that vested during 2013, which is included in selling, general and administrative expenses.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes	'
	Note 13 — Income taxes
	The following table summarizes the components of the provision for income taxes from continuing operations:
		2013				2012			2011
		(Dollars in thousands)
	Current:
	Federal	$	(2,974	)		$	20,959		$	(2,604	)
	State		1,736				3,623			4,621
	Foreign		36,400				30,476			48,600
	Deferred:
	Federal		(9,703	)			(34,629	)		(20,584	)
	State		(1,825	)			(720	)		(961	)
	Foreign		(87	)			(3,296	)		(3,294	)
		$	23,547			$	16,413		$	25,778
	In December 2011, the Company sold its cargo and container businesses and recorded a gain on sale of $217.8 million along with related taxes of $91.0 million. The gain and related taxes are reported as discontinued operations. A significant portion of these tax charges are included as part of the deferred tax liability for unremitted foreign earnings.
	At December 31, 2013, the cumulative unremitted earnings of other subsidiaries outside the United States, considered non-permanently reinvested, for which U.S. taxes have been provided, approximated $609.9 million.  At December 31, 2013, the cumulative unremitted earnings of other subsidiaries outside the United States, considered permanently reinvested, for which no income or withholding taxes have been provided, approximated $353.9 million. Such earnings are expected to be reinvested indefinitely and, as a result, no deferred tax liability has been recognized with regard to such earnings. Determination of the deferred income tax liability on these unremitted earnings is not practicable principally because such liability, if any, is dependent on circumstances existing if and when remittance occurs.
	The following table summarizes the United States and non-United States components of income from continuing operations before taxes:
		2013				2012			2011
		(Dollars in thousands)
	United States	$	(3,544	)		$	(315,928	)	$	(10,952	)
	Other		179,274				150,559			156,052
		$	175,730			$	(165,369	)	$	145,100
	Reconciliations between the statutory federal income tax rate and the effective income tax rate are as follows:
		2013				2012			2011
	Federal statutory rate		35	%			35	%		35	%
	Goodwill impairment		—				(60.84	)		—
	Tax effect of International items		(15.26	)			11.88			(15.36	)
	State taxes, net of federal benefit		(0.32	)			(0.90	)		1.18
	Uncertain tax contingencies		(4.06	)			4.85			(2.66	)
	Contingent consideration reversals		(2.04	)			—			—
	Other, net		0.08				0.08			(0.39	)
			13.4	%			(9.93	)%		17.77	%
	The effective income tax rate for 2013 was 13.4% compared to (9.9%) for 2012. The effective tax rate for 2013 was impacted by the realization of net tax benefits resulting from the expiration of statutes of limitation for U.S. federal and state and foreign matters, tax benefits associated with U.S. and foreign tax return filings and the realization of tax benefits resulting from the resolution of a foreign tax matter. The effective income tax rate for 2012 was impacted by a $332 million goodwill impairment charge recorded in the first quarter of 2012, for which only $45 million was tax deductible.
	The Company and its subsidiaries are routinely subject to examinations by various taxing authorities. In conjunction with these examinations and as a regular practice, the Company establishes and adjusts reserves with respect to its uncertain tax positions to address developments related to those positions. The Company realized a net benefit of approximately $7.1 million, $8.0 million and $3.9 million in 2013, 2012 and 2011, respectively, as a result of reducing its reserves with respect to uncertain tax positions. These reductions principally resulted from the expiration of a number of applicable statutes of limitations.
	The following table summarizes significant components of the Company’s deferred tax assets and liabilities at December 31, 2013 and 2012:
		2013				2012
		(Dollars in thousands)
	Deferred tax assets:
	Tax loss and credit carryforwards	$	104,043			$	92,282
	Pension		39,310				63,737
	Reserves and accruals		39,478				39,485
	Other		27,092				21,255
	Less: valuation allowances		(86,510	)			(69,527	)
	Total deferred tax assets		123,413				147,232
	Deferred tax liabilities:
	Property, plant and equipment		26,550				24,766
	Intangibles — stock acquisitions		400,297				324,983
	Unremitted foreign earnings		147,326				151,780
	Other		12,030				13,129
	Total deferred tax liabilities		586,203				514,658
	Net deferred tax liability	$	(462,790	)		$	(367,426	)
	Under the tax laws of various jurisdictions in which the Company operates, deductions or credits that cannot be fully utilized for tax purposes during the current year may be carried forward, subject to statutory limitations, to reduce taxable income or taxes payable in a future tax year. At December 31, 2013, the tax effect of such carryforwards approximated $104.0 million. Of this amount, $14.8 million has no expiration date, $0.6 million expires after 2013 but before the end of 2018 and $88.6 million expires after 2018. A portion of these carryforwards consists of tax losses and credits which were acquired in acquisitions by the Company and the utilization of these carryforwards are subject to an annual limitation imposed by Section 382 of the Internal Revenue Code, which limits a company’s ability to deduct prior net operating losses following a more than 50 percent change in ownership. The Vidacare Corporation acquisition in December 2013 included $7.4 million of tax losses, $0.5 million of which will not be realized as a result of the Section 382 limitation. A full valuation allowance on this component of the acquired tax losses was recorded in conjunction with the acquisition.  The Hotspur Technologies acquisition in June 2012 included $10.8 million of tax losses, $2.5 million of which will not be realized as a result of the Section 382 limitation. A full valuation allowance on this component of the acquired tax losses was recorded in conjunction with the acquisition. Except as described above, with respect to Vidacare Corporation and Hotspur Technologies, it is not expected that the Section 382 limitation will prevent the Company from utilizing its loss carryforwards. The determination of state net operating loss carryforwards is dependent upon the United States subsidiaries’ taxable income or loss, the state’s proportion of taxable net income and other respective state laws, which can change from year to year and impact the amount of such carryforward.
	The valuation allowance for deferred tax assets of $86.5 million and $69.5 million at December 31, 2013 and 2012, respectively, relates principally to the uncertainty of the Company’s ability to utilize certain deferred tax assets, primarily tax loss and credit carryforwards in various jurisdictions. The valuation allowance was calculated in accordance with applicable accounting standards, which require that a valuation allowance be established and maintained when it is “more likely than not” that all or a portion of deferred tax assets will not be realized.
	Uncertain Tax Positions: The following table is a reconciliation of the beginning and ending balances for liabilities associated with unrecognized tax benefits for the twelve month periods ending December 31, 2013,  2012 and 2011:
		2013				2012			2011
		(Dollars in thousands)
	Balance at January 1	$	62,108			$	75,026		$	89,281
	Increase in unrecognized tax benefits related to prior years		—				1,110			1,855
	Decrease in unrecognized tax benefits related to prior years		—				(6,134	)		(6,415	)
	Unrecognized tax benefits related to the current year		1,838				4,256			4,246
	Reductions in unrecognized tax benefits due to settlements		—				(8,816	)		(7,678	)
	Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations		(8,433	)			(3,503	)		(5,852	)
	Increase (decrease) in unrecognized tax benefits due to foreign currency translation		258				169			(411	)
	Balance at December 31	$	55,771			$	62,108		$	75,026
The total liabilities associated with the unrecognized tax benefits that, if recognized would impact the effective tax rate for continuing operations, were $22.5 million at December 31, 2013.
The Company accrues interest and penalties associated with unrecognized tax benefits in income tax expense in the consolidated statements of operations, and the corresponding liability is included in the consolidated balance sheets. The interest (benefit) expense (net of related tax benefits where applicable) and penalties reflected in income from continuing operations for the year ended December 31, 2013 was $1.3 million and $(0.8) million, respectively, ($0.8 million and $0.2 million, respectively, for the year ended December 31, 2012 and $(0.1) million and $0.3 million, respectively, for the year ended December 31, 2011). The corresponding liabilities in the consolidated balance sheets for interest and penalties were $5.7 million and $6.0 million, respectively, at December 31, 2013 ($6.5 million and $9.2 million, respectively, at December 31, 2012).
The taxable years that remain subject to examination by major tax jurisdictions are as follows:
	Beginning			Ending
United States	2010			2013
Canada	2005			2013
China	2008			2013
Czech Republic	2001			2013
France	2011			2013
Germany	2007			2013
Ireland	2009			2013
Italy	2009			2013
Malaysia	2008			2013
Singapore	2009			2013
The Company and its subsidiaries are routinely subject to income tax examinations by various taxing authorities. As of December 31, 2013, the most significant tax examinations in process are in the jurisdictions of Canada, Germany, the Czech Republic and Austria. The date at which these examinations may be concluded and the ultimate outcome of such examinations is uncertain. As a result of the uncertain outcome of these ongoing examinations, future examinations or the expiration of statutes of limitation, it is reasonably possible that the related unrecognized tax benefits for tax positions taken could materially change from those recorded as liabilities at December 31, 2013. Due to the potential for resolution of certain examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Company’s unrecognized tax benefits may change within the next twelve months by a range of zero to $2.5 million.

Pension_and_Other_Postretireme

Pension and Other Postretirement benefits	12 Months Ended
	Dec. 31, 2013
Pension and Other Postretirement Benefits	'
	Note 14 — Pension and other postretirement benefits
	The Company has a number of defined benefit pension and other postretirement plans covering eligible United States and non-United States employees. The defined benefit pension plans are noncontributory. The benefits under these plans are based primarily on years of service and employees’ pay near retirement. The Company’s funding policy for United States plans is to contribute annually, at a minimum, amounts required by applicable laws and regulations. Obligations under non-United States plans are systematically provided for by depositing funds with trustees or by book reserves. As of December 31, 2013, the Company’s United States defined benefit pension plans and the Company’s other postretirement benefit plans, except certain postretirement benefit plans covering employees subject to a collective bargaining agreement, are frozen.
	The Company and certain of its subsidiaries provide medical, dental and life insurance benefits to pensioners and survivors. The associated plans are unfunded and approved claims are paid from Company funds.
	The following table provides information for the net benefit cost of pension and postretirement benefit plans for continuing operations:
			Pension												Other Benefits
			2013				2012				2011				2013				2012				2011
			(Dollars in thousands)
	Service cost		$	1,819			$	2,331			$	2,297			$	663			$	704			$	479
	Interest cost			16,842				16,561				17,284				2,707				2,122				2,054
	Expected return on plan assets			(23,122	)			(20,245	)			(19,998	)			—				—				—
	Net amortization and deferral			5,847				6,474				4,018				1,348				761				(45	)
	Curtailment gain			—				(197	)			(37	)			—				—				—
	Settlement loss (gain)			—				106				(5	)			—				—				—
	Net benefit cost		$	1,386			$	5,030			$	3,559			$	4,718			$	3,587			$	2,488
	The following table provides information for the weighted average assumptions for United States and foreign plans used in determining net benefit cost:
			Pension											Other Benefits
			2013			2012				2011				2013				2012				2011
	Discount rate		4.27	%			4.28	%			5.5	%			3.83	%			3.95	%			5.1	%
	Rate of return		8.31	%			8.27	%			8.31	%			—				—				—
	Initial healthcare trend rate		—				—				—				8.15	%			8.5	%			8	%
	Ultimate healthcare trend rate		—				—				—				5	%			5	%			5	%
	The following table provides summarized information on the Company’s pension and postretirement benefit plans, measured as of December 31, 2013 and 2012, and the amounts recognized in the consolidated balance sheet and in accumulated other comprehensive income with respect to the plans:
				Pension							Other Benefits
				2013			2012				2013				2012
				Under Funded							Under Funded
				(Dollars in thousands)
	Benefit obligation, beginning of year		$	397,184			$	393,794			$	55,609			$	49,508
	Service cost			1,819				2,331				663				704
	Interest cost			16,842				16,561				2,707				2,122
	Actuarial (gain) loss			(30,755	)			2,345				(3,833	)			6,161
	Currency translation			861				678				—				—
	Benefits paid			(17,004	)			(16,227	)			(2,860	)			(3,106	)
	Medicare Part D reimbursement			—				—				162				220
	Settlements			—				(767	)			—				—
	Administrative costs			(1,216	)			(1,452	)			—				—
	Curtailments			—				(79	)			—				—
	Projected benefit obligation, end of year			367,731				397,184				52,448				55,609
	Fair value of plan assets, beginning of year			276,863				243,324				—				—
	Actual return on plan assets			28,813				33,946				—				—
	Contributions			17,724				17,567				—				—
	Benefits paid			(17,004	)			(16,227	)			—				—
	Settlements paid			—				(767	)			—				—
	Administrative costs			(1,216	)			(1,452	)			—				—
	Currency translation			301				472				—				—
	Fair value of plan assets, end of year			305,481				276,863				—				—
	Funded status, end of year		$	(62,250	)		$	(120,321	)		$	(52,448	)		$	(55,609	)
	The following table sets forth information as to amounts recognized in the consolidated balance sheet with respect to the plans:
			Pension								Other Benefits
			2013				2012				2013				2012
			(Dollars in thousands)
	Payroll and benefit-related liabilities		$	(1,819	)		$	(1,784	)		$	(3,381	)		$	(3,200	)
	Pension and postretirement benefit liabilities			(60,431	)			(118,537	)			(49,067	)			(52,409	)
	Accumulated other comprehensive loss			144,866				186,916				7,073				12,254
			$	82,616			$	66,595			$	(45,375	)		$	(43,355	)
	The following tables set forth information as to amounts recognized in accumulated other comprehensive income (loss) with respect to the plans:
			Pension
			Prior Service				Net (Gain)				Deferred				Accumulated
			Cost (Credit)				or Loss				Taxes				Other
															Comprehensive
															(Income) Loss,
															Net of Tax
			(Dollars in thousands)
	Balance at December 31, 2011		$	251			$	204,257			$	(74,488	)		$	130,020
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net amortization and deferral			(35	)			(6,439	)			2,287				(4,187	)
Curtailment			—				118				(44	)			74
Settlement			—				(106	)			40				(66	)
Amounts arising during the period:
Actuarial changes in benefit obligation			—				(11,356	)			4,696				(6,660	)
Impact of currency translation			—				226				(58	)			168
Balance at December 31, 2012			216				186,700				(67,567	)			119,349
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net amortization and deferral			(34	)			(5,813	)			1,947				(3,900	)
Amounts arising during the period:
Actuarial changes in benefit obligation			—				(36,446	)			13,206				(23,240	)
Impact of currency translation			—				243				(66	)			177
Balance at December 31, 2013		$	182			$	144,684			$	(52,480	)		$	92,386
		Other Benefits
		Prior Service				Initial				Net (Gain) or				Deferred				Accumulated
		Cost (Credit)				Obligation				Loss				Taxes				Other
																		Comprehensive
																		(Income) Loss,
																		Net of Tax
		(Dollars in thousands)
Balance at December 31, 2011		$	(93	)		$	102			$	6,845			$	(2,326	)		$	4,528
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net Amortization and deferral			55				(97	)			(719	)			277				(484	)
Amounts Arising During the period:
Actuarial changes in benefit obligation			—				—				6,161				(2,297	)			3,864
Balance at December 31, 2012			(38	)			5				12,287				(4,346	)			7,908
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net Amortization and deferral			55				(5	)			(1,398	)			492				(856	)
Amounts Arising During the period:
Actuarial changes in benefit obligation			—				—				(3,833	)			1,432				(2,401	)
Balance at December 31, 2013		$	17			$	—			$	7,056			$	(2,422	)		$	4,651
The following table provides the weighted average assumptions for United States and foreign plans used in determining benefit obligations:
		Pension									Other Benefits
		2013				2012				2013				2012
Discount rate			4.98	%			4.27	%			4.7	%			3.83	%
Rate of compensation increase			3	%			3	%			—				—
Initial healthcare trend rate			—				—				7	%			8.15	%
Ultimate healthcare trend rate			—				—				5	%			5	%
The discount rate represents the interest rate used to determine the present value of future cash flows currently expected to be required to settle the Company’s pension and other benefit obligations. The weighted average discount rates for United States pension plans and other benefit plans of 5.09% and 4.70%, respectively, were established by comparing the projection of expected benefit payments to the AA Above Median yield curve as of December 31, 2013. The expected benefit payments are discounted by each corresponding discount rate on the yield curve. For payments beyond 30 years, the Company extends the curve assuming that the discount rate derived in year 30 is extended to the end of the plan’s payment expectations. Once the present value of the string of benefit payments is established, the Company determines the single rate on the yield curve that, when applied to all obligations of the plan, will exactly match the previously determined present value.
As part of its evaluation of pension and other postretirement assumptions, assumptions for mortality and healthcare cost trends incorporate generational white and blue collar mortality trends. The Company currently uses the generational tables when determining the liability, which takes into consideration increases in plan participant longevity.  As a result, the Company expects less significant increases in plan obligations in the future.
The Company’s assumption for the Expected Return on Plan Assets is primarily based on the determination of an expected return for its current portfolio. This determination is made using assumptions for return and volatility of the portfolio. Asset class assumptions are set using a combination of empirical and forward-looking analysis. To the extent historical results have been affected by unsustainable trends or events, the effects of those trends are quantified and removed. The Company applies a variety of models for filtering historical data and isolating the fundamental characteristics of asset classes. These models provide empirical return estimates for each asset class, which are then reviewed and combined with a qualitative assessment of long term relationships between asset classes before a return estimate is finalized. The qualitative analysis is intended to provide an additional means for correcting for the effect of unrealistic or unsustainable short-term valuations or trends, resulting in return levels and behavior the Company believes are more likely to prevail over long periods.
Increasing the assumed healthcare trend rate by 1% would increase the benefit obligation by $4.3 million and would increase the 2013 benefit expense by $0.3 million. Decreasing the trend rate by 1% would decrease the benefit obligation by $3.7 million and would decrease the 2013 benefit expense by $0.2 million.
The accumulated benefit obligation for all United States and foreign defined benefit pension plans was $367.3 million and $396.7 million for 2013 and 2012, respectively. All of our pension plans had accumulated benefit obligations in excess of their respective plan assets as of December 31, 2013 and 2012.
The Company’s investment objective is to achieve an enhanced long-term rate of return on plan assets, subject to a prudent level of portfolio risk, for the purpose of enhancing the security of benefits for participants. These investments are held primarily in equity and fixed income mutual funds. The Company’s other investments are largely comprised of a hedge fund of funds and a structured credit fund. The equity funds are diversified in terms of domestic and international equity securities, as well as small, middle and large capitalization stocks. The domestic mutual funds held in the plans are subject to the diversification standards and industry limitations on concentration of holdings set forth in the Investment Company Act of 1940, as amended, and SEC staff guidance. The Company’s target allocation percentage is as follows: equity securities (45%); fixed-income securities (35%) and other securities (20%). The portfolio allocation was changed during 2012. The changes increase diversification of the portfolio and reduce expected variability of the portfolio returns, while maintaining the same expected return level. The new composition is expected to bring a better balance of return and risk expectations of the pension plan. Equity funds are held for their expected return over inflation. Fixed-income funds are held for diversification relative to equities and as a partial hedge of interest rate risk to plan liabilities. The other investments are held to further diversify assets within the plans and are designed to provide a mix of equity and bond like return with a bond like risk profile. The plans may also hold cash to meet liquidity requirements. Actual performance may not be consistent with the respective investment strategies. Investment risks and returns are measured and monitored on an ongoing basis through annual liability measurements and investment portfolio reviews to determine whether the asset allocation targets continue to represent an appropriate balance of expected risk and reward.
The following table provides the fair values of the Company’s pension plan assets at December 31, 2013 by asset category:
		Fair Value Measurements at 12/31/13
Asset Category (a)		Total				Quoted Prices in				Significant				Significant
						Active Markets for				Observable				Unobservable
						Identical Assets				Inputs				Inputs
						(Level 1)				(Level 2)				(Level 3)
		(Dollars in thousands)
Cash		$	472			$	472			$	—			$	—
Money market funds			310				310				—				—
Equity securities:
Managed volatility (b)			77,140				77,140				—				—
United States small/mid-cap equity (c)			19,760				19,760				—				—
World Equity (excluding United States) (d)			30,183				30,183				—				—
Common Equity Securities – Teleflex Incorporated			10,972				10,972				—				—
Diversified United Kingdom Equity			928				928				—				—
Diversified Global			2,319				2,319				—				—
Emerging Markets			1,270				1,270				—				—
Fixed income securities:
Long duration bond fund (e)			76,608				76,608				—				—
UK corporate bond fund			2,569				2,569				—				—
UK Government bond fund			4,455				4,455				—				—
High yield bond fund (f)			12,754				12,754				—				—
Emerging markets debt fund (g)			9,003				—				9,003				—
Corporate, government and foreign bonds			87				—				87				—
Asset backed – home loans			847				—				847				—
Other types of investments:
Structured credit (h)			29,109				—				—				29,109
Hedge fund of funds (i)			22,540				—				—				22,540
UK Property Fund (j)			1,402				—				1,402				—
Multi asset fund  (k)			2,748				2,748				—				—
Other			5				—				—				5
Total		$	305,481			$	242,488			$	11,339			$	51,654
The following table provides the fair values of the Company’s pension plan assets at December 31, 2012 by asset category:
		Fair Value Measurements at 12/31/12
Asset Category (a)		Total				Quoted Prices in				Significant				Significant
						Active Markets for				Observable				Unobservable
						Identical Assets				Inputs				Inputs
						(Level 1)				(Level 2)				(Level 3)
		(Dollars in thousands)
Cash		$	408			$	408			$	—			$	—
Money market funds			361				361				—				—
Equity securities:
Managed volatility (b)			66,413				66,413				—				—
United States small/mid-cap equity (c)			16,543				16,543				—				—
World Equity (excluding United States) (d)			27,257				27,257				—				—
Common Equity Securities – Teleflex Incorporated			8,336				8,336				—				—
Diversified United Kingdom Equity			6,681				6,681				—				—
Diversified Global (excluding United			3,267				3,267				—				—
Kingdom)
Fixed income securities:
Long duration bond fund (e)			73,370				73,370				—				—
High yield bond fund (f)			10,896				10,896				—				—
Emerging markets debt fund (g)			8,453				8,453				—				—
Corporate, government and foreign bonds			5,675				—				5,675				—
Asset backed – home loans			1,005				—				1,005				—
Other types of investments:
Structured credit (h)			26,828				—				—				26,828
Hedge fund of funds (i)			21,365				—				—				21,365
Other			5				—				—				5
Total		$	276,863			$	221,985			$	6,680			$	48,198
(a)	Information on asset categories described in notes (b)-(k) is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.
(b)	This category comprises mutual funds that invest in securities of United States and non-United States companies of all capitalization ranges that exhibit relatively low volatility.
(c)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of small and mid-sized companies. The fund invests in common stocks or exchange traded funds holding common stock of United States companies with market capitalizations in the range of companies in the Russell 2500 Index.
(d)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of foreign companies. These securities may include common stocks, preferred stocks, warrants, exchange traded funds based on an international equity index and derivative instruments whose value is based on an international equity index and derivative instruments whose value is based on an underlying equity security or a basket of equity securities. The fund invests in securities of foreign issuers located in developed and emerging market countries. However, the fund will not invest more than 30% of its assets in the common stocks or other equity securities of issuers located in emerging market countries.
(e)	This category comprises a mutual fund that invests in instruments or derivatives having economic characteristics similar to fixed income securities. The fund invests in investment grade fixed income instruments, including securities issued or guaranteed by the United States Government and its agencies and instrumentalities, corporate bonds, asset-backed securities, exchange traded funds, mortgage-backed securities and collateralized mortgage-backed securities. The fund invests primarily in long duration government and corporate fixed income securities, and uses derivative instruments, including interest rate swap agreements and Treasury futures contracts, for the purpose of managing the overall duration and yield curve exposure of the Fund’s portfolio of fixed income securities.
(f)	This category comprises a mutual fund that invests at least 80% of its net assets in higher-yielding fixed income securities, including corporate bonds and debentures, convertible and preferred securities and zero coupon obligations.
(g)	This category comprises a mutual fund that invests at least 80% of its net assets in fixed income securities of emerging market issuers, primarily in United States dollar-denominated debt of foreign governments, government-related and corporate issuers in emerging market countries and entities organized to restructure the debt of those issuers.
(h)	This category comprises a fund that invests primarily in collateralized debt obligations (“CDOs”) and other structured credit vehicles. The fund investments may include fixed income securities, loan participants, credit-linked notes, medium-term notes, pooled investment vehicles and derivative instruments.
(i)
This category comprises a hedge fund that invests in various other hedge funds. As of December 31, 2013 and 2012:
—	approximately 28% and 22%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;
—	approximately 18% and 30%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;
—	approximately 25% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;
—	approximately 23% and 17%, respectively, of the assets were held in funds with an event driven strategy; and
—	approximately 6% and 6%, respectively, of the assets were held in cash.
(j)	This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
(k)	This category comprises a mutual fund that invests primarily in equities, bonds and alternatives.
The following table provides a reconciliation of changes in Level 3 pension assets measured at fair value on a recurring basis from December 31, 2011 through December 31, 2013:
		Hedge Fund				Structured				Other
		of Funds				Credit				Investments
		(Dollars in thousands)
Balance at December 31, 2011		$	20,624			$	—			$	531
Purchases			—				26,000				—
Sales/redemptions			—				—				(509	)
Actual return on assets			741				828				(35	)
Foreign currency adjustment			—				—				18
Balance at December 31, 2012			21,365				26,828				5
Actual return on assets			1,175				2,281				—
Balance at December 31, 2013		$	22,540			$	29,109			$	5
The Company’s contributions to United States and foreign pension plans during 2014 are expected to be approximately $9.4 million. Contributions to postretirement healthcare plans during 2014 are expected to be approximately $3.4 million.
The following table provides information about the Company’s expected benefit payments for U.S. and foreign plans for each of the five succeeding years and the aggregate of the five years thereafter, net of the annual average Medicare Part D subsidy of approximately $0.2 million:
		Pension					Other Benefits
		(Dollars in thousands)
2014		$	16,969			$	3,381
2015			17,497				3,459
2016			18,145				3,580
2017			18,653				3,556
2018			19,382				3,859
Years 2019 — 2023			108,118				20,347
The Company maintains a number of defined contribution savings plans covering eligible United States and non-United States employees. The Company partially matches employee contributions. Costs related to these plans were $12.1 million, $10.1 million and $10.2 million for 2013, 2012 and 2011, respectively.

Commitments_and_contingent_lia

Commitments and contingent liabilities	12 Months Ended
	Dec. 31, 2013
Commitments and Contingent Liabilities	'
	Note 15 — Commitments and contingent liabilities
	Operating leases: The Company uses various leased facilities and equipment in its operations. The lease terms for these leased assets vary depending on the terms of the applicable lease agreement. At December 31, 2013, the Company had no residual value guarantees related to its operating leases.
	Future minimum lease payments as of December 31, 2013 under noncancelable operating leases are as follows:
		Future Lease Payments
		(Dollars in thousands)
	2014	$	21,700
	2015		17,000
	2016		13,700
	2017		11,800
	2018 and thereafter		46,200
	As of December 31, 2013, the Company has recorded approximately $13.6 million in property, plant and equipment representing the estimated fair value of the Company’s percentage of the costs to construct buildings under two separate build-to-suit leases. One build-to-suit lease relates to the Company’s corporate headquarters, which represents approximately $9.6 million of the asset recorded as of December 31, 2013. Construction of the corporate headquarters has been completed and the lease commenced on February 1, 2014. The estimated fair value of the Company’s percentage of the costs to construct the corporate headquarters at the end of the construction period is $11.2 million. The second build-to-suit lease was entered into in August of 2013 and relates to a United States operating facility. Construction on the second build-to-suit facility commenced shortly before the end of the third quarter of 2013 and is expected to be completed in October 2014. The estimated fair value of the Company’s percentage of the construction costs to complete the second build-to-suit lease is approximately $23.0 million. For accounting purposes, the Company is deemed the owner of the asset during the construction period and is required to record the estimated fair value of the Company’s percentage of the construction costs as construction in progress during the construction period and record a related current liability in the same amount. These amounts do not reflect the Company’s cash obligations, but represent the landlord’s costs to construct the Company’s portion of the building and tenant improvements. On February 1, 2014, the Company derecognized the assets and related liabilities of the corporate headquarters upon commencement of the respective lease terms.
	Rental expense under operating leases was $26.4 million, $24.0 million and $26.3 million in 2013, 2012 and 2011, respectively.
	Environmental:  The Company is subject to contingencies as a result of environmental laws and regulations that in the future may require the Company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the Company or other parties. Much of this liability results from the United States Comprehensive Environmental Response, Compensation and Liability Act, often referred to as Superfund, the United States Resource Conservation and Recovery Act and similar state laws. These laws require the Company to undertake certain investigative and remedial activities at sites where the Company conducts or once conducted operations or at sites where Company-generated waste was disposed.
	Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, the regulatory agencies involved and their enforcement policies, as well as the presence or absence of other potentially responsible parties. At December 31, 2013 and 2012, the Company has recorded approximately $2.5 million and $1.9 million, respectively, in accrued liabilities and approximately $5.8 million and $6.9 million, respectively, in other liabilities relating to these matters. Considerable uncertainty exists with respect to these liabilities and, if adverse changes in circumstances occur, potential liability may exceed the amount accrued as of December 31, 2013. The time frame over which the accrued amounts may be paid out, based on past history, is estimated to be 15-20 years.
	Litigation:  The Company is a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, intellectual property, employment and environmental matters. As of December 31, 2013 and 2012, the Company has recorded reserves of approximately $6.8 million and $2.3 million, respectively, in connection with such contingencies, representing its best estimate of the cost within the range of estimated possible loss that will be incurred to resolve these matters. Of the $6.8 million reserved for at December 31, 2013, $1.4 million pertains to discontinued operations.
	Based on information currently available, advice of counsel, established reserves and other resources, the Company does not believe that any such actions are likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. Legal costs such as outside counsel fees and expenses are charged to selling, general and administrative expenses in the period incurred.
	Tax audits and examinations: The Company and its subsidiaries are routinely subject to tax examinations by various taxing authorities. As of December 31 2013, the most significant tax examinations in process were in Canada, the Czech Republic, Germany and Austria. In conjunction with these examinations and as a regular and routine practice, the Company may establish reserves or adjust existing reserves with respect to uncertain tax positions. Accordingly, developments occurring with respect to these examinations, including resolution of uncertain tax positions, could result in increases or decreases to the Company’s recorded tax liabilities, which could impact the Company’s financial results.
	Other: The Company has various purchase commitments for materials, supplies and items of permanent investment incident to the ordinary conduct of business. On average, such commitments are not at prices in excess of current market prices.

Business_Segments_and_Other_In

Business Segments and Other Information	12 Months Ended
	Dec. 31, 2013
Business Segments and Other Information	'
	Note 16 — Business segments and other information
	An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. Based on these criteria, the Company identified its four operating segments, which also comprise its four reportable segments.
	Three of the four reportable segments are geographically based: Americas (representing the Company’s operations in North America and Latin America), EMEA (representing the Company’s operations in Europe, the Middle East and Africa) and Asia. The fourth reportable segment is Original Equipment Manufacturer and Development Services (“OEM”).
	The Company’s geographically based segments design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care and generally serve two end markets: hospitals and healthcare providers, and home health. The products of the geographically based segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM Segment designs, manufactures and supplies devices and instruments for other medical device manufacturers.
	The following tables present the Company’s segment results for the twelve months ended December 31, 2013, 2012 and 2011:
			Year Ended December 31, 2013
	Segment Results		Americas			EMEA			Asia			OEM		Totals
			(Dollars in thousands)
	Segment net revenues from external customers		$	800,464		$	557,427		$	207,207		$	131,173	$	1,696,271
	Segment depreciation and amortization			69,653			28,938			4,774			4,570		107,935
	Segment operating profit(1)			97,386			76,199			70,800			27,328		271,713
	Segment assets			2,266,161			1,008,329			240,535			62,743		3,577,768
	Segment expenditures for property, plant and equipment			47,554			11,487			754			2,625		62,420
	Restructuring and other impairment charges			18,265			19,007			592			588		38,452
	Intersegment revenues			128,512			153,951			40,579			519
			Year Ended December 31, 2012
	Segment Results		Americas			EMEA			Asia			OEM		Totals
			(Dollars in thousands)
	Segment net revenues from external customers		$	726,810		$	510,248		$	173,721		$	140,230	$	1,551,009
	Segment depreciation and amortization			64,174			22,974			3,653			4,083		94,884
	Segment operating profit(1)			91,627			54,746			59,421			31,664		237,458
	Segment assets			1,947,583			985,069			245,578			33,236		3,211,466
	Segment expenditures for property, plant and equipment			32,023			14,717			472			10,830		58,042
	Restructuring and other impairment charges			743			2,294			—			—		3,037
	Intersegment revenues			135,499			76,967			4,660			422
			Year Ended December 31, 2011
	Segment Results		Americas			EMEA			Asia			OEM		Totals
			(Dollars in thousands)
	Segment net revenues from external customers		$	688,036		$	525,277		$	149,585		$	129,630	$	1,492,528
	Segment depreciation and amortization			65,580			23,419			3,848			3,649		96,496
	Segment operating profit(1)			90,046			74,311			47,101			24,699		236,157
	Segment assets			2,078,850			789,978			199,684			27,240		3,095,752
	Segment expenditures for property, plant and			23,203			11,843			804			5,565		41,415
	equipment
	Restructuring and other impairment charges			4,626			1,379			—			—		6,005
	Intersegment revenues			137,499			67,199			1			464
	-1	Segment operating profit includes a segment’s net revenues from external customers reduced by its cost of goods sold, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Segment operating profit excludes goodwill impairment charges, restructuring and impairment charges, net (gain) loss on sales of businesses and assets, interest income and expense, loss on extinguishment of debt and taxes on income.
	The following tables present reconciliations of segment results to the Company’s consolidated income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes for the twelve months ended December 31, 2013,  2012 and , 2011:
	Reconciliation of Segment Operating Profit to Income (Loss) from		Year Ended
	Continuing Operations Before Interest, Loss on
	Extinguishments of Debt and Taxes
			2013			2012			2011
			(Dollars in thousands)
	Segment operating profit		$	271,713		$	237,458		$	236,157
	Goodwill impairment			—			(332,128	)		—
	Restructuring and other impairment charges			(38,452	)		(3,037	)		(6,005	)
	Net gain (loss) on sales of businesses and assets			—			332			(582	)
	Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes		$	233,261		$	(97,375	)	$	229,570
	Reconciliation of Segment Assets to Consolidated Total Assets		Year Ended
			2013			2012			2011
			(Dollars in thousands)
	Segment assets		$	3,577,768		$	3,211,466		$	3,095,752
	Corporate assets			620,811			514,258			767,231
	Assets of businesses divested			—			—			53,218
	Assets held for sale			10,428			7,963			7,902
	Total assets		$	4,209,007		$	3,733,687		$	3,924,103
	Reconciliation of Segment Expenditures for Property, Plant and		Year Ended
	Equipment to Consolidated Total Expenditures for Property,
	Plant and Equipment
			2013			2012			2011
			(Dollars in thousands)
	Segment expenditures for property, plant and equipment		$	62,420		$	58,042		$	41,415
	Corporate expenditures for property, plant and equipment			1,160			7,352			3,167
Total expenditures for property, plant and equipment		$	63,580		$	65,394		$	44,582
Effective January 1, 2014, the Company realigned its operating segments.  The Vascular, Anesthesia/Respiratory and Surgical businesses, which previously comprised much of the Americas reporting segment, are now separate reporting segments. Additionally, the Company made changes to the allocation methodology of certain costs, including manufacturing variances and research and development costs, amongst the businesses to improve accountability. Because the change in segment reporting structure became effective in the first quarter of 2014, the segment information presented above does not reflect this change.
The following table provides total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2013,  2012 and 2011:
		Year Ended
		2013			2012			2011
		(Dollars in thousands)
Net revenues (based on business unit location):
United States		$	844,884		$	789,771		$	762,957
Other Americas			57,656			53,665			55,228
Germany			133,598			123,355			128,072
Other Europe			438,567			393,627			403,274
All Other			221,566			190,591			142,997
		$	1,696,271		$	1,551,009		$	1,492,528
Net property, plant and equipment:
United States		$	203,985		$	180,833		$	159,042
Other Americas			12,350			12,828			12,492
Germany			12,135			12,197			8,549
Other Europe			61,891			58,843			53,775
All Other			35,539			33,244			18,054
		$	325,900		$	297,945		$	251,912

Condensed_Consolidating_Guaran

Condensed Consolidating Guarantor Financial Information	12 Months Ended
	Dec. 31, 2013
Condensed Consolidating Guarantor Financial Information	'
	Note 17 —Condensed consolidating guarantor financial information
	In June 2011, Teleflex Incorporated (referred to below as “Parent Company”) issued $250 million of 6.875% senior subordinated notes through a registered public offering. The notes are guaranteed, jointly and severally, by certain of the Parent Company’s subsidiaries (each, a “Guarantor Subsidiary” and collectively, the “Guarantor Subsidiaries”). The guarantees are full and unconditional, subject to certain customary release provisions. Each Guarantor Subsidiary is directly or indirectly 100% owned by the Parent Company. The Company’s condensed consolidating statements of income (loss) and comprehensive income (loss) and condensed consolidating statements of cash flows for the years ended December 31, 2013, December 31, 2012 and December 31, 2011 and condensed consolidating balance sheets as of December 31, 2013 and December 31, 2012, each of which are set forth below, provide condensed consolidating information for:
	a.	Parent Company, the issuer of the guaranteed obligations;
	b.	Guarantor Subsidiaries, on a combined basis;
	c.	Non-guarantor subsidiaries, on a combined basis; and
	d.	Parent Company and its subsidiaries on a consolidating basis.
	The same accounting policies as described in Note 1 to the consolidated financial statements are used by the Parent Company and each of its subsidiaries in connection with the condensed consolidating financial information set forth below, with the exception that the Parent Company and Guarantor Subsidiaries use the equity method of accounting to reflect ownership interests in subsidiaries which are eliminated upon consolidation.
	Consolidating entries and eliminations in the following condensed consolidating financial statements represent adjustments to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor Subsidiaries and the Non-guarantor subsidiaries, (b) eliminate the investments in subsidiaries and (c) record consolidating entries.
	During 2013, we made two adjustments to the 2012 condensed consolidating balance sheet included within the guarantor financial information to correct 1) the presentation of intercompany payables, receivables and loans, which had been improperly netted; and 2) the classification and elimination of an intercompany investment, which had been improperly classified as a non-guarantor rather than a guarantor.
	The following table illustrates the increase/(decrease) to the previously reported amounts as of December 31, 2012:
			Parent			Guarantor			Non-Guarantor						Condensed
			Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
			(Dollars in thousands)
	Accounts receivable, net		$	-		$	(763,757	)	$	(229,467	)	$	993,224			$	-
	Accounts receivable from consolidated subsidiaries			422,058			2,520,933			192,170			(3,135,161	)			-
	Investments in affiliates			-			87,855			-			(87,855	)			-
	Note receivable and other amounts due from consolidated subsidiaries			529,913			804,843			77			(1,334,833	)			-
	Other assets			-			(2,699,168	)		(700,354	)		3,399,522				-
	Total assets		$	951,971		$	(49,294	)	$	(737,574	)	$	(165,103	)		$	-
	Accounts payable		$	(77,129	)	$	(829,286	)	$	(86,809	)	$	993,224			$	-
	Accounts payable to consolidated subsidiaries			2,563,602			512,145			59,414			(3,135,161	)			-
	Notes payable and other amounts due to consolidated subsidiaries			878,148			275,674			183,741			(1,337,563	)			-
	Other liabilities			(2,412,650	)		(7,827	)		(981,775	)		3,402,252				-
	Total liabilities			951,971			(49,294	)		(825,429	)		(77,248	)			-
	Total common shareholders’ equity			-			-			87,855			(87,855	)			-
	Total equity			-			-			87,855			(87,855	)			-
	Total liabilities and equity		$	951,971		$	(49,294	)	$	(737,574	)	$	(165,103	)		$	-
	In addition, we adjusted the 2012 and 2011 condensed consolidating statement of cash flows included within the guarantor financial information to correctly present dividends received from subsidiaries as an operating activity.
	The following tables illustrate the increase/(decrease) to the previously reported amounts as of December 31, 2012 and 2011:
			Year Ended December 31, 2012
			Parent			Guarantor			Non-Guarantor						Condensed
			Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
			(Dollars in thousands)
	Cash Flows from Operating Activities of Continuing Operations		$	1,077		$	71,965		$	25,861		$	-98,903		$	-
	Cash Flows from Financing Activities of Continuing Operations:
	Intercompany transactions			(1,077	)		(55,065	)		56,142			-
																-
	Intercompany dividends paid			-			(16,900	)		(82,003	)		98,903			-
	Cash Flows from Financing Activities of Continuing Operations		$	(1,077	)	$	(71,965	)	$	(25,861	)	$	98,903		$	-
			Year Ended December 31, 2011
			Parent			Guarantor			Non-Guarantor						Condensed
			Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
			(Dollars in millions)
	Cash Flows from Operating Activities of Continuing Operations		$	1,450		$	86,896		$	15,278		$	(103,624	)	$	-
	Cash Flows from Financing Activities of Continuing Operations:
	Intercompany transactions			(1,450	)		(68,596	)		70,046			-			-
	Intercompany dividends paid						(18,300	)		(85,324	)		103,624			-
	Cash Flows from Financing Activities of Continuing Operations		$	(1,450	)	$	(86,896	)	$	(15,278	)	$	103,624		$	-
	The corrections had no impact on the consolidated financial information, but rather, resulted in reclassifications amongst the parent, guarantor subsidiaries, non-guarantor subsidiaries and eliminations as illustrated above.  We do not consider the errors to be material to the previously issued consolidated financial statements.  The Company will also revise the previously reported interim 2013 condensed consolidating statements of cash flows when presented in future filings.
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
			Year Ended December 31, 2013
			Parent			Guarantor			Non-Guarantor						Condensed
			Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
			(Dollars in thousands)
	Net revenues		$	-		$	1,001,404		$	963,184		$	(268,317	)	$	1,696,271
	Cost of goods sold			-			582,110			543,717			(268,501	)		857,326
	Gross profit			-			419,294			419,467			184			838,945
	Selling, general and administrative expenses			39,176			284,960			178,358			(307	)		502,187
	Research and development expenses			-			55,694			9,351			-			65,045
	Restructuring and other impairment charges			935			15,288			22,229			-			38,452
	Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes			(40,111	)		63,352			209,529			491			233,261
	Interest expense			134,879			(85,058	)		7,084			-			56,905
Interest income			(15	)		(5	)		(604	)		-			(624	)
Loss on extinguishments of debt			1,250			-			-			-			1,250
Income (loss) from continuing operations before taxes			(176,225	)		148,415			203,049			491			175,730
Taxes (benefit) on income (loss) from continuing operations			(63,857	)		42,804			45,354			(754	)		23,547
Equity in net income (loss) of consolidated subsidiaries			263,469			141,773			288			(405,530	)		-
Income (loss) from continuing operations			151,101			247,384			157,983			(404,285	)		152,183
Operating income (loss) from discontinued operations			(1,947	)		-			(258	)		-			(2,205	)
Taxes (benefit) on income (loss) from discontinued operations			(1,727	)		(170	)		127			-			(1,770	)
Income (loss) from discontinued operations			(220	)		170			(385	)		-			(435	)
Net income (loss)			150,881			247,554			157,598			(404,285	)		151,748
Less: Income from continuing operations attributable to noncontrolling interests			-			-			867			-			867
Net income (loss) attributable to common shareholders			150,881			247,554			156,731			(404,285	)		150,881
Other comprehensive income attributable to common shareholders			21,193			1,960			5,442			(7,402	)		21,193
Comprehensive income (loss) attributable to common shareholders		$	172,074		$	249,514		$	162,173		$	(411,687	)	$	172,074
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
Net revenues		$	-		$	950,888		$	833,903		$	(233,782	)	$	1,551,009
Cost of goods sold			-			552,726			482,881			(232,823	)		802,784
Gross profit			-			398,162			351,022			(959	)		748,225
Selling, general and administrative expenses			34,657			259,476			160,089			267			454,489
Research and development expenses			-			48,649			7,629			-			56,278
Goodwill impairment			-			331,779			349			-			332,128
Restructuring and other impairment charges			-			598			2,439			-			3,037
Net gain on sales of businesses and assets			(116,193	)		(149,240	)		(332	)		265,433			(332	)
Income (loss) from continuing operations before interest and taxes			81,536			(93,100	)		180,848			(266,659	)		(97,375	)
Interest expense			143,653			(81,328	)		7,240			-			69,565
Interest income			(372	)		(23	)		(1,176	)		-			(1,571	)
Income (loss) from continuing operations before taxes			(61,745	)		(11,749	)		174,784			(266,659	)		(165,369	)
Taxes (benefit) on income (loss) from continuing operations			(63,806	)		45,068			35,670			(519	)		16,413
Equity in net income (loss) of consolidated subsidiaries			(190,742	)		124,918			-			65,824			-
Income (loss) from continuing operations			(188,681	)		68,101			139,114			(200,316	)		(181,782	)
Operating income (loss) from discontinued operations			(2,647	)		(9,179	)		2,619			-			(9,207	)
Taxes (benefit) on income (loss) from discontinued operations			(1,271	)		(129	)		(487	)		-			(1,887	)
Income (loss) from discontinued operations			(1,376	)		(9,050	)		3,106			-			(7,320	)
Net income (loss)			(190,057	)		59,051			142,220			(200,316	)		(189,102	)
Less: Income from continuing operations attributable to noncontrolling interests			-			-			955			-			955
Net income (loss) attributable to common shareholders			(190,057	)		59,051			141,265			(200,316	)		(190,057	)
Other comprehensive income attributable to common shareholders			27,305			10,475			8,907			(19,382	)		27,305
Comprehensive income (loss) attributable to common shareholders		$	(162,752	)	$	69,526		$	150,172		$	(219,698	)	$	(162,752	)
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2011
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
Net revenues		$	-		$	923,000		$	804,867		$	(235,339	)	$	1,492,528
Cost of goods sold			-			552,606			467,711			(236,567	)		783,750
Gross profit			-			370,394			337,156			1,228			708,778
Selling, general and administrative expenses			39,614			231,490			152,573			232			423,909
Research and development expenses			-			41,648			7,064			-			48,712
Restructuring and other impairment charges			11			4,615			1,379			-			6,005
Net loss on sales of businesses and assets			-			-			582			-			582
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes			(39,625	)		92,641			175,558			996			229,570
Interest expense			138,460			(68,926	)		783			-			70,317
Interest income			(384	)		(67	)		(809	)		-			(1,260	)
Loss on extinguishments of debt			15,413			-			-			-			15,413
Income (loss) from continuing operations before taxes			(193,114	)		161,634			175,584			996			145,100
Taxes (benefit) on income (loss) from continuing operations			(73,608	)		52,667			47,044			(325	)		25,778
Equity in net income of consolidated subsidiaries			473,311			397,131			-			(870,442	)		-
Income from continuing operations			353,805			506,098			128,540			(869,121	)		119,322
Operating income (loss) from discontinued operations			(55,872	)		40,287			308,268			-			292,683
Taxes (benefit) on income (loss) from discontinued operations			(25,396	)		88,582			23,852			-			87,038
Income (loss) from discontinued operations			(30,476	)		(48,295	)		284,416			-			205,645
Net income			323,329			457,803			412,956			(869,121	)		324,967
Less: Income from continuing operations attributable to noncontrolling interests			-			-			1,021			-			1,021
Income from discontinued operations attributable to noncontrolling interest			-			-			617			-			617
Net income attributable to common shareholders			323,329			457,803			411,318			(869,121	)		323,329
Other comprehensive income (loss) attributable to common shareholders			(107,473	)		(75,928	)		(75,737	)		151,665			(107,473	)
Comprehensive income attributable to common shareholders		$	215,856		$	381,875		$	335,581		$	(717,456	)	$	215,856
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents		$	42,749		$	14,500		$	374,735		$	-		$	431,984
Accounts receivable, net			1,822			10,948			279,048			3,472			295,290
Accounts receivable from consolidated subsidiaries			42,865			2,623,314			214,469			(2,880,648	)		-
Inventories, net			-			211,165			138,165			(15,709	)		333,621
Prepaid expenses and other current assets			15,200			6,870			17,740			-			39,810
Prepaid taxes			27,487			-			9,017			-			36,504
Deferred tax assets			20,218			22,472			10,230			(3	)		52,917
Assets held for sale			1,669			3,503			5,256			-			10,428
Total current assets			152,010			2,892,772			1,048,660			(2,892,888	)		1,200,554
Property, plant and equipment, net			14,189			188,455			123,256			-			325,900
Goodwill			-			797,671			556,532			-			1,354,203
Intangibles assets, net			-			962,243			293,354			-			1,255,597
Investments in affiliates			5,489,676			1,478,429			21,382			(6,987,772	)		1,715
Deferred tax assets			35,877			-			4,476			(39,410	)		943
Notes receivable and other amounts due from consolidated subsidiaries			1,049,344			873,105			14,169			(1,936,618	)		-
Other assets			24,574			7,447			38,074			-			70,095
Total assets		$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
LIABILITIES AND EQUITY
Current liabilities
Notes payable		$	351,587		$	-		$	4,700		$	-		$	356,287
Accounts payable			2,194			45,802			23,971			-			71,967
Accounts payable to consolidated subsidiaries			2,644,296			147,957			88,395			(2,880,648	)		-
Accrued expenses			15,569			21,120			38,179			-			74,868
Current portion of contingent consideration			-			4,131			-			-			4,131
Payroll and benefit-related liabilities			15,976			21,818			35,296			-			73,090
Accrued interest			8,720			-			5			-			8,725
Income taxes payable			-			-			23,821			-			23,821
Other current liabilities			9,646			7,517			5,072			(4	)		22,231
Total current liabilities			3,047,988			248,345			219,439			(2,880,652	)		635,120
Long-term borrowings			930,000			-			-			-			930,000
Deferred tax liabilities			-			496,228			57,896			(39,409	)		514,715
Pension and other postretirement benefit liabilities			57,406			33,777			18,315			-			109,498
Noncurrent liability for uncertain tax positions			11,389			17,241			26,522			-			55,152
Notes payable and other amounts due to consolidated subsidiaries			785,476			957,451			197,173			(1,940,100	)		-
Other liabilities			19,884			16,221			12,401			-			48,506
Total liabilities			4,852,143			1,769,263			531,746			(4,860,161	)		2,292,991
Total common shareholders' equity			1,913,527			5,430,859			1,565,668			(6,996,527	)		1,913,527
Noncontrolling interest			-			-			2,489			-			2,489
Total equity			1,913,527			5,430,859			1,568,157			(6,996,527	)		1,916,016
Total liabilities and equity		$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents		$	70,860		$	1,989		$	264,190		$	-		$	337,039
Accounts receivable, net			2,147			10,523			282,142			3,164			297,976
Accounts receivable from consolidated subsidiaries			422,058			2,520,933			192,170			(3,135,161	)		-
Inventories, net			-			202,748			136,492			(15,893	)		323,347
Prepaid expenses and other current assets			7,769			5,294			15,649			-			28,712
Prepaid taxes			11,079			-			19,217			(3,136	)		27,160
Deferred tax assets			13,987			30,201			7,882			(1,045	)		51,025
Assets held for sale			-			2,738			5,225			-			7,963
Total current assets			527,900			2,774,426			922,967			(3,152,071	)		1,073,222
Property, plant and equipment, net			7,258			168,451			122,236			-			297,945
Goodwill			-			694,070			544,382			-			1,238,452
Intangibles assets, net			-			782,631			276,161			-			1,058,792
Investments in affiliates			5,226,567			1,369,056			21,379			(6,614,936	)		2,066
Deferred tax assets			59,644			-			4,248			(62,545	)		1,347
Notes receivable and other amounts due from consolidated subsidiaries			529,913			804,843			77			(1,334,833	)		-
Other assets			33,937			8,096			19,830			-			61,863
Total assets		$	6,385,219		$	6,601,573		$	1,911,280		$	(11,164,385	)	$	3,733,687
LIABILITIES AND EQUITY
Current liabilities
Notes payable		$	-		$	-		$	4,700		$	-		$	4,700
Accounts payable			3,366			44,468			27,331			-			75,165
Accounts payable to consolidated subsidiaries			2,563,602			512,145			59,414			(3,135,161	)		-
Accrued expenses			11,338			20,471			33,255			-			65,064
Current portion of contingent consideration			-			21,115			2,578			-			23,693
Payroll and benefit-related liabilities			24,633			19,799			30,154			-			74,586
Accrued interest			9,413			-			5			-			9,418
Income taxes payable			-			1,322			18,709			(3,136	)		16,895
Other current liabilities			598			704			5,522			(1,045	)		5,779
Total current liabilities			2,612,950			620,024			181,668			(3,139,342	)		275,300
Long-term borrowings			965,280			-			-			-			965,280
Deferred tax liabilities			-			426,754			54,664			(62,544	)		418,874
Pension and other postretirement benefit liabilities			114,257			37,269			19,420			-			170,946
Noncurrent liability for uncertain tax positions			13,131			22,127			26,721			-			61,979
Notes payable and other amounts due to consolidated subs			878,148			275,674			183,741			(1,337,563	)		-
Other liabilities			22,503			27,720			9,548			-			59,771
Total liabilities			4,606,269			1,409,568			475,762			(4,539,449	)		1,952,150
Total common shareholders' equity			1,778,950			5,192,005			1,432,931			(6,624,936	)		1,778,950
Noncontrolling interest			-			-			2,587			-			2,587
Total equity			1,778,950			5,192,005			1,435,518			(6,624,936	)		1,781,537
Total liabilities and equity		$	6,385,219		$	6,601,573		$	1,911,280		$	(11,164,385	)	$	3,733,687
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations		$	(132,459	)	$	205,954		$	304,278		$	(147,902	)	$	229,871
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment			(1,553	)		(47,633	)		(14,394	)		-			(63,580	)
Payments for businesses and intangibles acquired, net of cash acquired			-			(250,912	)		(58,096	)		-			(309,008	)
Investments in affiliates			(50	)		-			-			-			(50	)
Net cash used in investing activities from continuing operations			(1,603	)		(298,545	)		(72,490	)		-			(372,638	)
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings			680,000			-			-			-			680,000
Repayment of long-term borrowings			(375,000	)		-			-			-			(375,000	)
Debt issuance and amendment fees			(6,400	)		-			-			-			(6,400	)
Proceeds from stock compensation plans			7,609			-			-			-			7,609
Dividends			(55,917	)		-			-			-			(55,917	)
Payments to minority interest shareholders			-			-			(736	)		-			(736	)
Payments for contingent consideration			-			(14,802	)		(2,156	)		-			(16,958	)
Intercompany transactions			(141,614	)		137,304			4,310			-			-
Intercompany dividends paid			-			(17,400	)		(130,502	)		147,902			-
Net cash provided by (used in) financing activities from continuing operations			108,678			105,102			(129,084	)		147,902			232,598
Cash Flows from Discontinued Operations:
Net cash used in operating activities			(2,727	)		-			(600	)		-			(3,327	)
Net cash used in discontinued operations			(2,727	)		-			(600	)		-			(3,327	)
Effect of exchange rate changes on cash and cash equivalents			-			-			8,441			-			8,441
Net (decrease) increase in cash and cash equivalents			(28,111	)		12,511			110,545			-			94,945
Cash and cash equivalents at the beginning of the period			70,860			1,989			264,190			-			337,039
Cash and cash equivalents at the end of the period		$	42,749		$	14,500		$	374,735		$	-		$	431,984
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations		$	(178,782	)	$	310,736		$	160,802		$	(98,903	)	$	193,853
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment			(7,352	)		(39,118	)		(18,924	)		-			(65,394	)
Proceeds from sales of businesses and assets, net of cash sold			4,301			45,204			17,155			-			66,660
Payments for businesses and intangibles acquired, net of cash acquired			-			(105,195	)		(264,249	)		-			(369,444	)
Investments in affiliates			(80	)		-			-			-			(80	)
Net cash used in investing activities from continuing operations			(3,131	)		(99,109	)		(266,018	)		-			(368,258	)
Cash Flows from Financing Activities of Continuing Operations:
Decrease in notes payable and current borrowings			-			(421	)		(285	)		-			(706	)
Proceeds from stock compensation plans			9,003			-			-			-			9,003
Dividends			(55,589	)		-			-			-			(55,589	)
Payments for contingent consideration			-			(16,289	)		(1,307	)		-			(17,596	)
Intercompany transactions			196,850			(177,900	)		(18,950	)		-			-
Intercompany dividends paid			-			(16,900	)		(82,003	)		98,903			-
Net cash provided by (used in) financing activities from continuing operations			150,264			(211,510	)		(102,545	)		98,903			(64,888	)
Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities			(12,022	)		4,223			-			-			(7,799	)
Net cash used in investing activities			-			(2,351	)		-			-			(2,351	)
Net cash (used in) provided by discontinued operations			(12,022	)		1,872			-			-			(10,150	)
Effect of exchange rate changes on cash and cash equivalents			-			-			2,394			-			2,394
Net (decrease) increase in cash and cash equivalents			(43,671	)		1,989			(205,367	)		-			(247,049	)
Cash and cash equivalents at the beginning of the period			114,531			-			469,557			-			584,088
Cash and cash equivalents at the end of the period		$	70,860		$	1,989		$	264,190		$	-		$	337,039
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
		Year Ended December 31, 2011
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations		$	(107,279	)	$	234,145		$	71,115		$	(103,624	)	$	94,357
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment			(3,167	)		(25,840	)		(15,575	)		-			(44,582	)
Payments for businesses and intangibles acquired, net of cash acquired			-			(24,623	)		-			-			(24,623	)
Proceeds from sales of businesses and assets, net of cash sold			-			58,986			317,039			-			376,025
Investments in affiliates			(150	)		-			-			-			(150	)
Net cash (used in) provided by investing activities from continuing operations			(3,317	)		8,523			301,464			-			306,670
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from long-term borrowings			515,000			-			-			-			515,000
Repayment of long-term borrowings			(455,800	)		-			-			-			(455,800	)
Debt extinguishment, issuance and amendment fees			(18,518	)		-			-			-			(18,518	)
Decrease (increase) in notes payable and current borrowings			(25,000	)		-			286			-			(24,714	)
Proceeds from stock compensation plans			34,009			-			-			-			34,009
Dividends			(55,136	)		-			-			-			(55,136	)
Payments for contingent consideration			-			(5,947	)		-			-			(5,947	)
Intercompany transactions			220,302			(227,222	)		6,920			-			-
Intercompany dividends paid			-			(18,300	)		(85,324	)		103,624			-
Net cash provided by (used in) financing activities from continuing operations			214,857			(251,469	)		(78,118	)		103,624			(11,106	)
Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities			(12,359	)		9,306			3,174			-			121
Net cash used in investing activities			(3	)		(505	)		(2,367	)		-			(2,875	)
Net cash (used in) provided by discontinued operations			(12,362	)		8,801			807			-			(2,754	)
Effect of exchange rate changes on cash and cash equivalents			-			-			(11,531	)		-			(11,531	)
Net increase in cash and cash equivalents			91,899			-			283,737			-			375,636
Cash and cash equivalents at the beginning of the period			22,632			-			185,820			-			208,452
Cash and cash equivalents at the end of the period		$	114,531		$	-		$	469,557		$	-		$	584,088

DivestitureRelated_Activities

Divestiture-Related Activities	12 Months Ended
	Dec. 31, 2013
Divestiture-Related Activities	'
	Note 18 — Divestiture-related activities
	Assets Held for Sale
	The table below provides information regarding assets held for sale at December 31, 2013 and 2012. At December 31, 2013, these assets consisted of four buildings and other assets, which the Company is actively marketing.
			2013			2012
	Assets held for sale:		(Dollars in thousands)
	Property, plant and equipment		$	10,428		$	7,963
	Total assets held for sale		$	10,428		$	7,963
	Discontinued Operations
	The Company has recorded $2.2 million, $2.7 million and $17.1 million of expense during 2013, 2012 and 2011, respectively, associated with retained liabilities related to businesses that have been divested. Of the $17.1 million recorded in 2011, $7.5 million was associated with recall costs related to defective products, which was a subject of pending litigation related to the Company’s former Commercial Segment. During the third quarter 2011, the Company settled the litigation as it related to the recall costs and, as part of the settlement, paid $7.6 million in September 2011.
	On August 26, 2012, the Company completed the sale of the orthopedic business of its OEM Segment to Tecomet for $45.2 million in cash and realized a loss of $39 thousand, net of tax, from the sale of the business.
	On December 2, 2011, the Company completed the sale of its business units that design, engineer and manufacture air cargo systems and air cargo containers and pallets to a subsidiary of AAR CORP. for $280.0 million in cash and realized a gain of $126.8 million, net of tax, from the sale. In 2012, the Company received an additional $16.8 million in proceeds as a working capital adjustment pursuant to the terms of the agreement related to the sale of the business, which resulted in recognition of an additional gain on sale of $2.2 million, net of tax. These business units represented the sole remaining businesses in the Company’s former Aerospace Segment.
	On March 22, 2011, the Company completed the sale of its marine business to an affiliate of H.I.G. Capital, LLC for consideration of $123.1 million (consisting of $103.1 million in cash, plus a subordinated promissory note in the amount of $4.5 million and the assumption by the buyer of approximately $15.5 million in liabilities related to the marine business). Net assets transferred to the buyer in the sale included $1.5 million of cash, resulting in net cash proceeds to the Company of $101.6 million. The Company realized a gain of $57.3 million, net of tax benefits, from the sale of the business. The gain reflected the net effect of accumulated losses from pension and postretirement obligations realized by the Company of approximately $8.4 million and cumulative translation gains realized by the Company of approximately $33.4 million, resulting in a net change of approximately $25.0 million in accumulated other comprehensive income. In 2012, the $4.5 million subordinated promissory note plus related accrued interest of $0.7 million was paid by the buyer. The marine business consisted of the Company’s businesses that were engaged in the design, manufacture and distribution of steering and throttle controls and engine and drive assemblies for the recreational marine market, heaters for commercial vehicles and burner units for military field feeding appliances. The marine business represented the sole remaining business in the Company’s former Commercial Segment.
	The results of the Company’s discontinued operations for the years 2013, 2012 and 2011 were as follows:
			2013			2012			2011
			(Dollars in thousands)
	Net revenues		$	—		$	16,616		$	277,972
	Costs and other expenses			2,205			18,328			255,919
	Goodwill impairment(1)			—			9,700			—
	Gain on disposition(2)			—			2,205			270,630
	Income (loss) from discontinued operations before income taxes			(2,205	)		(9,207	)		292,683
	Taxes (benefit) on income (loss) from discontinued			(1,770	)		(1,887	)		87,038
	operations
	Income (loss) from discontinued operations			(435	)		(7,320	)		205,645
	Less: Income from discontinued operations attributable to noncontrolling interest			—			—			617
	Income (loss) from discontinued operations attributable to common shareholders		$	(435	)	$	(7,320	)	$	205,028
	-1	During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of the orthopedic business to its estimated fair value.
	-2	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the cargo systems and cargo container businesses.

Quarterly_Data

Quarterly Data	12 Months Ended
	Dec. 31, 2013
Quarterly Data	'
	QUARTERLY DATA (UNAUDITED)
			First			Second			Third			Fourth
			Quarter (2)			Quarter			Quarter			Quarter
			(Dollars in thousands, except per share)
	2013:00:00
	Net revenues		$	411,877		$	420,059		$	413,796		$	450,539
	Gross profit			200,520			209,490			203,992			224,943
	Income from continuing operations before interest, loss on extinguishment of debt and taxes			49,404			63,751			66,042			54,064
	Income from continuing operations			27,701			43,401			45,779			35,302
	Income (loss) from discontinued operations			(462	)		-766			1,029			(236	)
	Net income			27,239			42,635			46,808			35,066
	Less: Income from continuing operations attributable to noncontrolling interest			201			194			234			238
	Net income attributable to common shareholders			27,038			42,441			46,574			34,828
	Earnings per share available to common shareholders — basic(3):
	Income from continuing operations		$	0.67		$	1.05		$	1.11		$	0.85
	Income (loss) from discontinued operations			(0.01	)		(0.02	)		0.02			—
	Net income		$	0.66		$	1.03		$	1.13		$	0.85
	Earnings per share available to common shareholders — diluted(3):
	Income from continuing operations		$	0.64		$	0.99		$	1.05		$	0.78
	Income (loss) from discontinued operations			(0.01	)		(0.01	)		0.03			(0.01	)
	Net income		$	0.63		$	0.98		$	1.08		$	0.77
	2012(1):
	Net revenues		$	380,567		$	383,332		$	368,054		$	419,056
	Gross profit			184,114			184,364			180,567			199,180
	Income (loss) from continuing operations before interest and taxes			(270,378	)		64,722			49,841			58,440
	Income (loss) from continuing operations			(284,113	)		47,266			24,451			30,614
	Income (loss) from discontinued operations			605			(4,367	)		(2,521	)		(1,037	)
	Net income (loss)			(283,508	)		42,899			21,930			29,577
	Less: Income from continuing operations attributable to noncontrolling interest			227			286			188			254
	Net income (loss) attributable to common shareholders			(283,735	)		42,613			21,742			29,323
	Earnings per share available to common shareholders — basic(3):
	Income (loss) from continuing operations		$	(6.97	)	$	1.15		$	0.59		$	0.74
	Income (loss) from discontinued operations			0.01			(0.11	)		(0.06	)		(0.02	)
	Net income (loss)		$	(6.96	)	$	1.04		$	0.53		$	0.72
	Earnings per share available to common shareholders — diluted(3):
	Income (loss) from continuing operations		$	(6.97	)	$	1.14		$	0.58		$	0.72
	Income (loss) from discontinued operations			0.01			(0.10	)		(0.06	)		(0.02	)
	Net income (loss)		$	(6.96	)	$	1.04		$	0.52		$	0.7
	-1	Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.
	-2	Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.
	-3	Each quarter is calculated as a discrete period; the sum of the four quarters may not equal the calculated full year amount.

Schedule_II_Valuation_and_Qual

Schedule II - Valuation and Qualifing Accounts	12 Months Ended
	Dec. 31, 2013
Schedule II - Valuation and Qualifying Accounts	'
	TELEFLEX INCORPORATED
	SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
	ALLOWANCE FOR DOUBTFUL ACCOUNTS
		Balance at		Dispositions			Additions			Accounts			Translation			Balance at
		Beginning of					Charged to			Receivable			and Other			End of
		Year					Income			Write-offs						Year
	December 31, 2013	$	7,818	$	—		$	4,414		$	(1,446	)	$	(64	)	$	10,722
	December 31, 2012	$	6,452	$	—		$	1,730		$	(483	)	$	119		$	7,818
	December 31, 2011	$	4,138	$	(497	)	$	3,245		$	(884	)	$	450		$	6,452
	INVENTORY RESERVE
		Balance at		Dispositions			Additions			Inventory			Translation			Balance at
		Beginning of					Charged to			Write-offs			and Other			End of
		Year					Income									Year
	December 31, 2013
	Raw material	$	9,394	$	—		$	1,931		$	(5,774	)	$	136		$	5,687
	Work-in-process		1,646		—			855			(340	)		(432	)		1,729
	Finished goods		20,663		—			11,440			(11,663	)		4,517			24,957
		$	31,703	$	—		$	14,226		$	(17,777	)	$	4,221		$	32,373
	December 31, 2012
	Raw material	$	9,095	$	(504	)	$	5,206		$	(4,346	)	$	(57	)	$	9,394
	Work-in-process		2,742		—			1,107			(2,204	)		1			1,646
	Finished goods		21,082		—			13,175			(12,183	)		(1,411	)		20,663
		$	32,919	$	(504	)	$	19,488		$	(18,733	)	$	(1,467	)	$	31,703
	December 31, 2011
	Raw material	$	15,717	$	(5,064	)	$	877		$	(715	)	$	(1,720	)	$	9,095
	Work-in-process		5,908		(478	)		382			(355	)		(2,715	)		2,742
	Finished goods		16,659		(2,399	)		15,604			(14,426	)		5,644			21,082
		$	38,284	$	(7,941	)	$	16,863		$	(15,496	)	$	1,209		$	32,919
	DEFERRED TAX ASSET VALUATION ALLOWANCE
		Balance at		Additions			Reductions			Translation			Balance at
		Beginning of Year		Charged to			Credited to			and Other			End of Year
				Expense			Expense
	December 31, 2013	$	69,527	$	21,118		$	(1,553	)	$	-2,582		$	86,510
	December 31, 2012	$	66,305	$	6,103		$	(4,888	)	$	2,007		$	69,527
	December 31, 2011	$	49,522	$	26,743		$	(2,206	)	$	(7,754	)	$	66,305

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Consolidation	'
	Consolidation: The consolidated financial statements include the accounts of Teleflex Incorporated and its subsidiaries (the “Company”). Intercompany transactions are eliminated in consolidation. Investments in affiliates over which the Company has significant influence but not a controlling equity interest, including variable interest entities where the Company is not the primary beneficiary, are carried on the equity basis. Investments in affiliates over which the Company does not have significant influence are accounted for using the cost method of accounting. These consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and include management’s estimates and assumptions that affect the recorded amounts.
	In June 2013, the Company revised its Consolidated Statement of Cash Flows to reflect contingent consideration payments related to businesses acquired as a cash outflow from financing activities of continuing operations, thereby correcting a presentation error in previous filings.  Since 2011, these payments were reflected as a cash outflow from investing activities of continuing operations. The Company also revised the Consolidated Statements of Cash Flows, as well as the Condensed Consolidating Statements of Cash Flows included in Note 17, for the twelve months ended December 31, 2012 and 2011 to reclassify $17.6 million and $5.9 million, respectively, as cash outflows from financing activities to reflect this correction. The changes do not affect the Company’s consolidated balance sheets, statements of operations and comprehensive income or statements of changes in stockholders’ equity. Moreover the reclassifications resulting from the change were not considered material to any previously issued financial statements.
	We made certain other revisions to the 2012 and 2011 guarantor financial information presented in the 2012 and 2011 Form 10-Ks to correct errors identified in the current year.  Refer to Note 17 to the consolidated financial statements for additional details.
	Other assets in the consolidated balance sheet as of December 31, 2013 include $17.6 million of receivables outstanding greater than one year.
Use of Estimates	'
	Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	'
	Cash and cash equivalents: All highly liquid debt instruments with an original maturity of three months or less are classified as cash equivalents. The carrying value of cash equivalents approximates their current market value.
Accounts Receivable	'
	Accounts receivable: Accounts receivable represents amounts due from customers related to the sale of products and provision of services. An allowance for doubtful accounts is maintained and represents the Company’s estimate of the amount of uncollectible receivables. The allowance is provided at such time as management believes reasonable doubt exists that such balances will be collected within a reasonable period of time. The allowance is based on the Company’s historical experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. The allowance for doubtful accounts was $10.7 million and $7.8 million as of December 31, 2013 and 2012, respectively. See Note 9 to the consolidated financial statements for information on the Company’s concentration of credit risk. In addition, we maintain a reserve for returns and allowances based on the Company’s historical experience. The reserve for returns and allowances was $3.3 million and $2.9 million as of December 31, 2013 and 2012, respectively.
Inventories	'
	Inventories:  Inventories are valued at the lower of cost or market. The cost of the Company’s inventories is determined using the average cost method. Elements of cost in inventory include raw materials, direct labor, and manufacturing overhead. In estimating market value, the Company evaluates inventory for excess and obsolete quantities based on estimated usage and sales.
Property, Plant and Equipment	'
	Property, plant and equipment: Property, plant and equipment are stated at cost, net of accumulated depreciation. Costs incurred to develop internal-use computer software during the application development stage generally are capitalized. Costs of enhancements to internal-use computer software are capitalized, provided that these enhancements result in additional functionality. Other additions and those improvements which increase the capacity or lengthen the useful lives of the assets are also capitalized. With minor exceptions, composite useful lives for property, plant and equipment, which are depreciated on a straight-line basis are as follows: land improvements — 5 years; buildings — 30 years; machinery and equipment — 3 to 10 years; computer equipment and software — 3 to 10 years. Leasehold improvements are depreciated over the remaining lease periods. Repairs and maintenance costs are expensed as incurred.
Goodwill and Other Intangible Assets	'
	Goodwill and other intangible assets: Goodwill and other intangible assets with indefinite lives are not amortized but are tested for impairment annually during the fourth quarter or more frequently if events or changes in circumstances indicate that an impairment may exist. Impairment losses, if any, are included in income from operations. The goodwill impairment test is applied to each of the Company’s reporting units with goodwill. For purposes of this assessment, a reporting unit is an operating segment, or a business one level below that operating segment (a component) if discrete financial information is prepared and regularly reviewed by segment management. However, separate components are aggregated as a single reporting unit if they have similar economic characteristics.
	In applying the goodwill impairment test, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors may include, but are not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategies and financial performance. If, after completing such assessment, it is determined more likely than not that the fair value of a reporting unit is less than its carrying value, the Company proceeds to a two-step quantitative impairment test. Alternatively, the Company may proceed directly to testing goodwill for impairment through the two-step impairment test without conducting the qualitative analysis. In the fourth quarter 2013, the Company elected to forgo the qualitative assessment and test all reporting units with goodwill through the two-step quantitative impairment test.
	The first step of the two-step impairment test is to quantitatively compare the fair value of a reporting unit, including goodwill, to its carrying value. In performing the first step, the Company calculates the fair value of the reporting unit using equal weighting of two methods; one which estimates the discounted cash flows (“DCF”) of the reporting unit based on projected earnings in the future (the Income Approach) and one which is based on sales of similar assets in actual transactions (the Market Approach). If the reporting unit fair value exceeds the carrying value, there is no impairment. If the reporting unit carrying value exceeds the fair value, the Company would perform the second step of the goodwill impairment test, in which the Company would recognize an impairment loss if the carrying value of goodwill exceeds its implied fair value. The implied fair value of goodwill is determined by deducting the fair value of a reporting unit's identifiable assets and liabilities from the fair value of the reporting unit as a whole, as if that reporting unit had just been acquired and the fair value of the individual assets acquired and liabilities assumed initially were being determined. The Company performed the goodwill impairment test during the fourth quarter 2013, and for each reporting unit whose assets include goodwill, the fair value of each of the reporting units exceeded the carrying value.  As a result, no impairment in the carrying value of any of the Company’s reporting units was evident.
	The Company’s intangible assets consist of customer lists, intellectual property, distribution rights and trade names. The Company tests its indefinite-lived intangible assets for impairment annually, and more frequently if events or changes in circumstances indicate that an impairment may exist. Similar to the goodwill impairment test process, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If, after completing such qualitative assessment, the Company determines it is more likely than not that the fair value of the indefinite-lived intangible asset is greater than its carrying amount, the asset is not impaired. If the Company concludes it is more likely than not that the fair value of the indefinite-lived intangible assets is less than the carrying value, the Company then proceeds to a quantitative impairment test, which consists of a comparison of the fair value of the intangible assets to their carrying amounts. Alternatively, the Company may elect to forgo the qualitative analysis and proceed directly to testing the indefinite-lived intangible asset for impairment through the quantitative impairment test. The Company recorded IPR&D impairment charges of $7.4 million in 2013 upon the decision to abandon certain of the IPR&D projects. See Note 4 to the consolidated financial statements for further information related to these charges. No other impairment charge was evident for indefinite-lived intangible assets as a result of the fourth quarter 2013 impairment assessment.
	Intangible assets consisting of intellectual property, customer lists, distribution rights and certain tradenames are being amortized over their estimated useful lives, which are as follows: intellectual property, 3 to 20 years; customer lists, 5 to 30 years; distribution rights, 3 to 22 years; tradenames, 1 to 30 years. The weighted average amortization period is approximately 16 years. The Company periodically evaluates the reasonableness of the useful lives of these assets.
Long-Lived Assets	'
	Long-lived assets: We assess the remaining useful life and recoverability of long-lived assets whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. Such evaluation is based on various analyses, including undiscounted cash flow and profitability projections that incorporate, as applicable, the impact on the existing business.  Therefore, the evaluation involves significant management judgment. Any impairment loss, if indicated, is measured as the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset.
Foreign Currency Translation	'
	Foreign currency translation: Assets and liabilities of subsidiaries with non-United States dollar denominated functional currencies are translated into United States dollars at the rates of exchange at the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the year. The translation adjustments are reported as a component of accumulated other comprehensive income.
Derivative Financial Instruments	'
	Derivative financial instruments: The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in interest rates and foreign currency exchange rates. All instruments are entered into for other than trading purposes. All derivatives are recognized on the balance sheet at fair value. Changes in the fair value of derivatives are recorded in earnings or other comprehensive income, based on whether the instrument is designated as part of a hedge transaction and, if so, the type of hedge transaction. Gains or losses on derivative instruments reported in other comprehensive income are reclassified to earnings in the period in which earnings are affected by the underlying hedged item. The ineffective portion of all hedges is recognized in current period earnings. If the hedging relationship ceases to be highly effective or it becomes probable that an expected transaction will no longer occur, gains or losses on the derivative are recorded in current period earnings.
Share-Based Compensation	'
	Share-based compensation: The Company estimates the fair value of share-based awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods. Share-based compensation expense related to stock options is measured using a Black-Scholes option pricing model that takes into account highly subjective and complex assumptions. The expected life of options granted is derived from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that options granted are expected to be outstanding. Expected volatility is based on a blend of historical volatility and implied volatility derived from publicly traded options to purchase the Company’s common stock, which the Company believes is more reflective of the market conditions and a better indicator of expected volatility than would be the case if the Company only used historical volatility. The risk-free interest rate is the implied yield currently available on United States Treasury zero-coupon issues with a remaining term equal to the expected life of the option.
	Share-based compensation expense for 2013, 2012 and 2011 was $11.9 million, $8.6 million and $4.5 million, respectively, and is included in selling, general and administrative expenses. The total income tax benefit recognized for share-based compensation arrangements for 2013, 2012 and 2011 was $3.8 million, $2.7 million and $2.5 million, respectively. The higher share-based compensation expense in 2013 is primarily due to the increase in the market price of the Company’s common stock.  The lower share-based compensation expense for 2011 is primarily due to stock option and restricted share forfeitures of approximately $3 million related to the separation of the Company’s former chief executive officer.
	As of December 31, 2013, unamortized share-based compensation cost related to non-vested stock options, net of expected forfeitures, was $4.4 million, which is expected to be recognized over a weighted-average period of 1.92 years. Unamortized share-based compensation cost related to non-vested shares (restricted stock), net of expected forfeitures, was $9.2 million, which is expected to be recognized over a weighted-average period of 1.81 years.
	Share-based compensation expense recognized during a period is based on the value of the portion of stock-based awards that is ultimately expected to vest during the period less estimated forfeitures. Forfeitures are required to be estimated at the time of grant. To minimize fluctuations in share-based compensation expense, management reviews and revises the estimate of forfeitures for all share-based awards on a quarterly basis based on management’s expectation of the awards that will ultimately vest. The Company issued 148,191, 178,690 and 175,291 of non-vested shares (restricted stock) in 2013, 2012 and 2011, respectively, the majority of which vest on the third anniversary of the grant date (cliff vesting).
Income Taxes	'
	Income taxes: The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized to reflect the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases, and to reflect operating loss and tax credit carryforwards. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Provision has been made for income taxes on unremitted earnings of subsidiaries and affiliates, except for subsidiaries in which earnings are deemed to be permanently reinvested.
	Significant judgment is required in determining income tax provisions and in evaluating tax positions. The Company establishes additional provisions for income taxes when, despite the belief that tax positions are supportable, there remain certain positions that do not meet the minimum probability threshold, which is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of its provision for income taxes. Interest accrued related to unrecognized tax benefits and income tax related penalties are both included in taxes on income from continuing operations. The Company periodically assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, the current tax liability and deferred taxes in the period in which the facts that give rise to an adjustment become known.
Pensions and Other Postretirement Benefits	'
	Pensions and other postretirement benefits: The Company provides a range of benefits to eligible employees and retired employees, including pensions and postretirement healthcare. The Company records annual amounts relating to these plans based on calculations which include various actuarial assumptions such as discount rates, expected rates of return on plan assets, compensation increases, turnover rates and healthcare cost trend rates. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends when appropriate. The effect of the modifications is generally amortized over future periods.
Restructuring Costs	'
	Restructuring costs: Restructuring costs, which include termination benefits, facility closure costs, contract termination costs and other restructuring costs are recorded at estimated fair value. Key assumptions in calculating the restructuring costs include the terms and payments that may be negotiated to terminate certain contractual obligations and the timing of reductions in force.
Revenue Recognition	'
	Revenue recognition: The Company recognizes revenues from product sales, including sales to distributors, or services provided when the following revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectability is reasonably assured. This generally occurs when products are shipped, when services are rendered or upon customers’ acceptance. Revenues are net of estimated returns and other allowances. The Company’s estimated returns and allowances are calculated based on historical experience and current trends.
	The Company’s normal policy is to accept returns only in cases in which the product is defective and covered under the Company’s standard warranty provisions. However, in the limited cases where an arrangement provides a right of return to the customer, including a distributor, the Company believes it has the ability to reasonably estimate the amount of returns based on its substantial historical experience with respect to these arrangements. The Company accrues any costs or losses that may be expected in connection with any returns in accordance with FASB Accounting Standards Codification (“ASC”) Topic 450, “Contingencies.” Revenues and cost of goods sold are reduced to reflect estimated returns.
	Allowances related to customer incentive programs, which include discounts or rebates, are estimated and provided for in the period that the related sales are recorded. These allowances are recorded as a reduction of revenue.
	The Company offers rebates to certain distributors and reserves an estimate for the rebates as a reduction of revenues at the time of sale. In estimating rebates, the Company considers the lag time between the point of sale and the payment of the distributor’s rebate claim, distributor-specific trend analyses, contractual commitments, including stated rebate rates, historical experience and other relevant information. The Company adjusts reserves to reflect differences between estimated and actual experience, and record such adjustment as a reduction of sales in the period of adjustment.  The reserve for estimated rebates was $7.8 million and $19.5 million at December 31, 2013 and 2012, respectively. The decrease in accrued rebates in 2013 as compared to 2012 was primarily due to the continued migration to a common global ERP platform, specifically, the integration of our LMA and Arrow businesses, which resulted in reduced processing lag time (from monthly to daily payments in many instances).  There were no significant changes in estimates recorded during the year.  We expect the reserve as of December 31, 2013 to be paid within 90 days subsequent to year-end.

New_Accounting_Standards_Polic

New Accounting Standards (Policies)	12 Months Ended
	Dec. 31, 2013
New Accounting Pronouncements, Policy	'
	Recently adopted
	In February 2013, the FASB issued an amendment to its accounting guidance on reporting amounts reclassified out of accumulated other comprehensive income. The guidance requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items on the face of the statement where net income is presented, or in the notes to the financial statements, if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about the effect of the reclassifications. The guidance was effective prospectively for reporting periods beginning after December 15, 2012. Refer to Note 11 to the consolidated financial statements for new disclosures resulting from the adoption of this amendment.

Acquisitions_Tables

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Values Determination of Assets Acquired and Liabilities Assumed in Acquisition	'
	The following table presents the preliminary fair values determination of the assets acquired and liabilities assumed in the acquisitions that occurred during 2013:
		(Dollars in millions)
	Assets
	Current assets	$	21
	Property, plant and equipment		1.4
	Intangible assets:
	Intellectual property		159.5
	Tradenames		26.5
	In-process research and development		19.9
	Customer lists		49.6
	Goodwill		123.3
	Total assets acquired		401.2
	Less:
	Current liabilities		5.4
	Deferred tax liabilities		88.8
	Liabilities assumed		94.2
	Net assets acquired	$	307

Restructuring_and_other_impair1

Restructuring and other impairment charges (Tables)	12 Months Ended
	Dec. 31, 2013
Restructuring and Other Impairment Charges	'
	The amounts recognized in restructuring and other impairment charges for the twelve months ended December 31, 2013, 2012 and 2011 consisted of the following:
		2013				2012				2011
		(Dollars in thousands)
	LMA restructuring program	$	12,152			$	2,515			$	—
	2013 restructuring charges		10,230				—				—
	2012 restructuring charges		4,229				2,459				—
	2011 restructuring program		770				—				3,047
	2007 Arrow integration program		230				(1,937	)			461
	In-process research and development impairment		7,381				—				—
	Long-lived asset impairment		3,460				—				—
	Investments in affiliates impairment		—				—				2,497
	Restructuring and other impairment charges	$	38,452			$	3,037			$	6,005
LMA Restructuring Program	'
Restructuring and Other Impairment Charges	'
	The charges associated with this restructuring program that are included in restructuring and other impairment charges for the twelve months ended December 31, 2013 and 2012 were as follows:
		2013				2012
		(Dollars in thousands)
	Termination benefits	$	3,282			$	2,229
	Facility closure costs		788				—
	Contract termination costs		7,906				274
	Other restructuring costs		176				12
		$	12,152			$	2,515
Changes in Accrued Liability Associated with Restructuring Program	'
	A reconciliation of the changes in accrued liabilities associated with the LMA restructuring program from the inception of the program through December 31, 2013 is set forth in the following table:
		Termination							Contract			Other			Total
		benefits							Termination			Restructuring
					Facility Closure Costs				Costs			Costs
		(Dollars in thousands)
	Balance at December 31, 2011	$	—		$	—			$	—		$	—		$	—
	Subsequent accruals		2,229			—				274			12			2,515
	Cash payments		(488	)		—				—			—			(488	)
			3			—				3			—			6
	Foreign currency translation
	Balance at December 31, 2012		1,744			—				277			12			2,033
	Subsequent accruals		3,282			788				7,906			176			12,152
	Cash payments		(4,461	)		(362	)			(4,560	)		(164	)		(9,547	)
	Foreign currency translation		(13	)		1				63			(8	)		43
	Balance at December 31, 2013	$	552		$	427			$	3,686		$	16		$	4,681
2013 Restructuring Charges	'
Restructuring and Other Impairment Charges	'
	In 2013, the Company initiated programs to consolidate certain administrative and manufacturing facilities in North America and warehouse facilities in Europe and terminate certain European distributor agreements in an effort to reduce costs. The Company estimates that it will incur an aggregate of up to approximately $11 million in restructuring and other impairment charges over the term of this restructuring program. Of this amount, $5 million relates to employee termination costs, $3 million relates to termination of certain distributor agreements and $3 million relates to facility closures costs and other actions. The charges associated with this restructuring program that are included in restructuring and other impairment charges for the twelve months ending December 31, 2013 were as follows:
		2013
		(Dollars in thousands)
	Termination benefits	$	4,787
	Contract termination costs		3,326
	Other restructuring costs		2,117
		$	10,230
2012 Restructuring Charges	'
Restructuring and Other Impairment Charges	'
	In 2012, the Company identified opportunities to improve its supply chain strategy by consolidating its three North American warehouses into one centralized warehouse, lower costs and improve operating efficiencies through the termination of certain distributor agreements in Europe, the closure of certain North American facilities and workforce reductions. The charges associated with this restructuring program that are included in restructuring and other impairment charges for the twelve months ending December 31, 2013 and 2012 were as follows:
		2013				2012
		(Dollars in thousands)
	Termination benefits	$	2,993			$	1,681
	Facility closure costs		935				—
	Contract termination costs		296				758
	Other restructuring costs		5				20
		$	4,229			$	2,459

Inventories_Tables

Inventories (Tables)	12 Months Ended
	Dec. 31, 2013
Inventories	'
	Inventories at December 31, 2013 and 2012 consisted of the following:
		2013			2012
		(Dollars in thousands)
	Raw materials	$	70,209		$	84,636
	Work-in-process		53,672			47,440
	Finished goods		242,113			222,974
			365,994			355,050
	Less: Inventory reserves		(32,373	)		(31,703	)
	Inventories, net	$	333,621		$	323,347

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Major Classes of Property, Plant and Equipment, at Cost	'
	The major classes of property, plant and equipment, at cost, at December 31, 2013 and 2012 are as follows:
		2013			2012
		(Dollars in thousands)
	Land, buildings and leasehold improvements	$	199,741		$	201,155
	Machinery and equipment		322,060			313,325
	Computer equipment and software		102,527			70,618
	Construction in progress		55,092			41,424
			679,420			626,522
	Less: Accumulated depreciation		(353,520	)		(328,577	)
	Property, plant and equipment, net	$	325,900		$	297,945

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Changes in Carrying Amount of Goodwill, by Reporting Segment	'
	Changes in the carrying amount of goodwill, by reporting segment, for the twelve months ended December 31, 2013 and 2012 are as follows:
			Americas			EMEA			Asia			Total
			Segment			Segment			Segment
			(Dollars in thousands)
	Balance as of December 31, 2012
	Goodwill		$	1,077,829		$	353,282		$	139,469		$	1,570,580
	Accumulated impairment losses			(332,128	)		—			—			(332,128	)
				745,701			353,282			139,469			1,238,452
	Goodwill related to acquisitions			99,125			19,922			4,237			123,284
	Translation adjustment			(833	)		2,217			(8,917	)		(7,533	)
	Balance as of December 31, 2013
	Goodwill			1,176,121			375,421			134,789			1,686,331
	Accumulated impairment losses			(332,128	)		—			—			(332,128	)
			$	843,993		$	375,421		$	134,789		$	1,354,203
			Americas			EMEA			Asia			OEM			Total
			Segment			Segment			Segment			Segment
			(Dollars in thousands)
	Goodwill balance as of December 31, 2011		$	1,005,021		$	283,362		$	121,983		$	28,176		$	1,438,542
	Goodwill impairment charges			(332,128	)		—			—			—			(332,128	)
	Goodwill related to acquisitions			78,875			69,723			15,384			—			163,982
	Goodwill related to dispositions			—			—			—			(28,176	)		(28,176	)
	Purchase accounting adjustments(1)			(8,878	)		—			(2,126	)		—			(11,004	)
	Translation adjustment			2,132			876			4,228			—			7,236
	Transfer of goodwill			679			(679	)		—			—			—
	Balance as of December 31, 2012
	Goodwill			1,077,829			353,282			139,469			—			1,570,580
	Accumulated impairment losses			(332,128	)		—			—			—			(332,128	)
			$	745,701		$	353,282		$	139,469		$	—		$	1,238,452
	·	Purchase accounting adjustments related to the finalization of the purchase price allocation of uncertain tax positions and deferred taxes for the LMA acquisition. The purchase accounting adjustments were completed in 2013, however, in accordance with ASC Topic 805, “Business Combinations,” the Company retrospectively adjusted the December 31, 2012 balance sheet, as well as the Condensed Consolidating Balance Sheet included in Note 17, for these adjustments as the acquisition occurred in 2012.
Components of Intangible Assets	'
	Intangible assets at December 31, 2013 and 2012 consisted of the following:
			Gross Carrying Amount						Accumulated Amortization
			2013			2012			2013			2012
			(Dollars in thousands)
	Customer lists		$	628,020		$	580,151		$	(168,223	)	$	(141,520	)
	In-process research and development			68,786			53,157			—			—
	Intellectual property			435,869			276,458			(118,086	)		(95,967	)
	Distribution rights			16,797			16,567			(14,592	)		(13,880	)
	Trade names			407,879			384,131			(1,148	)		(305	)
	Noncompete agreements			337			—			(42	)		—
			$	1,557,688		$	1,310,464		$	(302,091	)	$	(251,672	)
Estimated Annual Amortization Expense	'
	Amortization expense related to intangible assets was $50.6 million, $44.3 million, and $42.6 million for 2013, 2012 and 2011, respectively. Estimated annual amortization expense for each of the five succeeding years is as follows:
			(Dollars in thousands)
	2014		$	59,100
	2015			53,300
	2016			52,900
	2017			52,400
	2018			51,900

Borrowings_Tables

Borrowings (Tables)	12 Months Ended
	Dec. 31, 2013
Components of Long-Term Debt	'
	The components of long-term debt at December 31, 2013 and 2012 are as follows:
		2013			2012
		(Dollars in thousands)
	Senior Credit Facility:
	Revolving credit facility, at a rate of 1.92% at December 31, 2013, due 7/16/2018	$	680,000		$	—
	Term loan facility, at a rate of 2.75% at December 31, 2012		—			375,000
	3.875% Convertible Senior Subordinated Notes		400,000			400,000
	6.875% Senior Subordinated Notes due 2019		250,000			250,000
			1,330,000			1,025,000
	Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes		(48,413	)		(59,720	)
			1,281,587			965,280
	Current portion of borrowings		(351,587	)		—
		$	930,000		$	965,280
Interest Expense Amounts Related to Convertible Notes	'
	The Company allocated the proceeds of the Convertible Notes between the liability and equity components of the debt. The initial $316.3 million liability component was determined based on the fair value of a similar debt instrument excluding the conversion feature. The initial $83.7 million ($53.3 million net of tax) equity component represented the difference between the fair value or carrying value of $316.3 million of the debt and the $400.0 million of proceeds. The related debt discount of $83.7 million will be amortized under the interest method over the remaining life of the Convertible Notes, which, at December 31, 2013, is approximately 3.6 years. An effective interest rate of 7.814% was used to calculate the debt discount on the Convertible Notes. The following table provides interest expense amounts related to the Convertible Notes for the periods presented:
	(in millions)	Year Ended			Year Ended			Year Ended
		December 31, 2013			December 31, 2012			December 31, 2011
	Interest cost related to contractual interest coupon	$	15.5		$	15.5		$	15.5
	Interest cost related to amortization of the discount	$	11.3		$	10.5		$	9.7
Carrying Value of Convertible Notes	'
	The following table provides the carrying value of the Convertible Notes as of December 31, 2013 and 2012:
	(in millions)	December 31, 2013			December 31, 2012
	Principal amount of the Convertible Notes	$	400		$	400
	Unamortized discount		(48.4	)		(59.7	)
	Net carrying amount	$	351.6		$	340.3
Fair Value of Debt	'
	The carrying amount of long-term debt reported in the consolidated balance sheet as of December 31, 2013 is $1,281.6 million. The Company uses a discounted cash flow technique that incorporates a market interest yield curve with adjustments for duration, optionality, and risk profile to determine the fair value of its debt. The Company’s implied credit rating is a factor in determining the market interest yield curve. The following table provides the fair value of the Company’s debt by fair value hierarchy level (see Note 10 to the consolidated financial statements further information) as of December 31, 2013 and 2012:
		Fair value of debt
		December 31, 2013			December 31, 2012
			(Dollars in thousands)
	Level 1	$	899,390		$	782,377
	Level 2		644,012			382,634
	Total	$	1,543,402		$	1,165,011
Aggregate Amounts of Long-Term Debt	'
	As of December 31, 2013, the aggregate amounts of long-term debt, demand loans and debt under the Company’s securitization program that will mature during each of the next four fiscal years and thereafter were as follows:
		(Dollars in thousands)
	2014(1)	$	404,700
	2015		—
	2016		—
	2017		—
	2018 and thereafter		930,000

Financial_instruments_Tables

Financial instruments (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Values of Derivative Instruments Designated as Hedging Instruments	'
	The following table presents the balance sheet location and fair values of derivative instruments designated as hedging instruments in the consolidated balance sheet as of December 31, 2013 and 2012:
		December 31, 2013			December 31, 2012
		Fair Value			Fair Value
		(Dollars in thousands)
	Asset derivatives:
	Foreign currency exchange contracts
	Other assets – current	$	—		$	1,279
	Total asset derivatives	$	—		$	1,279
	Liability derivatives:
	Foreign currency exchange contracts
	Derivative liabilities – current	$	—		$	598
	Total liability derivatives	$	—		$	598
After Tax Gain/(Loss) Recognized in OCI	'
	The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (“OCI”) for the years ended December 31, 2013, 2012 and 2011:
		After Tax Gain/(Loss)
		Recognized in OCI
		2013			2012			2011
		(Dollars in thousands)
	Interest rate swap	$	—		$	7,032		$	8,330
	Foreign currency exchange contracts		381			(156	)		(325	)
	Total	$	381		$	6,876		$	8,005
Aggregate Accounts Receivable, Net of Allowance for Doubtful Accounts	'
	Some of the Company’s customers, particularly in Europe, have extended or delayed payments for products and services already provided. Collectability concerns regarding the Company’s accounts receivable from these customers, for the most part in Greece, Italy, Spain and Portugal resulted in an increase in the allowance for doubtful accounts related to these countries. If the financial condition of these customers or the healthcare systems in these countries deteriorate such that the ability of an increasing number of customers to make payments is uncertain, additional allowances may be required in future periods. The aggregate net current and long-term accounts receivables for Spain, Italy, Greece and Portugal and the percentage of the Company’s total net current and long-term accounts receivables represented by the net current and long-term accounts receivables in those countries at December 31, 2013 and 2012 are as follows:
		December 31, 2013			December 31, 2012
		(Dollars in thousands)
	Current and long-term accounts receivable (net of allowances of $7.9 million and $6.3 million in 2013 and 2012, respectively) in Spain, Italy, Greece and Portugal	$	97,852		$	101,009
	Percentage of total net current and long-term accounts receivables		31	%		34	%

Fair_value_measurement_Tables

Fair value measurement (Tables)	12 Months Ended
	Dec. 31, 2013
Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis	'
	The following tables provide information regarding the financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2013 and 2012:
		Total carrying				Quoted prices in				Significant		Significant
		value at				active markets				other		unobservable
		December 31,				(Level 1)				observable		inputs (Level 3)
		2013								inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	6,150			$	6,150			$	—	$	—
	Contingent consideration liabilities		20,313				—				—		20,313
		Total carrying				Quoted prices in				Significant		Significant
		value at				active markets				other		unobservable
		December 31,				(Level 1)				observable		inputs (Level 3)
		2012								inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	4,785			$	4,785			$	—	$	—
	Derivative assets		1,279				—				1,279		—
	Derivative liabilities		598				—				598		—
	Contingent consideration liabilities		51,196				—				—		51,196
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis	'
	The following table provides information regarding changes in Level 3 financial liabilities related to contingent consideration in connection with various Company acquisitions, including those described in Note 3 to the consolidated financial statements during the twelve months ended December 31, 2013 and 2012:
			Contingent consideration
			2013				2012
			(Dollars in thousands)
	Beginning balance – January 1		$	51,196			$	9,676
	Initial estimate upon acquisition			—				58,895
	Payment			(18,880	)			(18,426	)
	Revaluations			(11,982	)			1,055
	Translation adjustment			(21	)			(4	)
	Ending balance – December 31		$	20,313			$	51,196
Valuation Technique and Inputs Used to Determine Fair Value of Assets or Liabilities	'
	The following table provides information regarding the valuation techniques and inputs used in determining the fair value of the contingent consideration liabilities categorized as Level 3 measurements:
			Valuation Technique		Unobservable Input		Range (Weighted Average)
	Contingent consideration		Discounted cash flow		Discount rate			1% - 10% (6%)
					Probability of payment			0 - 100% (31%)

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding	'
	Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased for dilutive securities. The difference between basic and diluted weighted average common shares results from the assumption that dilutive stock options were exercised. The following table provides a reconciliation of basic to diluted weighted average shares outstanding:
		2013		2012				2011
		(Shares in thousands)
	Basic	41,105			40,859				40,501
	Dilutive effect of share based awards	410			—				287
	Dilutive effect of 3.875% Convertible Notes and warrants	2,178			—				13
	Diluted	43,693			40,859				40,801
Change in Accumulated Other Comprehensive Income (Loss)	'
	The following tables provide information relating to the changes in accumulated other comprehensive income (loss), net of tax, for the twelve months ended December 31, 2013 and 2012:
		Cash Flow				Pension and				Foreign			Accumulated
		Hedges				Other				Currency			Other
						Postretirement				Translation			Comprehensive
						Benefit Plans				Adjustment			Income (Loss)
		(Dollars in thousands)
	Balance at December 31, 2011	$	(7,257	)		$	(134,548	)		$	(17,548	)	$	(159,353	)
	Other comprehensive income before reclassifications		515				2,628				13,138			16,281
	Amounts reclassified from accumulated other comprehensive income		6,361				4,663				—			11,024
	Net current-period other comprehensive income		6,876				7,291				13,138			27,305
	Balance at December 31, 2012		(381	)			(127,257	)			(4,410	)		(132,048	)
	Other comprehensive income (loss) before reclassifications		(549	)			25,464				(9,408	)		15,507
	Amounts reclassified from accumulated other comprehensive income		930				4,756				—			5,686
	Net current-period other comprehensive income (loss)		381				30,220				(9,408	)		21,193
	Balance at December 31, 2013	$	—			$	(97,037	)		$	(13,818	)	$	(110,855	)
Reclassification of Gain/Losses into Income/Expense, Net of Tax	'
	The following table provides information relating to the reclassifications of losses/(gain) in accumulated other comprehensive income into expense/(income), net of tax, for the twelve months ended December 31, 2013 and 2012:
		December 31,				December 31,
		2013				2012
		(Dollars in thousands)
	Gains and losses on cash flow hedges:
	Interest Rate Contracts:
	Interest expense	$	—			$	11,057
	Foreign Currency Exchange Contracts:
	Net Revenue		—				34
	Cost of goods sold		884				(898	)
	Total before tax		884				10,193
	Tax expense (benefit)		46				(3,832	)
	Net of tax	$	930			$	6,361
	Amortization of pension and other postretirement benefits items (1):
	Actuarial losses	$	7,211			$	7,158
	Prior-service costs		(21	)			(20	)
	Transition obligation		5				97
	Curtailment charge		—				(118	)
	Settlement charge		—				106
	Total before tax		7,195				7,223
	Tax benefit		(2,439	)			(2,560	)
	Net of tax	$	4,756			$	4,663
	Total reclassifications, net of tax	$	5,686			$	11,024

Stock_Compensation_Plans_Table

Stock Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Weighted-Average Assumptions used to Estimate Fair Value of Options Granted	'
	The fair value for options granted in 2013, 2012 and 2011 was estimated at the date of grant using a multiple point Black-Scholes option pricing model. The following weighted-average assumptions were used:
		2013		2012				2011
	Risk-free interest rate	0.75%			0.81	%			1.92	%
	Expected life of option	4.87 yrs.			4.85 yrs.				4.70 yrs.
	Expected dividend yield	1.73%			2.28	%			2.34	%
	Expected volatility	24.65%			28.46	%			26.82	%
Weighted-Average Assumptions used to Estimate Fair Value of Non-Vested Shares Granted	'
	The fair value for non-vested shares granted in 2013, 2012 and 2011 was estimated at the date of grant based on the market price for the underlying stock on the grant date discounted for the risk free interest rate and the present value of expected dividends over the vesting period. The following weighted-average assumptions were used:
		2013		2012				2011
	Risk-free interest rate	0.36%			0.37	%			1.04	%
	Expected dividend yield	1.71%			2.24	%			2.34	%
Summary of Stock Option Activity	'
	The following table summarizes the option activity during 2013:
		Shares				Weighted				Weighted				Aggregate
		Subject to				Average				Average				Intrinsic
		Options				Exercise				Remaining				Value
						Price				Contractual
										Life In Years
														(Dollars in thousands)
	Outstanding, beginning of the year		1,084,193			$	58.43
	Granted		417,484				79.37
	Exercised		(157,545	)			57.16
	Forfeited or expired		(64,652	)			65.79
	Outstanding, end of the year		1,279,480				65.05				7.1			$	36,900
	Exercisable, end of the year		652,431			$	59.31				5.7			$	22,543
Summary of Non-Vested Restricted Stock Unit Activity	'
	The following table summarizes the non-vested restricted stock unit activity during 2013:
		Number of				Weighted				Weighted		Aggregate
		Non-Vested				Average				Average		Intrinsic
		Shares				Grant-Date				Remaining		Value
						Fair Value				Contractual
										Life In Years
												(Dollars in thousands)
	Outstanding, beginning of the year		364,788			$	55.77
	Granted		148,191				75.6
	Vested		(99,666	)			63.01
	Forfeited		(59,956	)			59.87
	Outstanding, end of the year		353,357				62.49			1.3		$	33,166

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Components of Provision for Income Taxes from Continuing Operations	'
	The following table summarizes the components of the provision for income taxes from continuing operations:
		2013				2012			2011
		(Dollars in thousands)
	Current:
	Federal	$	(2,974	)		$	20,959		$	(2,604	)
	State		1,736				3,623			4,621
	Foreign		36,400				30,476			48,600
	Deferred:
	Federal		(9,703	)			(34,629	)		(20,584	)
	State		(1,825	)			(720	)		(961	)
	Foreign		(87	)			(3,296	)		(3,294	)
		$	23,547			$	16,413		$	25,778
Summaries of U.S. and Non-U.S. Components of Income from Continuing Operations Before Taxes	'
	The following table summarizes the United States and non-United States components of income from continuing operations before taxes:
		2013				2012			2011
		(Dollars in thousands)
	United States	$	(3,544	)		$	(315,928	)	$	(10,952	)
	Other		179,274				150,559			156,052
		$	175,730			$	(165,369	)	$	145,100
Reconciliations Between Statutory Federal Income Tax Rate and Effective Income Tax Rate	'
	Reconciliations between the statutory federal income tax rate and the effective income tax rate are as follows:
		2013				2012			2011
	Federal statutory rate		35	%			35	%		35	%
	Goodwill impairment		—				(60.84	)		—
	Tax effect of International items		(15.26	)			11.88			(15.36	)
	State taxes, net of federal benefit		(0.32	)			(0.90	)		1.18
	Uncertain tax contingencies		(4.06	)			4.85			(2.66	)
	Contingent consideration reversals		(2.04	)			—			—
	Other, net		0.08				0.08			(0.39	)
			13.4	%			(9.93	)%		17.77	%
Deferred Tax Assets and Liabilities	'
	The following table summarizes significant components of the Company’s deferred tax assets and liabilities at December 31, 2013 and 2012:
		2013				2012
		(Dollars in thousands)
	Deferred tax assets:
	Tax loss and credit carryforwards	$	104,043			$	92,282
	Pension		39,310				63,737
	Reserves and accruals		39,478				39,485
	Other		27,092				21,255
	Less: valuation allowances		(86,510	)			(69,527	)
	Total deferred tax assets		123,413				147,232
	Deferred tax liabilities:
	Property, plant and equipment		26,550				24,766
	Intangibles — stock acquisitions		400,297				324,983
	Unremitted foreign earnings		147,326				151,780
	Other		12,030				13,129
	Total deferred tax liabilities		586,203				514,658
	Net deferred tax liability	$	(462,790	)		$	(367,426	)
Uncertain Tax Positions for Liabilities Associated with Unrecognized Tax Benefits	'
	Uncertain Tax Positions: The following table is a reconciliation of the beginning and ending balances for liabilities associated with unrecognized tax benefits for the twelve month periods ending December 31, 2013,  2012 and 2011:
		2013				2012			2011
		(Dollars in thousands)
	Balance at January 1	$	62,108			$	75,026		$	89,281
	Increase in unrecognized tax benefits related to prior years		—				1,110			1,855
	Decrease in unrecognized tax benefits related to prior years		—				(6,134	)		(6,415	)
	Unrecognized tax benefits related to the current year		1,838				4,256			4,246
	Reductions in unrecognized tax benefits due to settlements		—				(8,816	)		(7,678	)
	Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations		(8,433	)			(3,503	)		(5,852	)
	Increase (decrease) in unrecognized tax benefits due to foreign currency translation		258				169			(411	)
	Balance at December 31	$	55,771			$	62,108		$	75,026
Examinations by Major Tax Jurisdictions	'
	The taxable years that remain subject to examination by major tax jurisdictions are as follows:
		Beginning			Ending
	United States	2010			2013
	Canada	2005			2013
	China	2008			2013
	Czech Republic	2001			2013
	France	2011			2013
	Germany	2007			2013
	Ireland	2009			2013
	Italy	2009			2013
	Malaysia	2008			2013
	Singapore	2009			2013

Pension_and_Other_Postretireme1

Pension and Other Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2013
Net Benefit Cost of Pension and Postretirement Benefit Plans	'
	The following table provides information for the net benefit cost of pension and postretirement benefit plans for continuing operations:
			Pension												Other Benefits
			2013				2012				2011				2013				2012				2011
			(Dollars in thousands)
	Service cost		$	1,819			$	2,331			$	2,297			$	663			$	704			$	479
	Interest cost			16,842				16,561				17,284				2,707				2,122				2,054
	Expected return on plan assets			(23,122	)			(20,245	)			(19,998	)			—				—				—
	Net amortization and deferral			5,847				6,474				4,018				1,348				761				(45	)
	Curtailment gain			—				(197	)			(37	)			—				—				—
	Settlement loss (gain)			—				106				(5	)			—				—				—
	Net benefit cost		$	1,386			$	5,030			$	3,559			$	4,718			$	3,587			$	2,488
Weighted Average Assumptions used in Determining Net Periodic Benefit Cost	'
	The following table provides information for the weighted average assumptions for United States and foreign plans used in determining net benefit cost:
			Pension											Other Benefits
			2013			2012				2011				2013				2012				2011
	Discount rate		4.27	%			4.28	%			5.5	%			3.83	%			3.95	%			5.1	%
	Rate of return		8.31	%			8.27	%			8.31	%			—				—				—
	Initial healthcare trend rate		—				—				—				8.15	%			8.5	%			8	%
	Ultimate healthcare trend rate		—				—				—				5	%			5	%			5	%
Pension and Postretirement Benefit Plans	'
	The following table provides summarized information on the Company’s pension and postretirement benefit plans, measured as of December 31, 2013 and 2012, and the amounts recognized in the consolidated balance sheet and in accumulated other comprehensive income with respect to the plans:
				Pension							Other Benefits
				2013			2012				2013				2012
				Under Funded							Under Funded
				(Dollars in thousands)
	Benefit obligation, beginning of year		$	397,184			$	393,794			$	55,609			$	49,508
	Service cost			1,819				2,331				663				704
	Interest cost			16,842				16,561				2,707				2,122
	Actuarial (gain) loss			(30,755	)			2,345				(3,833	)			6,161
	Currency translation			861				678				—				—
	Benefits paid			(17,004	)			(16,227	)			(2,860	)			(3,106	)
	Medicare Part D reimbursement			—				—				162				220
	Settlements			—				(767	)			—				—
	Administrative costs			(1,216	)			(1,452	)			—				—
	Curtailments			—				(79	)			—				—
	Projected benefit obligation, end of year			367,731				397,184				52,448				55,609
	Fair value of plan assets, beginning of year			276,863				243,324				—				—
	Actual return on plan assets			28,813				33,946				—				—
	Contributions			17,724				17,567				—				—
	Benefits paid			(17,004	)			(16,227	)			—				—
	Settlements paid			—				(767	)			—				—
	Administrative costs			(1,216	)			(1,452	)			—				—
	Currency translation			301				472				—				—
	Fair value of plan assets, end of year			305,481				276,863				—				—
	Funded status, end of year		$	(62,250	)		$	(120,321	)		$	(52,448	)		$	(55,609	)
Amounts Recognized in the Consolidated Balance Sheet	'
	The following table sets forth information as to amounts recognized in the consolidated balance sheet with respect to the plans:
			Pension								Other Benefits
			2013				2012				2013				2012
			(Dollars in thousands)
	Payroll and benefit-related liabilities		$	(1,819	)		$	(1,784	)		$	(3,381	)		$	(3,200	)
	Pension and postretirement benefit liabilities			(60,431	)			(118,537	)			(49,067	)			(52,409	)
	Accumulated other comprehensive loss			144,866				186,916				7,073				12,254
			$	82,616			$	66,595			$	(45,375	)		$	(43,355	)
Amounts Recognized in Accumulated Other Comprehensive (Income) Loss	'
	The following tables set forth information as to amounts recognized in accumulated other comprehensive income (loss) with respect to the plans:
			Pension
			Prior Service				Net (Gain)				Deferred				Accumulated
			Cost (Credit)				or Loss				Taxes				Other
															Comprehensive
															(Income) Loss,
															Net of Tax
			(Dollars in thousands)
	Balance at December 31, 2011		$	251			$	204,257			$	(74,488	)		$	130,020
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net amortization and deferral			(35	)			(6,439	)			2,287				(4,187	)
	Curtailment			—				118				(44	)			74
	Settlement			—				(106	)			40				(66	)
	Amounts arising during the period:
	Actuarial changes in benefit obligation			—				(11,356	)			4,696				(6,660	)
	Impact of currency translation			—				226				(58	)			168
	Balance at December 31, 2012			216				186,700				(67,567	)			119,349
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net amortization and deferral			(34	)			(5,813	)			1,947				(3,900	)
	Amounts arising during the period:
	Actuarial changes in benefit obligation			—				(36,446	)			13,206				(23,240	)
	Impact of currency translation			—				243				(66	)			177
	Balance at December 31, 2013		$	182			$	144,684			$	(52,480	)		$	92,386
			Other Benefits
			Prior Service				Initial				Net (Gain) or				Deferred				Accumulated
			Cost (Credit)				Obligation				Loss				Taxes				Other
																			Comprehensive
																			(Income) Loss,
																			Net of Tax
			(Dollars in thousands)
	Balance at December 31, 2011		$	(93	)		$	102			$	6,845			$	(2,326	)		$	4,528
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net Amortization and deferral			55				(97	)			(719	)			277				(484	)
	Amounts Arising During the period:
	Actuarial changes in benefit obligation			—				—				6,161				(2,297	)			3,864
	Balance at December 31, 2012			(38	)			5				12,287				(4,346	)			7,908
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net Amortization and deferral			55				(5	)			(1,398	)			492				(856	)
	Amounts Arising During the period:
	Actuarial changes in benefit obligation			—				—				(3,833	)			1,432				(2,401	)
	Balance at December 31, 2013		$	17			$	—			$	7,056			$	(2,422	)		$	4,651
Weighted Average Assumptions used in Determining Benefit Obligations	'
	The following table provides the weighted average assumptions for United States and foreign plans used in determining benefit obligations:
			Pension									Other Benefits
			2013				2012				2013				2012
	Discount rate			4.98	%			4.27	%			4.7	%			3.83	%
	Rate of compensation increase			3	%			3	%			—				—
	Initial healthcare trend rate			—				—				7	%			8.15	%
	Ultimate healthcare trend rate			—				—				5	%			5	%
Fair Values of Pension Plan Assets	'
	The following table provides the fair values of the Company’s pension plan assets at December 31, 2013 by asset category:
			Fair Value Measurements at 12/31/13
	Asset Category (a)		Total				Quoted Prices in				Significant				Significant
							Active Markets for				Observable				Unobservable
							Identical Assets				Inputs				Inputs
							(Level 1)				(Level 2)				(Level 3)
			(Dollars in thousands)
	Cash		$	472			$	472			$	—			$	—
	Money market funds			310				310				—				—
	Equity securities:
	Managed volatility (b)			77,140				77,140				—				—
	United States small/mid-cap equity (c)			19,760				19,760				—				—
	World Equity (excluding United States) (d)			30,183				30,183				—				—
	Common Equity Securities – Teleflex Incorporated			10,972				10,972				—				—
	Diversified United Kingdom Equity			928				928				—				—
	Diversified Global			2,319				2,319				—				—
	Emerging Markets			1,270				1,270				—				—
	Fixed income securities:
	Long duration bond fund (e)			76,608				76,608				—				—
	UK corporate bond fund			2,569				2,569				—				—
	UK Government bond fund			4,455				4,455				—				—
	High yield bond fund (f)			12,754				12,754				—				—
	Emerging markets debt fund (g)			9,003				—				9,003				—
	Corporate, government and foreign bonds			87				—				87				—
	Asset backed – home loans			847				—				847				—
	Other types of investments:
	Structured credit (h)			29,109				—				—				29,109
	Hedge fund of funds (i)			22,540				—				—				22,540
	UK Property Fund (j)			1,402				—				1,402				—
	Multi asset fund  (k)			2,748				2,748				—				—
	Other			5				—				—				5
	Total		$	305,481			$	242,488			$	11,339			$	51,654
	The following table provides the fair values of the Company’s pension plan assets at December 31, 2012 by asset category:
			Fair Value Measurements at 12/31/12
	Asset Category (a)		Total				Quoted Prices in				Significant				Significant
							Active Markets for				Observable				Unobservable
							Identical Assets				Inputs				Inputs
							(Level 1)				(Level 2)				(Level 3)
			(Dollars in thousands)
	Cash		$	408			$	408			$	—			$	—
	Money market funds			361				361				—				—
	Equity securities:
	Managed volatility (b)			66,413				66,413				—				—
	United States small/mid-cap equity (c)			16,543				16,543				—				—
	World Equity (excluding United States) (d)			27,257				27,257				—				—
	Common Equity Securities – Teleflex Incorporated			8,336				8,336				—				—
	Diversified United Kingdom Equity			6,681				6,681				—				—
	Diversified Global (excluding United			3,267				3,267				—				—
	Kingdom)
	Fixed income securities:
	Long duration bond fund (e)			73,370				73,370				—				—
	High yield bond fund (f)			10,896				10,896				—				—
	Emerging markets debt fund (g)			8,453				8,453				—				—
	Corporate, government and foreign bonds			5,675				—				5,675				—
	Asset backed – home loans			1,005				—				1,005				—
	Other types of investments:
	Structured credit (h)			26,828				—				—				26,828
	Hedge fund of funds (i)			21,365				—				—				21,365
	Other			5				—				—				5
	Total		$	276,863			$	221,985			$	6,680			$	48,198
	(a)	Information on asset categories described in notes (b)-(k) is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.
	(b)	This category comprises mutual funds that invest in securities of United States and non-United States companies of all capitalization ranges that exhibit relatively low volatility.
	(c)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of small and mid-sized companies. The fund invests in common stocks or exchange traded funds holding common stock of United States companies with market capitalizations in the range of companies in the Russell 2500 Index.
(d)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of foreign companies. These securities may include common stocks, preferred stocks, warrants, exchange traded funds based on an international equity index and derivative instruments whose value is based on an international equity index and derivative instruments whose value is based on an underlying equity security or a basket of equity securities. The fund invests in securities of foreign issuers located in developed and emerging market countries. However, the fund will not invest more than 30% of its assets in the common stocks or other equity securities of issuers located in emerging market countries.
(e)	This category comprises a mutual fund that invests in instruments or derivatives having economic characteristics similar to fixed income securities. The fund invests in investment grade fixed income instruments, including securities issued or guaranteed by the United States Government and its agencies and instrumentalities, corporate bonds, asset-backed securities, exchange traded funds, mortgage-backed securities and collateralized mortgage-backed securities. The fund invests primarily in long duration government and corporate fixed income securities, and uses derivative instruments, including interest rate swap agreements and Treasury futures contracts, for the purpose of managing the overall duration and yield curve exposure of the Fund’s portfolio of fixed income securities.
(f)	This category comprises a mutual fund that invests at least 80% of its net assets in higher-yielding fixed income securities, including corporate bonds and debentures, convertible and preferred securities and zero coupon obligations.
(g)	This category comprises a mutual fund that invests at least 80% of its net assets in fixed income securities of emerging market issuers, primarily in United States dollar-denominated debt of foreign governments, government-related and corporate issuers in emerging market countries and entities organized to restructure the debt of those issuers.
(h)	This category comprises a fund that invests primarily in collateralized debt obligations (“CDOs”) and other structured credit vehicles. The fund investments may include fixed income securities, loan participants, credit-linked notes, medium-term notes, pooled investment vehicles and derivative instruments.
(i)
This category comprises a hedge fund that invests in various other hedge funds. As of December 31, 2013 and 2012:
·	approximately 28% and 22%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;
·	approximately 18% and 30%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;
·	approximately 25% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;
·	approximately 23% and 17%, respectively, of the assets were held in funds with an event driven strategy; and
·	approximately 6% and 6%, respectively, of the assets were held in cash.
(j)	This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
(k)	This category comprises a mutual fund that invests primarily in equities, bonds and alternatives.
Reconciliation of Changes in Level 3 Pension Assets Measured at Fair Value on Recurring Basis	'
	The following table provides a reconciliation of changes in Level 3 pension assets measured at fair value on a recurring basis from December 31, 2011 through December 31, 2013:
			Hedge Fund				Structured				Other
			of Funds				Credit				Investments
			(Dollars in thousands)
	Balance at December 31, 2011		$	20,624			$	—			$	531
	Purchases			—				26,000				—
	Sales/redemptions			—				—				(509	)
	Actual return on assets			741				828				(35	)
	Foreign currency adjustment			—				—				18
	Balance at December 31, 2012			21,365				26,828				5
	Actual return on assets			1,175				2,281				—
	Balance at December 31, 2013		$	22,540			$	29,109			$	5
Expected Benefit Payments	'
	The following table provides information about the Company’s expected benefit payments for U.S. and foreign plans for each of the five succeeding years and the aggregate of the five years thereafter, net of the annual average Medicare Part D subsidy of approximately $0.2 million:
			Pension					Other Benefits
			(Dollars in thousands)
	2014		$	16,969			$	3,381
	2015			17,497				3,459
	2016			18,145				3,580
	2017			18,653				3,556
	2018			19,382				3,859
	Years 2019 — 2023			108,118				20,347

Commitments_and_contingent_lia1

Commitments and contingent liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Future Minimum Lease Payments Under Noncancelable Operating Leases	'
	Future minimum lease payments as of December 31, 2013 under noncancelable operating leases are as follows:
		Future Lease Payments
		(Dollars in thousands)
	2014	$	21,700
	2015		17,000
	2016		13,700
	2017		11,800
	2018 and thereafter		46,200

Business_Segment_and_Other_Inf

Business Segment and Other Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Results	'
	The following tables present the Company’s segment results for the twelve months ended December 31, 2013, 2012 and 2011:
			Year Ended December 31, 2013
	Segment Results		Americas			EMEA			Asia			OEM		Totals
			(Dollars in thousands)
	Segment net revenues from external customers		$	800,464		$	557,427		$	207,207		$	131,173	$	1,696,271
	Segment depreciation and amortization			69,653			28,938			4,774			4,570		107,935
	Segment operating profit(1)			97,386			76,199			70,800			27,328		271,713
	Segment assets			2,266,161			1,008,329			240,535			62,743		3,577,768
	Segment expenditures for property, plant and equipment			47,554			11,487			754			2,625		62,420
	Restructuring and other impairment charges			18,265			19,007			592			588		38,452
	Intersegment revenues			128,512			153,951			40,579			519
			Year Ended December 31, 2012
	Segment Results		Americas			EMEA			Asia			OEM		Totals
			(Dollars in thousands)
	Segment net revenues from external customers		$	726,810		$	510,248		$	173,721		$	140,230	$	1,551,009
	Segment depreciation and amortization			64,174			22,974			3,653			4,083		94,884
	Segment operating profit(1)			91,627			54,746			59,421			31,664		237,458
	Segment assets			1,947,583			985,069			245,578			33,236		3,211,466
	Segment expenditures for property, plant and equipment			32,023			14,717			472			10,830		58,042
	Restructuring and other impairment charges			743			2,294			—			—		3,037
	Intersegment revenues			135,499			76,967			4,660			422
			Year Ended December 31, 2011
	Segment Results		Americas			EMEA			Asia			OEM		Totals
			(Dollars in thousands)
	Segment net revenues from external customers		$	688,036		$	525,277		$	149,585		$	129,630	$	1,492,528
	Segment depreciation and amortization			65,580			23,419			3,848			3,649		96,496
	Segment operating profit(1)			90,046			74,311			47,101			24,699		236,157
	Segment assets			2,078,850			789,978			199,684			27,240		3,095,752
	Segment expenditures for property, plant and			23,203			11,843			804			5,565		41,415
	equipment
	Restructuring and other impairment charges			4,626			1,379			—			—		6,005
	Intersegment revenues			137,499			67,199			1			464
	-1	Segment operating profit includes a segment’s net revenues from external customers reduced by its cost of goods sold, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Segment operating profit excludes goodwill impairment charges, restructuring and impairment charges, net (gain) loss on sales of businesses and assets, interest income and expense, loss on extinguishment of debt and taxes on income.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated	'
	The following tables present reconciliations of segment results to the Company’s consolidated income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes for the twelve months ended December 31, 2013,  2012 and , 2011:
	Reconciliation of Segment Operating Profit to Income (Loss) from		Year Ended
	Continuing Operations Before Interest, Loss on
	Extinguishments of Debt and Taxes
			2013			2012			2011
			(Dollars in thousands)
	Segment operating profit		$	271,713		$	237,458		$	236,157
	Goodwill impairment			—			(332,128	)		—
	Restructuring and other impairment charges			(38,452	)		(3,037	)		(6,005	)
	Net gain (loss) on sales of businesses and assets			—			332			(582	)
	Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes		$	233,261		$	(97,375	)	$	229,570
Reconciliation of Assets from Segment to Consolidated	'
	Reconciliation of Segment Assets to Consolidated Total Assets		Year Ended
			2013			2012			2011
			(Dollars in thousands)
	Segment assets		$	3,577,768		$	3,211,466		$	3,095,752
	Corporate assets			620,811			514,258			767,231
	Assets of businesses divested			—			—			53,218
	Assets held for sale			10,428			7,963			7,902
	Total assets		$	4,209,007		$	3,733,687		$	3,924,103
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated	'
	Reconciliation of Segment Expenditures for Property, Plant and		Year Ended
	Equipment to Consolidated Total Expenditures for Property,
	Plant and Equipment
			2013			2012			2011
			(Dollars in thousands)
	Segment expenditures for property, plant and equipment		$	62,420		$	58,042		$	41,415
	Corporate expenditures for property, plant and equipment			1,160			7,352			3,167
	Total expenditures for property, plant and equipment		$	63,580		$	65,394		$	44,582
Total Net Revenues and Total Net Property, Plant and Equipment by Geographic Region	'
	Effective January 1, 2014, the Company realigned its operating segments.  The Vascular, Anesthesia/Respiratory and Surgical businesses, which previously comprised much of the Americas reporting segment, are now separate reporting segments. Additionally, the Company made changes to the allocation methodology of certain costs, including manufacturing variances and research and development costs, amongst the businesses to improve accountability. Because the change in segment reporting structure became effective in the first quarter of 2014, the segment information presented above does not reflect this change.
	The following table provides total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2013,  2012 and 2011:
			Year Ended
			2013			2012			2011
			(Dollars in thousands)
	Net revenues (based on business unit location):
	United States		$	844,884		$	789,771		$	762,957
	Other Americas			57,656			53,665			55,228
	Germany			133,598			123,355			128,072
	Other Europe			438,567			393,627			403,274
	All Other			221,566			190,591			142,997
			$	1,696,271		$	1,551,009		$	1,492,528
	Net property, plant and equipment:
	United States		$	203,985		$	180,833		$	159,042
	Other Americas			12,350			12,828			12,492
	Germany			12,135			12,197			8,549
	Other Europe			61,891			58,843			53,775
	All Other			35,539			33,244			18,054
			$	325,900		$	297,945		$	251,912

Condensed_Consolidating_Guaran1

Condensed Consolidating Guarantor Financial Information (Tables)	12 Months Ended
	Dec. 31, 2013
Condensed Consolidating Financial Statement Adjustments	'
	The following table illustrates the increase/(decrease) to the previously reported amounts as of December 31, 2012:
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	Accounts receivable, net	$	-		$	(763,757	)	$	(229,467	)	$	993,224			$	-
	Accounts receivable from consolidated subsidiaries		422,058			2,520,933			192,170			(3,135,161	)			-
	Investments in affiliates		-			87,855			-			(87,855	)			-
	Note receivable and other amounts due from consolidated subsidiaries		529,913			804,843			77			(1,334,833	)			-
	Other assets		-			(2,699,168	)		(700,354	)		3,399,522				-
	Total assets	$	951,971		$	(49,294	)	$	(737,574	)	$	(165,103	)		$	-
	Accounts payable	$	(77,129	)	$	(829,286	)	$	(86,809	)	$	993,224			$	-
	Accounts payable to consolidated subsidiaries		2,563,602			512,145			59,414			(3,135,161	)			-
	Notes payable and other amounts due to consolidated subsidiaries		878,148			275,674			183,741			(1,337,563	)			-
	Other liabilities		(2,412,650	)		(7,827	)		(981,775	)		3,402,252				-
	Total liabilities		951,971			(49,294	)		(825,429	)		(77,248	)			-
	Total common shareholders’ equity		-			-			87,855			(87,855	)			-
	Total equity		-			-			87,855			(87,855	)			-
	Total liabilities and equity	$	951,971		$	(49,294	)	$	(737,574	)	$	(165,103	)		$	-
	The following tables illustrate the increase/(decrease) to the previously reported amounts as of December 31, 2012 and 2011:
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	Cash Flows from Operating Activities of Continuing Operations	$	1,077		$	71,965		$	25,861		$	-98,903		$	-
	Cash Flows from Financing Activities of Continuing Operations:
	Intercompany transactions		(1,077	)		(55,065	)		56,142			-
															-
	Intercompany dividends paid		-			(16,900	)		(82,003	)		98,903			-
	Cash Flows from Financing Activities of Continuing Operations	$	(1,077	)	$	(71,965	)	$	(25,861	)	$	98,903		$	-
		Year Ended December 31, 2011
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in millions)
	Cash Flows from Operating Activities of Continuing Operations	$	1,450		$	86,896		$	15,278		$	(103,624	)	$	-
	Cash Flows from Financing Activities of Continuing Operations:
	Intercompany transactions		(1,450	)		(68,596	)		70,046			-			-
	Intercompany dividends paid					(18,300	)		(85,324	)		103,624			-
	Cash Flows from Financing Activities of Continuing Operations	$	(1,450	)	$	(86,896	)	$	(15,278	)	$	103,624		$	-
Condensed Consolidating Statements of Income (Loss) and Comprehensive Income (Loss)	'
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	Net revenues	$	-		$	1,001,404		$	963,184		$	(268,317	)	$	1,696,271
	Cost of goods sold		-			582,110			543,717			(268,501	)		857,326
	Gross profit		-			419,294			419,467			184			838,945
	Selling, general and administrative expenses		39,176			284,960			178,358			(307	)		502,187
	Research and development expenses		-			55,694			9,351			-			65,045
	Restructuring and other impairment charges		935			15,288			22,229			-			38,452
	Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes		(40,111	)		63,352			209,529			491			233,261
	Interest expense		134,879			(85,058	)		7,084			-			56,905
	Interest income		(15	)		(5	)		(604	)		-			(624	)
	Loss on extinguishments of debt		1,250			-			-			-			1,250
	Income (loss) from continuing operations before taxes		(176,225	)		148,415			203,049			491			175,730
	Taxes (benefit) on income (loss) from continuing operations		(63,857	)		42,804			45,354			(754	)		23,547
	Equity in net income (loss) of consolidated subsidiaries		263,469			141,773			288			(405,530	)		-
	Income (loss) from continuing operations		151,101			247,384			157,983			(404,285	)		152,183
	Operating income (loss) from discontinued operations		(1,947	)		-			(258	)		-			(2,205	)
	Taxes (benefit) on income (loss) from discontinued operations		(1,727	)		(170	)		127			-			(1,770	)
	Income (loss) from discontinued operations		(220	)		170			(385	)		-			(435	)
	Net income (loss)		150,881			247,554			157,598			(404,285	)		151,748
	Less: Income from continuing operations attributable to noncontrolling interests		-			-			867			-			867
	Net income (loss) attributable to common shareholders		150,881			247,554			156,731			(404,285	)		150,881
	Other comprehensive income attributable to common shareholders		21,193			1,960			5,442			(7,402	)		21,193
	Comprehensive income (loss) attributable to common shareholders	$	172,074		$	249,514		$	162,173		$	(411,687	)	$	172,074
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	Net revenues	$	-		$	950,888		$	833,903		$	(233,782	)	$	1,551,009
	Cost of goods sold		-			552,726			482,881			(232,823	)		802,784
	Gross profit		-			398,162			351,022			(959	)		748,225
	Selling, general and administrative expenses		34,657			259,476			160,089			267			454,489
	Research and development expenses		-			48,649			7,629			-			56,278
	Goodwill impairment		-			331,779			349			-			332,128
	Restructuring and other impairment charges		-			598			2,439			-			3,037
	Net gain on sales of businesses and assets		(116,193	)		(149,240	)		(332	)		265,433			(332	)
	Income (loss) from continuing operations before interest and taxes		81,536			(93,100	)		180,848			(266,659	)		(97,375	)
	Interest expense		143,653			(81,328	)		7,240			-			69,565
	Interest income		(372	)		(23	)		(1,176	)		-			(1,571	)
	Income (loss) from continuing operations before taxes		(61,745	)		(11,749	)		174,784			(266,659	)		(165,369	)
	Taxes (benefit) on income (loss) from continuing operations		(63,806	)		45,068			35,670			(519	)		16,413
	Equity in net income (loss) of consolidated subsidiaries		(190,742	)		124,918			-			65,824			-
	Income (loss) from continuing operations		(188,681	)		68,101			139,114			(200,316	)		(181,782	)
	Operating income (loss) from discontinued operations		(2,647	)		(9,179	)		2,619			-			(9,207	)
	Taxes (benefit) on income (loss) from discontinued operations		(1,271	)		(129	)		(487	)		-			(1,887	)
	Income (loss) from discontinued operations		(1,376	)		(9,050	)		3,106			-			(7,320	)
	Net income (loss)		(190,057	)		59,051			142,220			(200,316	)		(189,102	)
	Less: Income from continuing operations attributable to noncontrolling interests		-			-			955			-			955
	Net income (loss) attributable to common shareholders		(190,057	)		59,051			141,265			(200,316	)		(190,057	)
	Other comprehensive income attributable to common shareholders		27,305			10,475			8,907			(19,382	)		27,305
	Comprehensive income (loss) attributable to common shareholders	$	(162,752	)	$	69,526		$	150,172		$	(219,698	)	$	(162,752	)
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2011
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
Net revenues	$	-		$	923,000		$	804,867		$	(235,339	)	$	1,492,528
Cost of goods sold		-			552,606			467,711			(236,567	)		783,750
Gross profit		-			370,394			337,156			1,228			708,778
Selling, general and administrative expenses		39,614			231,490			152,573			232			423,909
Research and development expenses		-			41,648			7,064			-			48,712
Restructuring and other impairment charges		11			4,615			1,379			-			6,005
Net loss on sales of businesses and assets		-			-			582			-			582
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes		(39,625	)		92,641			175,558			996			229,570
Interest expense		138,460			(68,926	)		783			-			70,317
Interest income		(384	)		(67	)		(809	)		-			(1,260	)
Loss on extinguishments of debt		15,413			-			-			-			15,413
Income (loss) from continuing operations before taxes		(193,114	)		161,634			175,584			996			145,100
Taxes (benefit) on income (loss) from continuing operations		(73,608	)		52,667			47,044			(325	)		25,778
Equity in net income of consolidated subsidiaries		473,311			397,131			-			(870,442	)		-
Income from continuing operations		353,805			506,098			128,540			(869,121	)		119,322
Operating income (loss) from discontinued operations		(55,872	)		40,287			308,268			-			292,683
Taxes (benefit) on income (loss) from discontinued operations		(25,396	)		88,582			23,852			-			87,038
Income (loss) from discontinued operations		(30,476	)		(48,295	)		284,416			-			205,645
Net income		323,329			457,803			412,956			(869,121	)		324,967
Less: Income from continuing operations attributable to noncontrolling interests		-			-			1,021			-			1,021
Income from discontinued operations attributable to noncontrolling interest		-			-			617			-			617
Net income attributable to common shareholders		323,329			457,803			411,318			(869,121	)		323,329
Other comprehensive income (loss) attributable to common shareholders		(107,473	)		(75,928	)		(75,737	)		151,665			(107,473	)
Comprehensive income attributable to common shareholders	$	215,856		$	381,875		$	335,581		$	(717,456	)	$	215,856
Condensed Consolidating Balance Sheets	'
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING BALANCE SHEETS
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	ASSETS
	Current assets
	Cash and cash equivalents	$	42,749		$	14,500		$	374,735		$	-		$	431,984
	Accounts receivable, net		1,822			10,948			279,048			3,472			295,290
	Accounts receivable from consolidated subsidiaries		42,865			2,623,314			214,469			(2,880,648	)		-
	Inventories, net		-			211,165			138,165			(15,709	)		333,621
	Prepaid expenses and other current assets		15,200			6,870			17,740			-			39,810
	Prepaid taxes		27,487			-			9,017			-			36,504
	Deferred tax assets		20,218			22,472			10,230			(3	)		52,917
	Assets held for sale		1,669			3,503			5,256			-			10,428
	Total current assets		152,010			2,892,772			1,048,660			(2,892,888	)		1,200,554
	Property, plant and equipment, net		14,189			188,455			123,256			-			325,900
	Goodwill		-			797,671			556,532			-			1,354,203
	Intangibles assets, net		-			962,243			293,354			-			1,255,597
	Investments in affiliates		5,489,676			1,478,429			21,382			(6,987,772	)		1,715
	Deferred tax assets		35,877			-			4,476			(39,410	)		943
	Notes receivable and other amounts due from consolidated subsidiaries		1,049,344			873,105			14,169			(1,936,618	)		-
	Other assets		24,574			7,447			38,074			-			70,095
	Total assets	$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
	LIABILITIES AND EQUITY
	Current liabilities
	Notes payable	$	351,587		$	-		$	4,700		$	-		$	356,287
	Accounts payable		2,194			45,802			23,971			-			71,967
	Accounts payable to consolidated subsidiaries		2,644,296			147,957			88,395			(2,880,648	)		-
	Accrued expenses		15,569			21,120			38,179			-			74,868
	Current portion of contingent consideration		-			4,131			-			-			4,131
	Payroll and benefit-related liabilities		15,976			21,818			35,296			-			73,090
	Accrued interest		8,720			-			5			-			8,725
	Income taxes payable		-			-			23,821			-			23,821
	Other current liabilities		9,646			7,517			5,072			(4	)		22,231
	Total current liabilities		3,047,988			248,345			219,439			(2,880,652	)		635,120
	Long-term borrowings		930,000			-			-			-			930,000
	Deferred tax liabilities		-			496,228			57,896			(39,409	)		514,715
	Pension and other postretirement benefit liabilities		57,406			33,777			18,315			-			109,498
	Noncurrent liability for uncertain tax positions		11,389			17,241			26,522			-			55,152
	Notes payable and other amounts due to consolidated subsidiaries		785,476			957,451			197,173			(1,940,100	)		-
	Other liabilities		19,884			16,221			12,401			-			48,506
	Total liabilities		4,852,143			1,769,263			531,746			(4,860,161	)		2,292,991
	Total common shareholders' equity		1,913,527			5,430,859			1,565,668			(6,996,527	)		1,913,527
	Noncontrolling interest		-			-			2,489			-			2,489
	Total equity		1,913,527			5,430,859			1,568,157			(6,996,527	)		1,916,016
	Total liabilities and equity	$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING BALANCE SHEETS
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	ASSETS
	Current assets
	Cash and cash equivalents	$	70,860		$	1,989		$	264,190		$	-		$	337,039
	Accounts receivable, net		2,147			10,523			282,142			3,164			297,976
	Accounts receivable from consolidated subsidiaries		422,058			2,520,933			192,170			(3,135,161	)		-
	Inventories, net		-			202,748			136,492			(15,893	)		323,347
	Prepaid expenses and other current assets		7,769			5,294			15,649			-			28,712
	Prepaid taxes		11,079			-			19,217			(3,136	)		27,160
	Deferred tax assets		13,987			30,201			7,882			(1,045	)		51,025
Assets held for sale		-			2,738			5,225			-			7,963
Total current assets		527,900			2,774,426			922,967			(3,152,071	)		1,073,222
Property, plant and equipment, net		7,258			168,451			122,236			-			297,945
Goodwill		-			694,070			544,382			-			1,238,452
Intangibles assets, net		-			782,631			276,161			-			1,058,792
Investments in affiliates		5,226,567			1,369,056			21,379			(6,614,936	)		2,066
Deferred tax assets		59,644			-			4,248			(62,545	)		1,347
Notes receivable and other amounts due from consolidated subsidiaries		529,913			804,843			77			(1,334,833	)		-
Other assets		33,937			8,096			19,830			-			61,863
Total assets	$	6,385,219		$	6,601,573		$	1,911,280		$	(11,164,385	)	$	3,733,687
LIABILITIES AND EQUITY
Current liabilities
Notes payable	$	-		$	-		$	4,700		$	-		$	4,700
Accounts payable		3,366			44,468			27,331			-			75,165
Accounts payable to consolidated subsidiaries		2,563,602			512,145			59,414			(3,135,161	)		-
Accrued expenses		11,338			20,471			33,255			-			65,064
Current portion of contingent consideration		-			21,115			2,578			-			23,693
Payroll and benefit-related liabilities		24,633			19,799			30,154			-			74,586
Accrued interest		9,413			-			5			-			9,418
Income taxes payable		-			1,322			18,709			(3,136	)		16,895
Other current liabilities		598			704			5,522			(1,045	)		5,779
Total current liabilities		2,612,950			620,024			181,668			(3,139,342	)		275,300
Long-term borrowings		965,280			-			-			-			965,280
Deferred tax liabilities		-			426,754			54,664			(62,544	)		418,874
Pension and other postretirement benefit liabilities		114,257			37,269			19,420			-			170,946
Noncurrent liability for uncertain tax positions		13,131			22,127			26,721			-			61,979
Notes payable and other amounts due to consolidated subs		878,148			275,674			183,741			(1,337,563	)		-
Other liabilities		22,503			27,720			9,548			-			59,771
Total liabilities		4,606,269			1,409,568			475,762			(4,539,449	)		1,952,150
Total common shareholders' equity		1,778,950			5,192,005			1,432,931			(6,624,936	)		1,778,950
Noncontrolling interest		-			-			2,587			-			2,587
Total equity		1,778,950			5,192,005			1,435,518			(6,624,936	)		1,781,537
Total liabilities and equity	$	6,385,219		$	6,601,573		$	1,911,280		$	(11,164,385	)	$	3,733,687
Condensed Consolidating Statements of Cash Flows	'
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	Net cash (used in) provided by operating activities from continuing operations	$	(132,459	)	$	205,954		$	304,278		$	(147,902	)	$	229,871
	Cash Flows from Investing Activities of Continuing Operations:
	Expenditures for property, plant and equipment		(1,553	)		(47,633	)		(14,394	)		-			(63,580	)
	Payments for businesses and intangibles acquired, net of cash acquired		-			(250,912	)		(58,096	)		-			(309,008	)
	Investments in affiliates		(50	)		-			-			-			(50	)
	Net cash used in investing activities from continuing operations		(1,603	)		(298,545	)		(72,490	)		-			(372,638	)
	Cash Flows from Financing Activities of Continuing Operations:
	Proceeds from new borrowings		680,000			-			-			-			680,000
	Repayment of long-term borrowings		(375,000	)		-			-			-			(375,000	)
	Debt issuance and amendment fees		(6,400	)		-			-			-			(6,400	)
	Proceeds from stock compensation plans		7,609			-			-			-			7,609
	Dividends		(55,917	)		-			-			-			(55,917	)
	Payments to minority interest shareholders		-			-			(736	)		-			(736	)
	Payments for contingent consideration		-			(14,802	)		(2,156	)		-			(16,958	)
	Intercompany transactions		(141,614	)		137,304			4,310			-			-
	Intercompany dividends paid		-			(17,400	)		(130,502	)		147,902			-
	Net cash provided by (used in) financing activities from continuing operations		108,678			105,102			(129,084	)		147,902			232,598
	Cash Flows from Discontinued Operations:
	Net cash used in operating activities		(2,727	)		-			(600	)		-			(3,327	)
	Net cash used in discontinued operations		(2,727	)		-			(600	)		-			(3,327	)
	Effect of exchange rate changes on cash and cash equivalents		-			-			8,441			-			8,441
	Net (decrease) increase in cash and cash equivalents		(28,111	)		12,511			110,545			-			94,945
	Cash and cash equivalents at the beginning of the period		70,860			1,989			264,190			-			337,039
	Cash and cash equivalents at the end of the period	$	42,749		$	14,500		$	374,735		$	-		$	431,984
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor						Condensed
		Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
		(Dollars in thousands)
	Net cash (used in) provided by operating activities from continuing operations	$	(178,782	)	$	310,736		$	160,802		$	(98,903	)	$	193,853
	Cash Flows from Investing Activities of Continuing Operations:
	Expenditures for property, plant and equipment		(7,352	)		(39,118	)		(18,924	)		-			(65,394	)
	Proceeds from sales of businesses and assets, net of cash sold		4,301			45,204			17,155			-			66,660
	Payments for businesses and intangibles acquired, net of cash acquired		-			(105,195	)		(264,249	)		-			(369,444	)
	Investments in affiliates		(80	)		-			-			-			(80	)
	Net cash used in investing activities from continuing operations		(3,131	)		(99,109	)		(266,018	)		-			(368,258	)
	Cash Flows from Financing Activities of Continuing Operations:
	Decrease in notes payable and current borrowings		-			(421	)		(285	)		-			(706	)
	Proceeds from stock compensation plans		9,003			-			-			-			9,003
	Dividends		(55,589	)		-			-			-			(55,589	)
	Payments for contingent consideration		-			(16,289	)		(1,307	)		-			(17,596	)
	Intercompany transactions		196,850			(177,900	)		(18,950	)		-			-
	Intercompany dividends paid		-			(16,900	)		(82,003	)		98,903			-
	Net cash provided by (used in) financing activities from continuing operations		150,264			(211,510	)		(102,545	)		98,903			(64,888	)
	Cash Flows from Discontinued Operations:
	Net cash (used in) provided by operating activities		(12,022	)		4,223			-			-			(7,799	)
	Net cash used in investing activities		-			(2,351	)		-			-			(2,351	)
	Net cash (used in) provided by discontinued operations		(12,022	)		1,872			-			-			(10,150	)
	Effect of exchange rate changes on cash and cash equivalents		-			-			2,394			-			2,394
	Net (decrease) increase in cash and cash equivalents		(43,671	)		1,989			(205,367	)		-			(247,049	)
	Cash and cash equivalents at the beginning of the period		114,531			-			469,557			-			584,088
	Cash and cash equivalents at the end of the period	$	70,860		$	1,989		$	264,190		$	-		$	337,039
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
		Year Ended December 31, 2011
		Parent			Guarantor			Non-Guarantor						Condensed
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations	$	(107,279	)	$	234,145		$	71,115		$	(103,624	)	$	94,357
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		(3,167	)		(25,840	)		(15,575	)		-			(44,582	)
Payments for businesses and intangibles acquired, net of cash acquired		-			(24,623	)		-			-			(24,623	)
Proceeds from sales of businesses and assets, net of cash sold		-			58,986			317,039			-			376,025
Investments in affiliates		(150	)		-			-			-			(150	)
Net cash (used in) provided by investing activities from continuing operations		(3,317	)		8,523			301,464			-			306,670
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from long-term borrowings		515,000			-			-			-			515,000
Repayment of long-term borrowings		(455,800	)		-			-			-			(455,800	)
Debt extinguishment, issuance and amendment fees		(18,518	)		-			-			-			(18,518	)
Decrease (increase) in notes payable and current borrowings		(25,000	)		-			286			-			(24,714	)
Proceeds from stock compensation plans		34,009			-			-			-			34,009
Dividends		(55,136	)		-			-			-			(55,136	)
Payments for contingent consideration		-			(5,947	)		-			-			(5,947	)
Intercompany transactions		220,302			(227,222	)		6,920			-			-
Intercompany dividends paid		-			(18,300	)		(85,324	)		103,624			-
Net cash provided by (used in) financing activities from continuing operations		214,857			(251,469	)		(78,118	)		103,624			(11,106	)
Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities		(12,359	)		9,306			3,174			-			121
Net cash used in investing activities		(3	)		(505	)		(2,367	)		-			(2,875	)
Net cash (used in) provided by discontinued operations		(12,362	)		8,801			807			-			(2,754	)
Effect of exchange rate changes on cash and cash equivalents		-			-			(11,531	)		-			(11,531	)
Net increase in cash and cash equivalents		91,899			-			283,737			-			375,636
Cash and cash equivalents at the beginning of the period		22,632			-			185,820			-			208,452
Cash and cash equivalents at the end of the period	$	114,531		$	-		$	469,557		$	-		$	584,088

DivestitureRelated_Activities_

Divestiture-Related Activities (Tables)	12 Months Ended
	Dec. 31, 2013
Assets Held for Sale	'
	The table below provides information regarding assets held for sale at December 31, 2013 and 2012. At December 31, 2013, these assets consisted of four buildings and other assets, which the Company is actively marketing.
			2013			2012
	Assets held for sale:		(Dollars in thousands)
	Property, plant and equipment		$	10,428		$	7,963
	Total assets held for sale		$	10,428		$	7,963
Operating Results of Operations Treated as Discontinued Operations	'
	The results of the Company’s discontinued operations for the years 2013, 2012 and 2011 were as follows:
			2013			2012			2011
			(Dollars in thousands)
	Net revenues		$	—		$	16,616		$	277,972
	Costs and other expenses			2,205			18,328			255,919
	Goodwill impairment(1)			—			9,700			—
	Gain on disposition(2)			—			2,205			270,630
	Income (loss) from discontinued operations before income taxes			(2,205	)		(9,207	)		292,683
	Taxes (benefit) on income (loss) from discontinued			(1,770	)		(1,887	)		87,038
	operations
	Income (loss) from discontinued operations			(435	)		(7,320	)		205,645
	Less: Income from discontinued operations attributable to noncontrolling interest			—			—			617
	Income (loss) from discontinued operations attributable to common shareholders		$	(435	)	$	(7,320	)	$	205,028
	-1	During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of the orthopedic business to its estimated fair value.
	-2	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the cargo systems and cargo container businesses.

Quarterly_Data_Tables

Quarterly Data (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Data	'
			First			Second			Third			Fourth
			Quarter (2)			Quarter			Quarter			Quarter
			(Dollars in thousands, except per share)
	2013:00:00
	Net revenues		$	411,877		$	420,059		$	413,796		$	450,539
	Gross profit			200,520			209,490			203,992			224,943
	Income from continuing operations before interest, loss on extinguishment of debt and taxes			49,404			63,751			66,042			54,064
	Income from continuing operations			27,701			43,401			45,779			35,302
	Income (loss) from discontinued operations			(462	)		-766			1,029			(236	)
	Net income			27,239			42,635			46,808			35,066
	Less: Income from continuing operations attributable to noncontrolling interest			201			194			234			238
	Net income attributable to common shareholders			27,038			42,441			46,574			34,828
	Earnings per share available to common shareholders — basic(3):
	Income from continuing operations		$	0.67		$	1.05		$	1.11		$	0.85
	Income (loss) from discontinued operations			(0.01	)		(0.02	)		0.02			—
	Net income		$	0.66		$	1.03		$	1.13		$	0.85
	Earnings per share available to common shareholders — diluted(3):
	Income from continuing operations		$	0.64		$	0.99		$	1.05		$	0.78
	Income (loss) from discontinued operations			(0.01	)		(0.01	)		0.03			(0.01	)
	Net income		$	0.63		$	0.98		$	1.08		$	0.77
	2012(1):
	Net revenues		$	380,567		$	383,332		$	368,054		$	419,056
	Gross profit			184,114			184,364			180,567			199,180
	Income (loss) from continuing operations before interest and taxes			(270,378	)		64,722			49,841			58,440
	Income (loss) from continuing operations			(284,113	)		47,266			24,451			30,614
	Income (loss) from discontinued operations			605			(4,367	)		(2,521	)		(1,037	)
	Net income (loss)			(283,508	)		42,899			21,930			29,577
	Less: Income from continuing operations attributable to noncontrolling interest			227			286			188			254
	Net income (loss) attributable to common shareholders			(283,735	)		42,613			21,742			29,323
	Earnings per share available to common shareholders — basic(3):
	Income (loss) from continuing operations		$	(6.97	)	$	1.15		$	0.59		$	0.74
	Income (loss) from discontinued operations			0.01			(0.11	)		(0.06	)		(0.02	)
	Net income (loss)		$	(6.96	)	$	1.04		$	0.53		$	0.72
	Earnings per share available to common shareholders — diluted(3):
	Income (loss) from continuing operations		$	(6.97	)	$	1.14		$	0.58		$	0.72
	Income (loss) from discontinued operations			0.01			(0.10	)		(0.06	)		(0.02	)
	Net income (loss)		$	(6.96	)	$	1.04		$	0.52		$	0.7
	-1	Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.
	-2	Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.
	-3	Each quarter is calculated as a discrete period; the sum of the four quarters may not equal the calculated full year amount.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Contingent consideration payments	$16,958,000	$17,596,000	$5,947,000
Allowance for doubtful accounts	10,700,000	7,800,000	'
Reserve for returns and allowances	3,300,000	2,900,000	'
Weighted average amortization period of intangible assets, in years	'16 years	'	'
Stock-based compensation	11,871,000	8,623,000	4,532,000
Total income tax benefit recognized for share-based compensation arrangements	3,800,000	2,700,000	2,500,000
Stock issued during period, non-vested shares	148,191	178,690	175,291
Asset Impairment Charges	'	'	2,497,000
Receivables outstanding, noncurrent	17,600,000	'	'
Reserve for estimated rebates	7,800,000	19,500,000	'
In-process Research and Development Asset	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Asset Impairment Charges	7,400,000	'	'
Stock Option	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Unamortized share based compensation cost related to non-vested stock option, net of expected forfeitures	4,400,000	'	'
Weighted average period of unamortized share based compensation cost related to non-vested stock option, net of expected forfeitures in years	'1 year 11 months 1 day	'	'
Restricted Stock	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Unamortized share based compensation cost related to non-vested stock option, net of expected forfeitures	9,200,000	'	'
Weighted average period of unamortized share based compensation cost related to non-vested stock option, net of expected forfeitures in years	'1 year 9 months 22 days	'	'
Chief Executive Officer	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Reduction in share based compensation expense	'	'	3,000,000
Minimum | Intellectual property	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'3 years	'	'
Minimum | Customer Lists	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'5 years	'	'
Minimum | Distribution rights	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'3 years	'	'
Minimum | Trade Names	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'1 year	'	'
Maximum | Intellectual property	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'20 years	'	'
Maximum | Customer Lists	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'30 years	'	'
Maximum | Distribution rights	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'22 years	'	'
Maximum | Trade Names	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of Intangible assets, in years	'30 years	'	'
Land Improvements	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of plant and equipment, in years	'5 years	'	'
Building	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of plant and equipment, in years	'30 years	'	'
Machinery and Equipment | Minimum	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of plant and equipment, in years	'3 years	'	'
Machinery and Equipment | Maximum	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of plant and equipment, in years	'10 years	'	'
Computer Equipment and Software | Minimum	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of plant and equipment, in years	'3 years	'	'
Computer Equipment and Software | Maximum	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Useful life of plant and equipment, in years	'10 years	'	'
Reclassifications	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Contingent consideration payments	'	$17,600,000	$5,900,000

Fair_Values_Determination_of_A

Fair Values Determination of Assets Acquired and Liabilities Assumed in Acquisition (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Business Acquisition [Line Items]	'	'
Goodwill	$1,354,203,000	$1,238,452,000
2013 Acquisition	'	'
Business Acquisition [Line Items]	'	'
Current assets	21,000,000	'
Property, plant and equipment	1,400,000	'
Goodwill	123,300,000	'
Total assets acquired	401,200,000	'
Current liabilities	5,400,000	'
Deferred tax liabilities	88,800,000	'
Liabilities assumed	94,200,000	'
Net assets acquired	307,000,000	'
2013 Acquisition | Intellectual property	'	'
Business Acquisition [Line Items]	'	'
Intangible assets	159,500,000	'
2013 Acquisition | Trade Names	'	'
Business Acquisition [Line Items]	'	'
Intangible assets	26,500,000	'
2013 Acquisition | Customer Lists	'	'
Business Acquisition [Line Items]	'	'
Intangible assets	49,600,000	'
2013 Acquisition | In-process Research and Development Asset	'	'
Business Acquisition [Line Items]	'	'
Intangible assets	$19,900,000	'

Acquisitions_Additional_Inform

Acquisitions - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

$450,539,000

$413,796,000

$420,059,000

$411,877,000

[1]

$419,056,000

[2]

$368,054,000

[2]

$383,332,000

[2]

$380,567,000

[1],[2]

$1,696,271,000

$1,551,009,000

$1,492,528,000

Operating profit

54,064,000

66,042,000

63,751,000

49,404,000

[1]

58,440,000

[2]

49,841,000

[2]

64,722,000

[2]

-270,378,000

[1],[2]

233,261,000

-97,375,000

229,570,000

Goodwill

1,354,203,000

'

'

'

1,238,452,000

'

'

'

1,354,203,000

1,238,452,000

'

Contingent consideration payments

'

'

'

'

'

'

'

'

16,958,000

17,596,000

5,947,000

2013 Acquisition

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Fair value of the consideration at the date of acquisition

307,000,000

'

'

'

'

'

'

'

307,000,000

'

'

Transaction expenses

'

'

'

'

'

'

'

'

3,800,000

'

'

Revenue

'

'

'

'

'

'

'

'

9,700,000

'

'

Operating profit

'

'

'

'

'

'

'

'

2,800,000

'

'

Liability related to post-closing obligations

'

'

'

'

'

'

'

'

2,800,000

'

'

Liabilities settlement obligation

800,000

'

'

'

'

'

'

'

800,000

'

'

Goodwill

123,300,000

'

'

'

'

'

'

'

123,300,000

'

'

2013 Acquisition | Intellectual property

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intangible assets

159,500,000

'

'

'

'

'

'

'

159,500,000

'

'

2013 Acquisition | Customer Lists

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intangible assets

49,600,000

'

'

'

'

'

'

'

49,600,000

'

'

2013 Acquisition | Trade Names

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intangible assets

26,500,000

'

'

'

'

'

'

'

26,500,000

'

'

2013 Acquisition | Minimum | Intellectual property

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Useful life of intangible assets acquired, years

'

'

'

'

'

'

'

'

'10 years

'

'

2013 Acquisition | Minimum | Customer Lists

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Useful life of intangible assets acquired, years

'

'

'

'

'

'

'

'

'16 years

'

'

2013 Acquisition | Minimum | Trade Names

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Useful life of intangible assets acquired, years

'

'

'

'

'

'

'

'

'1 year

'

'

2013 Acquisition | Maximum | Intellectual property

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Useful life of intangible assets acquired, years

'

'

'

'

'

'

'

'

'18 years

'

'

2013 Acquisition | Maximum | Customer Lists

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Useful life of intangible assets acquired, years

'

'

'

'

'

'

'

'

'27 years

'

'

2013 Acquisition | Maximum | Trade Names

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Useful life of intangible assets acquired, years

'

'

'

'

'

'

'

'

'30 years

'

'

2012 Acquisitions

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Fair value of the consideration at the date of acquisition

422,200,000

'

'

'

'

'

'

'

422,200,000

'

'

Initial payment of Fair value

'

'

'

'

'

'

'

'

367,900,000

'

'

Estimated fair value of the consideration to be paid to former security holders

55,800,000

'

'

'

'

'

'

'

55,800,000

'

'

Working capital adjustment related to acquisition

'

'

'

'

'

'

'

'

1,500,000

'

'

Intangible assets

227,500,000

'

'

'

'

'

'

'

227,500,000

'

'

Goodwill

153,000,000

'

'

'

'

'

'

'

153,000,000

'

'

Contingent consideration payments

'

'

'

'

'

'

'

'

27,000,000

'

'

Contingent consideration arrangement, low

0

'

'

'

'

'

'

'

0

'

'

Contingent consideration arrangement, high

62,000,000

'

'

'

'

'

'

'

62,000,000

'

'

Net asset value

$42,000,000

'

'

'

'

'

'

'

$42,000,000

'

'

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

Recovered_Sheet1

Restructuring and Other Impairment Charges (Detail) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

LMA Restructuring Program

LMA Restructuring Program

2013 Restructuring Program

2012 Restructuring Program

2012 Restructuring Program

2011 Restructuring Program

2011 Restructuring Program

2007 Arrow Integration Program

2007 Arrow Integration Program

2007 Arrow Integration Program

2007 Arrow Integration Program

Restructuring Cost And Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring charges

'

'

'

'

$12,152

$2,515

$10,230

$4,229

$2,459

$770

$3,047

'

$230

($1,937)

$461

In-process research and development impairment

'

7,381

'

'

'

'

'

'

'

'

'

2,900

'

'

'

Long-lived asset impairment

3,500

3,460

'

'

'

'

'

'

'

'

'

'

'

'

'

Asset Impairment Charges

'

'

'

2,497

'

'

'

'

'

'

'

'

'

'

'

Restructuring and other impairment charges

'

$38,452

$3,037

$6,005

'

'

'

'

'

'

'

'

'

'

'

Recovered_Sheet2

Restructuring and Other Impairment Charges, Restructuring Program (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
LMA Restructuring Program	'	'
Restructuring Cost And Reserve [Line Items]	'	'
Termination benefits	$3,282	$2,229
Facility closure costs	788	'
Contract termination costs	7,906	274
Other restructuring costs	176	12
Restructuring charges	12,152	2,515
2013 Restructuring Program	'	'
Restructuring Cost And Reserve [Line Items]	'	'
Termination benefits	4,787	'
Contract termination costs	3,326	'
Other restructuring costs	2,117	'
Restructuring charges	10,230	'
2012 Restructuring Charges	'	'
Restructuring Cost And Reserve [Line Items]	'	'
Termination benefits	2,993	1,681
Facility closure costs	935	'
Contract termination costs	296	758
Other restructuring costs	5	20
Restructuring charges	$4,229	$2,459

Reconciliation_of_Changes_in_A

Reconciliation of Changes in Accrued Liabilities Associated with Restructuring Program (Detail) (LMA Restructuring Program, USD $)	12 Months Ended						12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
			Termination Benefits	Termination Benefits	Facility Closing	Facility Closing	Contract Termination Costs	Contract Termination Costs	Other Restructuring Costs	Other Restructuring Costs
Restructuring Cost And Reserve [Line Items]	'	'	'	'	'	'	'	'	'	'
Balance, beginning	$2,033	'	$1,744	'	'	'	$277	'	$12	'
Subsequent accruals	12,152	2,515	3,282	2,229	788	'	7,906	274	176	12
Cash payments	-9,547	-488	-4,461	-488	-362	'	-4,560	'	-164	'
Foreign currency translation	43	6	-13	3	1	'	63	3	-8	'
Balance, ending	$4,681	$2,033	$552	$1,744	$427	'	$3,686	$277	$16	$12

Restructuring_and_Other_Impair2

Restructuring and Other Impairment Charges - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2011

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Axiom Technology Partners L L C

2013 Restructuring Program

2013 Restructuring Program

2013 Restructuring Program

2013 Restructuring Program

2012 Restructuring Charges

2012 Restructuring Charges

2011 Restructuring Program

2011 Restructuring Program

2011 Restructuring Program

2007 Arrow Integration Program

2007 Arrow Integration Program

2007 Arrow Integration Program

2007 Arrow Integration Program

Employee Termination Cost

Contract Termination Costs

Facility Closing

Facility

Facility

Restructuring Cost And Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected restructuring charges

'

'

'

'

$11,000,000

$3,000,000

$5,000,000

$3,000,000

'

'

'

'

'

'

'

'

'

Number of facilities under restructuring program

'

'

'

'

'

'

'

'

'

3

'

'

3

'

'

'

'

Contract termination costs

'

'

'

'

3,326,000

'

'

'

296,000

758,000

800,000

'

2,600,000

'

'

'

'

Percentage of premises eliminated

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

Termination benefits

'

'

'

'

4,787,000

'

'

'

2,993,000

1,681,000

'

'

400,000

'

'

'

'

Restructuring charges

'

'

'

'

10,230,000

'

'

'

4,229,000

2,459,000

'

770,000

3,047,000

'

230,000

-1,937,000

461,000

In-process research and development impairment

'

7,381,000

'

4,500,000

'

'

'

'

'

'

'

'

'

2,900,000

'

'

'

Impairment of long-lived assets

3,500,000

3,460,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Impairment charges

'

'

2,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring reserve

'

'

'

'

$4,200,000

'

'

'

'

'

'

'

'

'

'

'

'

Inventories_Detail

Inventories (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'
Raw materials	$70,209	$84,636
Work-in-process	53,672	47,440
Finished goods	242,113	222,974
Inventories, gross	365,994	355,050
Less: Inventory reserves	-32,373	-31,703
Inventories, net	$333,621	$323,347

Major_Classes_of_Property_Plan

Major Classes of Property, Plant and Equipment, at Cost (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Property Plant And Equipment [Line Items]	'	'	'
Land, buildings and leasehold improvements	$199,741	$201,155	'
Machinery and equipment	322,060	313,325	'
Computer equipment and software	102,527	70,618	'
Construction in progress	55,092	41,424	'
Property, plant and equipment, gross	679,420	626,522	'
Less: Accumulated depreciation	-353,520	-328,577	'
Property, plant and equipment, net	$325,900	$297,945	$251,912

Changes_in_Carrying_Amount_of_

Changes in Carrying Amount of Goodwill, by Reporting Segment (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Goodwill [Line Items]	'	'	'
Goodwill gross	$1,438,542	$1,570,580	$1,438,542
Accumulated impairment losses	'	-332,128	'
Goodwill net	'	1,238,452	'
Goodwill impairment charges	-332,100	'	-332,128
Goodwill related to acquisitions	'	123,284	163,982
Goodwill related to dispositions	'	'	-28,176
Purchase accounting adjustments(1)	'	'	-11,004	[1]
Translation adjustment	'	-7,533	7,236
Goodwill gross	'	1,686,331	1,570,580
Accumulated impairment losses	'	-332,128	-332,128
Goodwill net	'	1,354,203	1,238,452
Americas Segment	'	'	'
Goodwill [Line Items]	'	'	'
Goodwill gross	1,005,021	1,077,829	1,005,021
Accumulated impairment losses	'	-332,128	'
Goodwill net	'	745,701	'
Goodwill impairment charges	'	'	-332,128
Goodwill related to acquisitions	'	99,125	78,875
Purchase accounting adjustments(1)	'	'	-8,878	[1]
Translation adjustment	'	-833	2,132
Transfer of goodwill	'	'	679
Goodwill gross	'	1,176,121	1,077,829
Accumulated impairment losses	'	-332,128	-332,128
Goodwill net	'	843,993	745,701
EMEA Segment	'	'	'
Goodwill [Line Items]	'	'	'
Goodwill gross	283,362	353,282	283,362
Goodwill net	'	353,282	'
Goodwill related to acquisitions	'	19,922	69,723
Translation adjustment	'	2,217	876
Transfer of goodwill	'	'	-679
Goodwill gross	'	375,421	353,282
Goodwill net	'	375,421	353,282
Asia Segment	'	'	'
Goodwill [Line Items]	'	'	'
Goodwill gross	121,983	139,469	121,983
Goodwill net	'	139,469	'
Goodwill related to acquisitions	'	4,237	15,384
Purchase accounting adjustments(1)	'	'	-2,126	[1]
Translation adjustment	'	-8,917	4,228
Goodwill gross	'	134,789	139,469
Goodwill net	'	134,789	139,469
OEM Segment	'	'	'
Goodwill [Line Items]	'	'	'
Goodwill gross	28,176	'	28,176
Goodwill related to dispositions	'	'	($28,176)
[1]	Purchase accounting adjustments related to the finalization of the purchase price allocation of uncertain tax positions and deferred taxes for the LMA acquisition. The purchase accounting adjustments were completed in 2013, however, in accordance with ASC Topic 805, “Business Combinations,” the Company retrospectively adjusted the December 31, 2012 balance sheet, as well as the Condensed Consolidating Balance Sheet included in Note 17, for these adjustments as the acquisition occurred in 2012.

Components_of_Intangible_Asset

Components of Intangible Assets (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Finite Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$1,557,688	$1,310,464
Accumulated Amortization	-302,091	-251,672
In-process Research and Development Asset	'	'
Finite Lived Intangible Assets [Line Items]	'	'
In-process research and development	68,786	53,157
Customer Relationships	'	'
Finite Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	628,020	580,151
Accumulated Amortization	-168,223	-141,520
Intellectual property	'	'
Finite Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	435,869	276,458
Accumulated Amortization	-118,086	-95,967
Distribution rights	'	'
Finite Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	16,797	16,567
Accumulated Amortization	-14,592	-13,880
Trade Names	'	'
Finite Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	407,879	384,131
Accumulated Amortization	-1,148	-305
Noncompete Agreements	'	'
Finite Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	337	'
Accumulated Amortization	($42)	'

Estimated_Annual_Amortization_

Estimated Annual Amortization Expense (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
2014	$59,100
2015	53,300
2016	52,900
2017	52,400
2018	$51,900

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Finite Lived Intangible Assets [Line Items]	'	'	'	'
Amortization expense of intangible assets	'	$50,608,000	$44,264,000	$42,634,000
Goodwill impairment charges	332,100,000	'	332,128,000	'
Vascular Reporting Unit	'	'	'	'
Finite Lived Intangible Assets [Line Items]	'	'	'	'
Goodwill impairment charges	220,000,000	'	'	'
Anesthesia/Respiratory Reporting Unit	'	'	'	'
Finite Lived Intangible Assets [Line Items]	'	'	'	'
Goodwill impairment charges	107,000,000	'	'	'
Cardiac Reporting Unit	'	'	'	'
Finite Lived Intangible Assets [Line Items]	'	'	'	'
Goodwill impairment charges	5,000,000	'	'	'
Trade Names	'	'	'	'
Finite Lived Intangible Assets [Line Items]	'	'	'	'
Indefinite lived intangible assets	'	371,600,000	'	'
In-process Research and Development Asset	'	'	'	'
Finite Lived Intangible Assets [Line Items]	'	'	'	'
Indefinite lived intangible assets	'	$68,800,000	'	'

Changes_in_Carrying_Amount_of_1

Changes in Carrying Amount of Goodwill, by Reporting Segment (Parenthetical) (Detail) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Goodwill [Line Items]	'
Deferred tax related to finalization of purchase price allocation for LMA acquisition	$0

Components_of_LongTerm_Debt_De

Components of Long-Term Debt (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Jun. 13, 2011
In Thousands, unless otherwise specified
Line Of Credit Facility [Line Items]	'	'	'
Long-term debt, Gross	$1,330,000	$1,025,000	'
Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes	-48,413	-59,720	'
Total long-term debt	1,281,587	965,280	'
Current portion of borrowings	-351,587	'	'
Total long-term debt	930,000	965,280	'
Revolving Credit Facility	'	'	'
Line Of Credit Facility [Line Items]	'	'	'
Senior Credit Facility	680,000	'	'
Term loan facility, at a rate of 2.75%	'	'	'
Line Of Credit Facility [Line Items]	'	'	'
Senior Credit Facility	'	375,000	'
3.875% Convertible Senior Subordinated Notes	'	'	'
Line Of Credit Facility [Line Items]	'	'	'
3.875% Convertible Senior Subordinated Notes	400,000	400,000	'
6.875% Senior Subordinated Notes Due 2019	'	'	'
Line Of Credit Facility [Line Items]	'	'	'
6.875% Senior Subordinated Notes due 2019	$250,000	$250,000	$250,000

Components_of_LongTerm_Debt_Pa

Components of Long-Term Debt (Parenthetical) (Detail)	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 13, 2011
		Revolving Credit Facility	Term loan facility, at a rate of 2.75%	3.875% Convertible Senior Subordinated Notes	3.875% Convertible Senior Subordinated Notes	6.875% Senior Subordinated Notes Due 2019	6.875% Senior Subordinated Notes Due 2019	6.875% Senior Subordinated Notes Due 2019
Line Of Credit Facility [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	1.92%	2.75%	'	'	'	'	'
Interest rate	3.88%	'	'	3.88%	3.88%	6.88%	6.88%	6.88%
Debt instrument maturity date	'	'	'	'	'	'2019	'2019	'2019
Debt maturity date	'	16-Jul-18	'	'	'	'	'	'

Interest_Expense_Amounts_Relat

Interest Expense Amounts Related to Convertible Notes (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Line Of Credit Facility [Line Items]	'	'	'
Interest cost related to contractual interest coupon	$15.50	$15.50	$15.50
Interest cost related to amortization of the discount	$11.30	$10.50	$9.70

Carrying_Value_of_Convertible_

Carrying Value of Convertible Notes (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Convertible Debt [Line Items]	'	'
Principal amount of the Convertible Notes	$400,000,000	$400,000,000
Unamortized discount	-48,413,000	-59,720,000
Net carrying amount	$351,600,000	$340,300,000

Borrowings_Additional_Informat

Borrowings - Additional Information (Detail) (USD $)

12 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2012

Dec. 31, 2013

Jul. 16, 2013

Jul. 16, 2013

Jul. 16, 2013

Jul. 16, 2013

Dec. 31, 2013

Jul. 16, 2013

Jul. 16, 2013

Jul. 16, 2013

Jul. 16, 2013

Jul. 16, 2013

Jul. 16, 2013

Dec. 31, 2013

Dec. 31, 2012

Jun. 13, 2011

Jul. 01, 2012

Dec. 31, 2013

Dec. 31, 2012

Securitization Program

Senior Credit Facility

Senior Credit Facility

Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

New Senior Credit Facility

3.875% Convertible Senior Subordinated Notes

3.875% Convertible Senior Subordinated Notes

6.875% Senior Subordinated Notes Due 2019

6.875% Senior Subordinated Notes Due 2019

6.875% Senior Subordinated Notes Due 2019

6.875% Senior Subordinated Notes Due 2019

Term Loan

Revolving Credit Facility

Libor Rate Plus

Libor Rate Plus

Libor Rate Plus

Rate Spread

Prime Rate

Prime Rate

Minimum

Maximum

Minimum

Maximum

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum amount available for borrowing

'

'

'

'

$43,900,000

$775,000,000

$375,000,000

$400,000,000

$850,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Transaction fees recorded as Deferred asset

'

'

'

'

'

'

'

'

6,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of debt issuance costs

'

'

'

'

'

'

'

'

1,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Borrowing under revolving credit

'

'

'

'

'

'

'

'

382,000,000

298,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Federal funds effective rate plus

'

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

Prime rate or one month LIBOR plus

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Applicable margin

'

'

'

'

'

'

'

'

'

'

'

1.25%

2.00%

'

0.25%

1.00%

'

'

'

'

'

'

Senior credit facility interest rate

'

'

'

'

'

'

'

'

1.92%

'

0.17%

'

'

1.75%

'

'

'

'

'

'

'

'

Principal amount of convertible notes

400,000,000

'

'

400,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate

3.88%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.88%

3.88%

6.88%

'

6.88%

6.88%

Number of trading days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 days

'

'

'

'

'

Number of Consecutive trading days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'30 days

'

'

'

'

'

Percentage of conversion price of applicable trading day

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130.00%

'

'

'

'

'

Number of business days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 days

'

'

'

'

'

Principal amount of Convertible Notes

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

'

'

'

'

'

Percentage of the product of the last reported sale price of the common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

98.00%

'

'

'

'

'

Convertible Notes conversion rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16.3084

'

'

'

'

'

Conversion price, per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$61.32

'

'

'

'

'

Convertible note hedge transactions, purchased call options

88,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible note hedge transactions, net of tax

56,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible notes, latest date of termination

28-Jul-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of convertible notes, shares issued upon conversion

600,000

'

7,981,422

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants expiration period

'

'

'180 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants expiration date

'

'

1-Nov-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Strike price of warrants

$74.65

'

$74.65

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from sale of warrants

'

'

59,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible debt, fair value

316,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Initial equity component

83,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible notes, carrying value, net of tax

53,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt discount

83,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remaining life of the convertible notes

'3 years 7 months 6 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Effective interest rate

7.81%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.875% Senior Subordinated Notes due 2019

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000,000

'

250,000,000

250,000,000

Debt instrument maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2019

'

'2019

'2019

Transaction fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,700,000

'

'

'

Repayment of Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

125,000,000

'

'

'

Write-off of debt issuance costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

800,000

'

'

Percent of redemption price to principal amount any time on or after June 1, 2015

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

103.44%

'

Debt instrument, earliest date of redemption

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1-Jun-15

'

Declining percent of redemption price to principal amount on June1, 2017

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

Percent of redemption price to principal amount on redemption at any time prior to June 1, 2015

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

Make-whole premium as percentage of principal amount of Notes subject to redemption

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

Percent of principal amount of notes redeemable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35.00%

'

Percent of redemption price of the principal amount of the notes redeemed, plus accrued and unpaid interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

106.88%

'

Basis spread

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

Notional amount

'

350,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate swap liability position

'

14,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accrued interest

'

3,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Long-term Debt

1,281,587,000

'

'

965,280,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum amount available under receivable securitization

50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding borrowings under accounts receivable securitization facility

$4,700,000

'

'

$4,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair_Value_of_Debt_Detail

Fair Value of Debt (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value Measurements [Line Items]	'	'
Fair value of debt	$1,543,402	$1,165,011
Quoted Prices In Active Markets (Level 1)	'	'
Fair Value Measurements [Line Items]	'	'
Fair value of debt	899,390	782,377
Significant Other Observable Inputs (Level 2)	'	'
Fair Value Measurements [Line Items]	'	'
Fair value of debt	$644,012	$382,634

Aggregate_Amounts_of_LongTerm_

Aggregate Amounts of Long-Term Debt (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Long Term Debt Maturities Repayments Of Principal [Line Items]	'
2014	$404,700	[1]
2015	'
2016	'
2017	'
2018 and thereafter	$930,000
[1]	(1) The Convertible Senior Subordinated Notes are included in amounts that will mature in 2014 due to the trigger of the conversion feature, which is described in more detail in the “Convertible Notes” section above.

Fair_Values_of_Derivative_Inst

Fair Values of Derivative Instruments Designated as Hedging Instruments (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Derivatives Fair Value [Line Items]	'	'
Total asset derivatives	'	$1,279
Total liability derivatives	'	598
Other Assets - Current | Foreign Currency Exchange Contracts	'	'
Derivatives Fair Value [Line Items]	'	'
Total asset derivatives	'	1,279
Derivative Liabilities - Current | Foreign Currency Exchange Contracts	'	'
Derivatives Fair Value [Line Items]	'	'
Total liability derivatives	'	$598

After_Tax_GainLoss_Reclassifie

After Tax (Gain)/Loss Reclassified from Accumulated Other Comprehensive Income into Income (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments Gain Loss [Line Items]	'	'	'
Derivatives qualifying as hedges, net of tax	$381	$6,876	$8,005
Interest Rate Swap	'	'	'
Derivative Instruments Gain Loss [Line Items]	'	'	'
Derivatives qualifying as hedges, net of tax	'	7,032	8,330
Foreign Currency Exchange Contracts	'	'	'
Derivative Instruments Gain Loss [Line Items]	'	'	'
Derivatives qualifying as hedges, net of tax	$381	($156)	($325)

Aggregate_Accounts_Receivable_

Aggregate Accounts Receivable, Net of Allowance for Doubtful Accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Unusual Risk Or Uncertainty [Line Items]	'	'
Current and long-term accounts receivable, net	$295,290	$297,976
Spain, Italy, Portugal, and Greece	'	'
Unusual Risk Or Uncertainty [Line Items]	'	'
Current and long-term accounts receivable, net	$97,852	$101,009
Percentage of total net current and long-term accounts receivables	31.00%	34.00%

Aggregate_Accounts_Receivable_1

Aggregate Accounts Receivable, Net of Allowance for Doubtful Accounts (Parenthetical) (Detail) (Spain, Italy, Portugal, and Greece, USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Spain, Italy, Portugal, and Greece	'	'
Unusual Risk Or Uncertainty [Line Items]	'	'
Current and long-term accounts receivable, allowances	$7.90	$6.30

Financial_Instruments_Addition

Financial Instruments - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Derivatives Fair Value [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Amount of loss in accumulated other comprehensive income to be reclassified as expense to the statement of income

$0

'

'

'

$0

'

'

'

$0

$0

$0

Pre-tax loss on forward exchange contract

'

'

'

'

'

'

'

'

'

7,600,000

'

Net revenues

450,539,000

413,796,000

420,059,000

411,877,000

[1]

419,056,000

[2]

368,054,000

[2]

383,332,000

[2]

380,567,000

[1],[2]

1,696,271,000

1,551,009,000

1,492,528,000

Spain, Italy, Portugal, and Greece

'

'

'

'

'

'

'

'

'

'

'

Derivatives Fair Value [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

142,600,000

132,500,000

138,400,000

Interest Rate Swap | Cash Flow Hedges

'

'

'

'

'

'

'

'

'

'

'

Derivatives Fair Value [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Interest rate swap, notional amount designated as a hedge

'

'

'

'

'

'

'

'

'

'

$350,000,000

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

Financial_Assets_and_Liabiliti

Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'	'
Investments in marketable securities	$6,150	$4,785
Contingent consideration liabilities	20,313	51,196
Derivative assets	'	1,279
Derivative liabilities	'	598
Quoted Prices In Active Markets (Level 1)	'	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'	'
Investments in marketable securities	6,150	4,785
Contingent consideration liabilities	'	'
Derivative assets	'	'
Derivative liabilities	'	'
Significant Other Observable Inputs (Level 2)	'	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'	'
Investments in marketable securities	'	'
Contingent consideration liabilities	'	'
Derivative assets	'	1,279
Derivative liabilities	'	598
Significant Unobservable Inputs (Level 3)	'	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'	'
Investments in marketable securities	'	'
Contingent consideration liabilities	20,313	51,196
Derivative assets	'	'
Derivative liabilities	'	'

Reconciliation_of_Changes_in_L

Reconciliation of Changes in Level Three Financial Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'
Beginning balance	$51,196	$9,676
Initial estimate upon acquisition	'	58,895
Payment	-18,880	-18,426
Revaluations	-11,982	1,055
Translation adjustment	-21	-4
Ending balance	$20,313	$51,196

Valuation_Technique_and_Inputs

Valuation Technique and Inputs Used to Determine Fair Value of Assets Or Liabilities (Detail)	12 Months Ended
	Dec. 31, 2013
Discount Rate	'
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]	'
Contingent consideration, weighted average	6.00%
Probability of Payment	'
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]	'
Contingent consideration, weighted average	31.00%
Minimum | Discount Rate	'
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]	'
Contingent consideration	1.00%
Minimum | Probability of Payment	'
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]	'
Contingent consideration	0.00%
Maximum | Discount Rate	'
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]	'
Contingent consideration	10.00%
Maximum | Probability of Payment	'
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]	'
Contingent consideration	100.00%

Fair_Value_Measurement_Additio

Fair Value Measurement - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Fair Value Measurements [Line Items]	'
Contingent consideration	$20.30
Current contingent consideration	4.1
Other liabilities	16.2
Reversal of contingent consideration	12.3
Minimum	'
Fair Value Measurements [Line Items]	'
Fair value of contingent consideration liability associated with future milestone	0
Maximum	'
Fair Value Measurements [Line Items]	'
Fair value of contingent consideration liability associated with future milestone	$77

Reconciliation_of_Basic_to_Dil

Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule Of Earnings Per Share Basic And Diluted By Common Class [Line Items]	'	'	'
Basic	41,105	40,859	40,501
Dilutive effect of share based awards	410	'	287
Dilutive effect of 3.875% Convertible Notes and warrants	2,178	'	13
Diluted	43,693	40,859	40,801

Reconciliation_of_Basic_to_Dil1

Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Parenthetical) (Detail)	Dec. 31, 2013
Schedule Of Earnings Per Share Basic And Diluted By Common Class [Line Items]	'
Convertible senior notes percentage	3.88%

Change_in_Accumulated_Other_Co

Change in Accumulated Other Comprehensive Income (Loss), Net of tax (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Accumulated Other Comprehensive Income Loss [Line Items]	'	'
Beginning balance, accumulated other comprehensive income (loss), net of tax	($132,048)	($159,353)
Other comprehensive income (loss) before reclassifications	15,507	16,281
Amounts reclassified from accumulated other comprehensive income	5,686	11,024
Net current-period other comprehensive income (loss)	21,193	27,305
Ending balance, accumulated other comprehensive income (loss), net of tax	-110,855	-132,048
Cash Flow Hedges	'	'
Accumulated Other Comprehensive Income Loss [Line Items]	'	'
Beginning balance, accumulated other comprehensive income (loss), net of tax	-381	-7,257
Other comprehensive income (loss) before reclassifications	-549	515
Amounts reclassified from accumulated other comprehensive income	930	6,361
Net current-period other comprehensive income (loss)	381	6,876
Ending balance, accumulated other comprehensive income (loss), net of tax	'	-381
Pension and Other Postretirement Benefits Plans	'	'
Accumulated Other Comprehensive Income Loss [Line Items]	'	'
Beginning balance, accumulated other comprehensive income (loss), net of tax	-127,257	-134,548
Other comprehensive income (loss) before reclassifications	25,464	2,628
Amounts reclassified from accumulated other comprehensive income	4,756	4,663
Net current-period other comprehensive income (loss)	30,220	7,291
Ending balance, accumulated other comprehensive income (loss), net of tax	-97,037	-127,257
Foreign Currency Translation Adjustment	'	'
Accumulated Other Comprehensive Income Loss [Line Items]	'	'
Beginning balance, accumulated other comprehensive income (loss), net of tax	-4,410	-17,548
Other comprehensive income (loss) before reclassifications	-9,408	13,138
Net current-period other comprehensive income (loss)	-9,408	13,138
Ending balance, accumulated other comprehensive income (loss), net of tax	($13,818)	($4,410)

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss) into Income Expense (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

$450,539

$413,796

$420,059

$411,877

[1]

$419,056

[2]

$368,054

[2]

$383,332

[2]

$380,567

[1],[2]

$1,696,271

$1,551,009

$1,492,528

Cost of goods sold

'

'

'

'

'

'

'

'

-857,326

-802,784

-783,750

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

175,730

-165,369

145,100

Tax expense (benefit)

'

'

'

'

'

'

'

'

-23,547

-16,413

-25,778

Net of tax

35,302

45,779

43,401

27,701

[1]

30,614

[2]

24,451

[2]

47,266

[2]

-284,113

[1],[2]

152,183

-181,782

119,322

Reclassification out of Accumulated Other Comprehensive Income

'

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total reclassifications, net of tax

'

'

'

'

'

'

'

'

5,686

11,024

'

Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income

'

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

884

10,193

'

Tax expense (benefit)

'

'

'

'

'

'

'

'

46

-3,832

'

Net of tax

'

'

'

'

'

'

'

'

930

6,361

'

Pension and Other Postretirement Benefits Plans | Reclassification out of Accumulated Other Comprehensive Income

'

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

7,195

7,223

'

Tax expense (benefit)

'

'

'

'

'

'

'

'

-2,439

-2,560

'

Net of tax

'

'

'

'

'

'

'

'

4,756

4,663

'

Actuarial losses

'

'

'

'

'

'

'

'

7,211

[3]

7,158

[3]

'

Prior-service costs

'

'

'

'

'

'

'

'

-21

[3]

-20

[3]

'

Transition obligation

'

'

'

'

'

'

'

'

5

[3]

97

[3]

'

Curtailment charge

'

'

'

'

'

'

'

'

'

-118

[3]

'

Settlement charge

'

'

'

'

'

'

'

'

'

106

[3]

'

Interest Rate Contracts | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income

'

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Interest expense

'

'

'

'

'

'

'

'

'

11,057

'

Commodity Contract | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income

'

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

'

34

'

Cost of goods sold

'

'

'

'

'

'

'

'

$884

($898)

'

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

[3]

These accumulated other comprehensive income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 14 to the consolidated financial statements for additional information).

Shareholders_Equity_Additional

Shareholder's Equity - Additional Information (Detail) (USD $)	1 Months Ended	12 Months Ended			12 Months Ended
In Millions, except Share data, unless otherwise specified	Jun. 30, 2007	Dec. 31, 2013	Dec. 31, 2010	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
					Convertible Note	Convertible Note	Stock Option	Stock Option	Stock Option
Shareholders Equity [Line Items]	'	'	'	'	'	'	'	'	'
Common shares, authorized	'	200,000,000	'	'	'	'	'	'	'
Common shares, par value	'	$1	'	$1	'	'	'	'	'
Preference shares, authorized	'	500,000	'	'	'	'	'	'	'
Repurchase of outstanding common stock, authorized amount	$300	'	'	'	'	'	'	'	'
Average market price of common stock	'	$61.32	'	'	'	'	'	'	'
Weighted average antidilutive which were not included in the calculation of earnings per share	'	'	'	'	1,600,000	300,000	7,700,000	9,000,000	8,800,000
Strike price of warrants	'	$74.65	$74.65	'	'	'	'	'	'
Conversion of convertible notes, shares issued upon conversion	'	600,000	7,981,422	'	'	'	'	'	'

WeightedAverage_Assumptions_us

Weighted-Average Assumptions used to Estimate Fair Value of Options Granted (Detail) (Stock Options)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Weighted Average Fair Values [Line Items]	'	'	'
Risk-free interest rate	0.75%	0.81%	1.92%
Expected life of option	'4 years 10 months 13 days	'4 years 10 months 6 days	'4 years 8 months 12 days
Expected dividend yield	1.73%	2.28%	2.34%
Expected volatility	24.65%	28.46%	26.82%

WeightedAverage_Assumptions_us1

Weighted-Average Assumptions used to Estimate Fair Value of Non-Vested Shares Granted (Detail) (Stock Options)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Weighted Average Fair Values [Line Items]	'	'	'
Risk-free interest rate	0.36%	0.37%	1.04%
Expected dividend yield	1.71%	2.24%	2.34%

Summary_of_Stock_Option_Activi

Summary of Stock Option Activity (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013
Schedule Of Stock Options [Line Items]	'
Shares Subject to Options, Outstanding, beginning of the year	1,084,193
Shares Subject to Options, Granted	417,484
Shares Subject to Options, Exercised	-157,545
Shares Subject to Options, Forfeited or expired	-64,652
Shares Subject to Options, Outstanding, end of the year	1,279,480
Shares Subject to Options, Exercisable, end of the year	652,431
Weighted Average Exercise Price, Outstanding, beginning of the year	$58.43
Weighted Average Exercise Price, Granted	$79.37
Weighted Average Exercise Price, Exercised	$57.16
Weighted Average Exercise Price, Forfeited or expired	$65.79
Weighted Average Exercise Price, Outstanding, end of the year	$65.05
Weighted Average Exercise Price, Exercisable, end of the year	$59.31
Weighted Average Remaining Contractual Life in Years, Outstanding, end of the year	'7 years 1 month 6 days
Weighted Average Remaining Contractual Life in Years, Exercisable, end of the year	'5 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding, end of the year	$36,900
Aggregate Intrinsic Value, Exercisable, end of the year	$22,543

Summary_of_Non_Vested_Restrict

Summary of Non Vested Restricted Stock Unit Activity (Detail) (Restricted Stock Units, USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restricted Stock Units	'	'	'
Schedule Of Activity Related To Restricted Shares And Restricted Share [Line Items]	'	'	'
Number of Non-Vested Shares, Outstanding, beginning of the year	364,788	'	'
Number of Non-Vested Shares, Granted	148,191	'	'
Number of Non-Vested Shares, Vested	-99,666	'	'
Number of Non-Vested Shares, Forfeited	-59,956	'	'
Number of Non-Vested Shares, Outstanding, end of the year	353,357	364,788	'
Weighted Average Grant Date Fair Value, Outstanding, beginning of the year	$55.77	'	'
Weighted Average Grant Date Fair Value, Granted	$75.60	$56.95	$54.33
Weighted Average Grant Date Fair Value, Vested	$63.01	'	'
Weighted Average Grant Date Fair Value, Forfeited	$59.87	'	'
Weighted Average Grant Date Fair Value, Outstanding, end of the year	$62.49	$55.77	'
Weighted Average Remaining Contractual Life In Years, Outstanding, end of the year	'1 year 3 months 18 days	'	'
Aggregate Intrinsic Value, Outstanding, end of the year	$33,166	'	'

Stock_Compensation_Plans_Addit

Stock Compensation Plans - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Grant of incentive and non-qualified options	417,484	'	'
Stock option granted, weighted average grant date fair value	$14.30	$11.78	$11.45
Stock option granted, weighted average grant date fair value	$4.10	$2.70	$6.90
Stock option expenses including selling general and administrative expenses	4.4	'	'
Non vested restricted stock expense including selling general and administrative expense	7.5	'	'
2000 Stock Compensation Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Maximum number of common stock authorized to be issued under plan	4,000,000	'	'
Exercise price of common stock	0.25	'	'
Unrecognized compensation expense	1	'	'
Shares available for future grants	760,979	'	'
2000 Stock Compensation Plan Restricted Stock	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Maximum number of common stock authorized to be issued under plan	800,000	'	'
2008 Stock Incentive Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Maximum number of common stock authorized to be issued under plan	2,500,000	'	'
Unrecognized compensation expense	$16.10	'	'
Shares available for future grants	839,542	'	'
2008 Stock Incentive Plan Stock Appreciation Rights	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Maximum number of common stock authorized to be issued under plan	875,000	'	'
Restricted Stock Units	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Grant of restricted stock awards	148,191	'	'
Weighted Average Grant Date Fair Value, Granted	$75.60	$56.95	$54.33
Common Stock | 2000 Stock Compensation Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Grant of incentive and non-qualified options	29,875	'	'
Common Stock | 2008 Stock Incentive Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Grant of incentive and non-qualified options	387,609	'	'
Restricted Stock Units | 2000 Stock Compensation Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Grant of restricted stock awards	8,092	'	'
Restricted Stock Units | 2008 Stock Incentive Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Grant of restricted stock awards	140,099	'	'
Minimum | 2000 Stock Compensation Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Exercisable period of option granted, in years	'3 years	'	'
Minimum | 2000 Stock Compensation Plan Restricted Stock	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Exercisable period of option granted, in years	'1 year	'	'
Maximum | 2000 Stock Compensation Plan	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Exercisable period of option granted, in years	'5 years	'	'
Expiration period of option granted, after the date of grant in years	'10 years	'	'
Maximum | 2000 Stock Compensation Plan Restricted Stock	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'
Exercisable period of option granted, in years	'3 years	'	'

Components_of_Provision_for_In

Components of Provision for Income Taxes from Continuing Operations (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Provision For Income Taxes [Line Items]	'	'	'
Federal, Current	($2,974)	$20,959	($2,604)
State, Current	1,736	3,623	4,621
Foreign, Current	36,400	30,476	48,600
Federal, Deferred	-9,703	-34,629	-20,584
State, Deferred	-1,825	-720	-961
Foreign, Deferred	-87	-3,296	-3,294
Provision for income taxes from continuing operations	$23,547	$16,413	$25,778

Summary_of_US_and_NonUS_Compon

Summary of U.S. and Non-U.S. Components of Income from Continuing Operations before Taxes (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule Of Income Loss From Continuing Operations [Line Items]	'	'	'
United States	($3,544)	($315,928)	($10,952)
Other	179,274	150,559	156,052
Income (loss) from continuing operations before taxes	$175,730	($165,369)	$145,100

Reconciliations_between_Statut

Reconciliations between Statutory Federal Income Tax Rate and Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule Of Effective Tax Rates [Line Items]	'	'	'
Federal statutory rate	35.00%	35.00%	35.00%
Goodwill impairment	'	-60.84%	'
Tax effect of International items	-15.26%	11.88%	-15.36%
State taxes, net of federal benefit	-0.32%	-0.90%	1.18%
Uncertain tax contingencies	-4.06%	4.85%	-2.66%
Contingent consideration reversals	-2.04%	'	'
Other, net	0.08%	0.08%	-0.39%
Effective income tax rate, total	13.40%	-9.93%	17.77%

Deferred_Tax_Assets_and_Liabil

Deferred Tax Assets and Liabilities (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Deferred Tax Assets And Liabilities [Line Items]	'	'
Tax loss and credit carryforwards	$104,043	$92,282
Pension	39,310	63,737
Reserves and accruals	39,478	39,485
Other	27,092	21,255
Less: valuation allowances	-86,510	-69,527
Total deferred tax assets	123,413	147,232
Property, plant and equipment	26,550	24,766
Intangibles — stock acquisitions	400,297	324,983
Unremitted foreign earnings	147,326	151,780
Other	12,030	13,129
Total deferred tax liabilities	586,203	514,658
Net deferred tax liability	($462,790)	($367,426)

Uncertain_Tax_Positions_for_Li

Uncertain Tax Positions for Liabilities Associated with Unrecognized Tax Benefits (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reconciliation Of Unrecognized Tax Benefits [Line Items]	'	'	'
Beginning balance	$62,108	$75,026	$89,281
Increase in unrecognized tax benefits related to prior years	'	1,110	1,855
Decrease in unrecognized tax benefits related to prior years	'	-6,134	-6,415
Unrecognized tax benefits related to the current year	1,838	4,256	4,246
Reductions in unrecognized tax benefits due to settlements	'	-8,816	-7,678
Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations	-8,433	-3,503	-5,852
Increase (decrease) in unrecognized tax benefits due to foreign currency translation	258	169	-411
Ending balance	$55,771	$62,108	$75,026

Examination_by_Major_Tax_Juris

Examination by Major Tax Jurisdictions (Detail)	12 Months Ended
	Dec. 31, 2013
United States | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2010
United States | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Canada | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2005
Canada | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
China | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2008
China | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Czech Republic | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2001
Czech Republic | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
France | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2011
France | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Germany | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2007
Germany | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Ireland | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2009
Ireland | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Italy | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2009
Italy | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Malaysia | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2008
Malaysia | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013
Singapore | Beginning	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2009
Singapore | Ending	'
Income Tax Examination [Line Items]	'
Taxable years remain subject to examination	'2013

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jun. 30, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Minimum

Maximum

Vidacare Corporation

Hotspur Technologies

Excess Tax Deductions

Excess Tax Deductions

Excess Tax Deductions

Cargo And Container Businesses

After 2018

No Expiration Date

After 2013 but before the end of 2018

Income Tax Contingency [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain on the sale of business

'

'

$2,205,000

[1]

$270,630,000

[1]

'

'

'

'

'

'

'

'

$217,800,000

'

'

'

Gain on sale of business, related taxes

'

'

'

'

'

'

'

'

'

'

'

'

91,000,000

'

'

'

Effective income tax rate, total

'

13.40%

-9.93%

17.77%

'

'

'

'

'

'

13.40%

9.90%

'

'

'

'

Goodwill impairment charges

332,000,000

'

'

'

'

'

'

'

'

45,000,000

'

'

'

'

'

'

Cumulative unremitted earnings

'

353,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cumulative unremitted earnings, non-permanently reinvested

'

609,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Realized net benefit as result of reducing our reserves with respect to uncertain tax positions

'

7,100,000

8,000,000

3,900,000

'

'

'

'

'

'

'

'

'

'

'

'

Tax effect, carry forwards

'

104,000,000

'

'

'

'

'

7,400,000

10,800,000

'

'

'

'

88,600,000

14,800,000

600,000

Percentage of change in ownership

'

50.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrealized tax losses related to acquisition

'

'

'

'

2,500,000

'

'

500,000

'

'

'

'

'

'

'

'

Deferred tax assets, valuation allowance

'

86,510,000

69,527,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits that would impact effective tax rate

'

22,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits, interest (benefit) expense

'

1,300,000

800,000

-100,000

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits, penalties

'

-800,000

200,000

300,000

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits, interest (benefit) expense accrued

'

5,700,000

6,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits, penalties accrued

'

6,000,000

9,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits change within next twelve months due to potential for resolution of foreign and U.S. examinations

'

$258,000

$169,000

($411,000)

'

$0

$2,500,000

'

'

'

'

'

'

'

'

'

[1]

The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the cargo systems and cargo container businesses.

Net_Benefit_Cost_of_Pension_an

Net Benefit Cost of Pension and Postretirement Benefit Plans (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Service cost	$1,819	$2,331	$2,297
Interest cost	16,842	16,561	17,284
Expected return on plan assets	-23,122	-20,245	-19,998
Net amortization and deferral	5,847	6,474	4,018
Curtailment gain	'	-197	-37
Settlement loss (gain)	'	106	-5
Net benefit cost	1,386	5,030	3,559
Other Benefits	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Service cost	663	704	479
Interest cost	2,707	2,122	2,054
Expected return on plan assets	'	'	'
Net amortization and deferral	1,348	761	-45
Curtailment gain	'	'	'
Settlement loss (gain)	'	'	'
Net benefit cost	$4,718	$3,587	$2,488

Weighted_Average_Assumptions_u

Weighted Average Assumptions used in Determining Net Periodic Benefit Cost (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Discount rate	4.27%	4.28%	5.50%
Rate of return	8.31%	8.27%	8.31%
Initial healthcare trend rate	'	'	'
Ultimate healthcare trend rate	'	'	'
Other Benefits	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Discount rate	3.83%	3.95%	5.10%
Rate of return	'	'	'
Initial healthcare trend rate	8.15%	8.50%	8.00%
Ultimate healthcare trend rate	5.00%	5.00%	5.00%

Pension_and_Postretirement_Ben

Pension and Postretirement Benefit Plans (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Defined Benefit Plan Disclosure [Line Items]	'		'		'
Balance at end of year	$305,481	[1]	$276,863	[1]	'
Pension	'		'		'
Defined Benefit Plan Disclosure [Line Items]	'		'		'
Benefit obligation, beginning of year	397,184		393,794		'
Service cost	1,819		2,331		2,297
Interest cost	16,842		16,561		17,284
Actuarial (gain) loss	-30,755		2,345		'
Currency translation, benefit obligation	861		678		'
Benefits paid	-17,004		-16,227		'
Medicare Part D reimbursement	'		'		'
Settlements	'		-767		'
Administrative costs	-1,216		-1,452		'
Curtailments	'		-79		'
Projected benefit obligation, end of year	367,731		397,184		393,794
Balance at beginning of year	276,863		243,324		'
Actual return on plan assets	28,813		33,946		'
Contributions	17,724		17,567		'
Benefits paid	-17,004		-16,227		'
Settlements paid	'		-767		'
Currency translation, fair value of plan assets	301		472		'
Balance at end of year	305,481		276,863		243,324
Funded status, end of year	-62,250		-120,321		'
Other Benefits	'		'		'
Defined Benefit Plan Disclosure [Line Items]	'		'		'
Benefit obligation, beginning of year	55,609		49,508		'
Service cost	663		704		479
Interest cost	2,707		2,122		2,054
Actuarial (gain) loss	-3,833		6,161		'
Currency translation, benefit obligation	'		'		'
Benefits paid	-2,860		-3,106		'
Medicare Part D reimbursement	162		220		'
Settlements	'		'		'
Administrative costs	'		'		'
Curtailments	'		'		'
Projected benefit obligation, end of year	52,448		55,609		49,508
Balance at beginning of year	'		'		'
Actual return on plan assets	'		'		'
Contributions	'		'		'
Benefits paid	'		'		'
Settlements paid	'		'		'
Currency translation, fair value of plan assets	'		'		'
Balance at end of year	'		'		'
Funded status, end of year	($52,448)		($55,609)		'
[1]	Information on asset categories described in notes (b)-(k) is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.

Amounts_Recognized_in_Consolid

Amounts Recognized in Consolidated Balance Sheet (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Defined Benefit Plan Disclosure [Line Items]	'	'
Payroll and benefit-related liabilities	($73,090)	($74,586)
Pension and postretirement benefit liabilities	-109,498	-170,946
Pension	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Payroll and benefit-related liabilities	-1,819	-1,784
Pension and postretirement benefit liabilities	-60,431	-118,537
Accumulated other comprehensive loss	144,866	186,916
Amounts recognized in balance sheet	82,616	66,595
Other Benefit	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Payroll and benefit-related liabilities	-3,381	-3,200
Pension and postretirement benefit liabilities	-49,067	-52,409
Accumulated other comprehensive loss	7,073	12,254
Amounts recognized in balance sheet	($45,375)	($43,355)

Amounts_Recognized_in_Accumula

Amounts Recognized in Accumulated Other Comprehensive (Income) Loss (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Ending balance, accumulated other comprehensive (income) loss, net of tax	$110,855	$132,048	$159,353
Pension	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Beginning balance, prior service cost (credit)	216	251	'
Net Amortization and deferral	-34	-35	'
Actuarial changes in benefit obligation, prior service cost (credit)	'	'	'
Impact of currency translation, prior service cost (credit)	'	'	'
Ending balance, prior service cost (credit)	182	216	251
Beginning balance, net (gain) or loss	186,700	204,257	'
Net amortization and deferral, net (gain) or loss	-5,813	-6,439	'
Curtailment, net (gain) or loss	'	118	'
Settlement, net (gain) or loss	'	-106	5
Actuarial changes in benefit obligation, net (gain) or loss	-36,446	-11,356	'
Impact of currency translation, net (gain) or loss	243	226	'
Ending balance, net (gain) or loss	144,684	186,700	204,257
Beginning balance, deferred taxes	-67,567	-74,488	'
Net amortization and deferral, deferred taxes	1,947	2,287	'
Curtailment, deferred taxes	'	-44	'
Settlement, deferred taxes	'	40	'
Actuarial changes in benefit obligation, deferred taxes	13,206	4,696	'
Impact of currency translation, deferred taxes	-66	-58	'
Ending balance, deferred taxes	-52,480	-67,567	-74,488
Beginning balance, accumulated other comprehensive (income) loss, net of tax	119,349	130,020	'
Net amortization and deferral, accumulated other comprehensive (income) loss, net of tax	-3,900	-4,187	'
Curtailment, accumulated other comprehensive (income) loss, net of tax	'	74	'
Settlement, accumulated other comprehensive (income) loss, net of tax	'	-66	'
Actuarial changes in benefit obligation, accumulated other comprehensive (income) loss, net of tax	-23,240	-6,660	'
Impact of currency translation, accumulated other comprehensive (income) loss, net of tax	177	168	'
Ending balance, accumulated other comprehensive (income) loss, net of tax	92,386	119,349	130,020
Other Benefit	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Beginning balance, prior service cost (credit)	-38	-93	'
Net Amortization and deferral	55	55	'
Actuarial changes in benefit obligation, prior service cost (credit)	'	'	'
Ending balance, prior service cost (credit)	17	-38	-93
Beginning balance, net (gain) or loss	12,287	6,845	'
Net amortization and deferral, net (gain) or loss	-1,398	-719	'
Settlement, net (gain) or loss	'	'	'
Actuarial changes in benefit obligation, net (gain) or loss	-3,833	6,161	'
Ending balance, net (gain) or loss	7,056	12,287	6,845
Beginning balance, deferred taxes	-4,346	-2,326	'
Net amortization and deferral, deferred taxes	492	277	'
Actuarial changes in benefit obligation, deferred taxes	1,432	-2,297	'
Ending balance, deferred taxes	-2,422	-4,346	-2,326
Beginning balance, accumulated other comprehensive (income) loss, net of tax	7,908	4,528	'
Net amortization and deferral, accumulated other comprehensive (income) loss, net of tax	-856	-484	'
Actuarial changes in benefit obligation, accumulated other comprehensive (income) loss, net of tax	-2,401	3,864	'
Ending balance, accumulated other comprehensive (income) loss, net of tax	4,651	7,908	4,528
Beginning balance, initial obligation	5	102	'
Net amortization and deferral, initial obligation	-5	-97	'
Actuarial changes in benefit obligation, initial obligation	'	'	'
Ending balance, initial obligation	'	$5	$102

Weighted_Average_Assumptions_u1

Weighted Average Assumptions used in Determining Benefit Obligations (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Discount rate	4.98%	4.27%	'
Rate of compensation increase	3.00%	3.00%	'
Initial healthcare trend rate	'	'	'
Ultimate healthcare trend rate	'	'	'
Other Benefit	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Discount rate	4.70%	3.83%	'
Rate of compensation increase	'	'	'
Initial healthcare trend rate	7.00%	8.15%	'
Ultimate healthcare trend rate	5.00%	5.00%	5.00%

Fair_Values_of_Pension_Plan_As

Fair Values of Pension Plan Assets (Detail) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	$305,481	[1]	$276,863	[1]
Cash	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	472		408
Money Market Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	310		361
Equity Securities | Managed Volatility	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	77,140	[2]	66,413	[2]
Equity Securities | U.S. Small/Mid-Cap Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	19,760	[3]	16,543	[3]
Equity Securities | World Equity Exclude United States	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	30,183	[4]	27,257	[4]
Equity Securities | Common Equity Securities - Teleflex Incorporated	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	10,972		8,336
Equity Securities | Diversified United Kingdom Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	928		6,681
Equity Securities | Diversified Global Exclude United Kingdom	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	2,319		3,267
Equity Securities | Emerging Markets Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	1,270		'
Fixed Income Investments | Emerging Markets Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	9,003	[5]	8,453	[5]
Fixed Income Investments | Long Duration Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	76,608	[6]	73,370	[6]
Fixed Income Investments | U K Corporate Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	2,569		'
Fixed Income Investments | U K Government Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	4,455		'
Fixed Income Investments | High Yield Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	12,754	[7]	10,896	[7]
Fixed Income Investments | Corporate, Government And Foreign Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	87		5,675
Fixed Income Investments | Asset Backed - Home Loans	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	847		1,005
Other Investments | Structured Credit	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	29,109	[8]	26,828	[8]
Other Investments | Hedge Fund Of Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	22,540	[9]	21,365	[10]
Other Investments | UK Property Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	1,402	[11]	'
Other Investments | Multi Asset Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	2,748	[12]	'
Other Investments | Other Credit Derivatives	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	5		5
Quoted Prices In Active Markets (Level 1)	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	242,488	[1]	221,985	[1]
Quoted Prices In Active Markets (Level 1) | Cash	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	472		408
Quoted Prices In Active Markets (Level 1) | Money Market Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	310		361
Quoted Prices In Active Markets (Level 1) | Equity Securities | Managed Volatility	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	77,140	[2]	66,413	[2]
Quoted Prices In Active Markets (Level 1) | Equity Securities | U.S. Small/Mid-Cap Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	19,760	[3]	16,543	[3]
Quoted Prices In Active Markets (Level 1) | Equity Securities | World Equity Exclude United States	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	30,183	[4]	27,257	[4]
Quoted Prices In Active Markets (Level 1) | Equity Securities | Common Equity Securities - Teleflex Incorporated	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	10,972		8,336
Quoted Prices In Active Markets (Level 1) | Equity Securities | Diversified United Kingdom Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	928		6,681
Quoted Prices In Active Markets (Level 1) | Equity Securities | Diversified Global Exclude United Kingdom	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	2,319		3,267
Quoted Prices In Active Markets (Level 1) | Equity Securities | Emerging Markets Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	1,270		'
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Emerging Markets Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		8,453	[5]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Long Duration Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	76,608	[6]	73,370	[6]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | U K Corporate Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	2,569		'
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | U K Government Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	4,455		'
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | High Yield Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	12,754	[7]	10,896	[7]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Corporate, Government And Foreign Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Asset Backed - Home Loans	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Quoted Prices In Active Markets (Level 1) | Other Investments | Structured Credit	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[8]
Quoted Prices In Active Markets (Level 1) | Other Investments | Hedge Fund Of Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[10]
Quoted Prices In Active Markets (Level 1) | Other Investments | Multi Asset Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	2,748	[12]	'
Quoted Prices In Active Markets (Level 1) | Other Investments | Other Credit Derivatives	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Other Observable Inputs (Level 2)	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	11,339	[1]	6,680	[1]
Significant Other Observable Inputs (Level 2) | Cash	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Other Observable Inputs (Level 2) | Money Market Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Other Observable Inputs (Level 2) | Equity Securities | Managed Volatility	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[2]
Significant Other Observable Inputs (Level 2) | Equity Securities | U.S. Small/Mid-Cap Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[3]
Significant Other Observable Inputs (Level 2) | Equity Securities | World Equity Exclude United States	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[4]
Significant Other Observable Inputs (Level 2) | Equity Securities | Common Equity Securities - Teleflex Incorporated	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Other Observable Inputs (Level 2) | Equity Securities | Diversified United Kingdom Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Other Observable Inputs (Level 2) | Equity Securities | Diversified Global Exclude United Kingdom	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Emerging Markets Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	9,003	[5]	'	[5]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Long Duration Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[6]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | High Yield Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[7]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Corporate, Government And Foreign Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	87		5,675
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Asset Backed - Home Loans	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	847		1,005
Significant Other Observable Inputs (Level 2) | Other Investments | Structured Credit	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[8]
Significant Other Observable Inputs (Level 2) | Other Investments | Hedge Fund Of Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[10]
Significant Other Observable Inputs (Level 2) | Other Investments | UK Property Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	1,402	[11]	'
Significant Other Observable Inputs (Level 2) | Other Investments | Other Credit Derivatives	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3)	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	51,654	[1]	48,198	[1]
Significant Unobservable Inputs (Level 3) | Cash	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Money Market Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Equity Securities | Managed Volatility	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[2]
Significant Unobservable Inputs (Level 3) | Equity Securities | U.S. Small/Mid-Cap Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[3]
Significant Unobservable Inputs (Level 3) | Equity Securities | World Equity Exclude United States	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[4]
Significant Unobservable Inputs (Level 3) | Equity Securities | Common Equity Securities - Teleflex Incorporated	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Equity Securities | Diversified United Kingdom Equity	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Equity Securities | Diversified Global Exclude United Kingdom	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Emerging Markets Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[5]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Long Duration Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[6]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | High Yield Bond Fund	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'	[7]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Corporate, Government And Foreign Bonds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Asset Backed - Home Loans	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	'		'
Significant Unobservable Inputs (Level 3) | Other Investments | Structured Credit	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	29,109	[8]	26,828	[8]
Significant Unobservable Inputs (Level 3) | Other Investments | Hedge Fund Of Funds	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	22,540	[9]	21,365	[10]
Significant Unobservable Inputs (Level 3) | Other Investments | Other Credit Derivatives	'		'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'		'
Fair value of plan assets	$5		$5
[1]	Information on asset categories described in notes (b)-(k) is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.
[2]	This category comprises mutual funds that invest in securities of United States and non-United States companies of all capitalization ranges that exhibit relatively low volatility.
[3]	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of small and mid-sized companies. The fund invests in common stocks or exchange traded funds holding common stock of United States companies with market capitalizations in the range of companies in the Russell 2500 Index.
[4]	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of foreign companies. These securities may include common stocks, preferred stocks, warrants, exchange traded funds based on an international equity index and derivative instruments whose value is based on an international equity index and derivative instruments whose value is based on an underlying equity security or a basket of equity securities. The fund invests in securities of foreign issuers located in developed and emerging market countries. However, the fund will not invest more than 30% of its assets in the common stocks or other equity securities of issuers located in emerging market countries.
[5]	This category comprises a mutual fund that invests at least 80% of its net assets in fixed income securities of emerging market issuers, primarily in United States dollar-denominated debt of foreign governments, government-related and corporate issuers in emerging market countries and entities organized to restructure the debt of those issuers.
[6]	This category comprises a mutual fund that invests in instruments or derivatives having economic characteristics similar to fixed income securities. The fund invests in investment grade fixed income instruments, including securities issued or guaranteed by the United States Government and its agencies and instrumentalities, corporate bonds, asset-backed securities, exchange traded funds, mortgage-backed securities and collateralized mortgage-backed securities. The fund invests primarily in long duration government and corporate fixed income securities, and uses derivative instruments, including interest rate swap agreements and Treasury futures contracts, for the purpose of managing the overall duration and yield curve exposure of the Fund’s portfolio of fixed income securities.
[7]	This category comprises a mutual fund that invests at least 80% of its net assets in higher-yielding fixed income securities, including corporate bonds and debentures, convertible and preferred securities and zero coupon obligations.
[8]	This category comprises a fund that invests primarily in collateralized debt obligations (“CDOs”) and other structured credit vehicles. The fund investments may include fixed income securities, loan participants, credit-linked notes, medium-term notes, pooled investment vehicles and derivative instruments.
[9]	This category comprises a hedge fund that invests in various other hedge funds. As of December 31, 2013 and 2012:  approximately 28% and 22%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;  approximately 18% and 30%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;  approximately 25% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;  approximately 23% and 17%, respectively, of the assets were held in funds with an event driven strategy; and  approximately 6% and 6%, respectively, of the assets were held in cash.
[10]	(i) This category comprises a hedge fund that invests in various other hedge funds. As of December 31, 2013 and 2012:  approximately 28% and 22%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;  approximately 18% and 30%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;  approximately 25% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;  approximately 23% and 17%, respectively, of the assets were held in funds with an event driven strategy; and  approximately 6% and 6%, respectively, of the assets were held in cash. (j)This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
[11]	This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
[12]	This category comprises a mutual fund that invests primarily in equities, bonds and alternatives.

Fair_Values_of_Pension_Plan_As1

Fair Values of Pension Plan Assets (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Maximum percentage of net assets invested in emerging market	30.00%	'
Equity Hedge Based Funds	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested in funds	28.00%	22.00%
Tactical Directional Based Funds	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested in funds	18.00%	30.00%
Relative Value Based Funds	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested in funds	25.00%	25.00%
Event Driven Strategy	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested in funds	23.00%	17.00%
High Yield Fixed Income	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested	80.00%	'
Fixed Income Securities	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested	80.00%	'
Foreign Companies	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested in foreign equity securities	80.00%	'
Cash	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested in funds	6.00%	6.00%
U.S. Russell 2500 Index | Small and Mid-Sized Companies | Equity Securities	'	'
Schedule Of Pension Plan Assets By Fair Value [Line Items]	'	'
Percentage of net assets invested	80.00%	'

Recovered_Sheet3

Reconciliation Of Changes In Level Three Pension Assets Measured At Fair Value On Recurring Basis (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Hedge Fund Of Funds	'	'
Schedule Of Reconciliation Of Changes In Fair Value Of Assets And Liabilities [Line Items]	'	'
Balance at beginning of year	$21,365	$20,624
Purchases	'	'
Sales/redemptions	'	'
Actual return on plan assets	1,175	741
Foreign currency adjustment	'	'
Balance at end of year	22,540	21,365
Structured Credit	'	'
Schedule Of Reconciliation Of Changes In Fair Value Of Assets And Liabilities [Line Items]	'	'
Balance at beginning of year	26,828	'
Purchases	'	26,000
Sales/redemptions	'	'
Actual return on plan assets	2,281	828
Foreign currency adjustment	'	'
Balance at end of year	29,109	26,828
Other Investments	'	'
Schedule Of Reconciliation Of Changes In Fair Value Of Assets And Liabilities [Line Items]	'	'
Balance at beginning of year	5	531
Purchases	'	'
Sales/redemptions	'	-509
Actual return on plan assets	'	-35
Foreign currency adjustment	'	18
Balance at end of year	$5	$5

Expected_Benefit_Payments_Deta

Expected Benefit Payments (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Pension	'
Schedule Of Pension Expected Future Benefit Payments [Line Items]	'
2014	$16,969
2015	17,497
2016	18,145
2017	18,653
2018	19,382
Years 2019 — 2023	108,118
Other Benefits	'
Schedule Of Pension Expected Future Benefit Payments [Line Items]	'
2014	3,381
2015	3,459
2016	3,580
2017	3,556
2018	3,859
Years 2019 — 2023	$20,347

Pension_and_Other_Postretireme2

Pension and Other Postretirement Benefits - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Increase trend rate by 1%, increase the benefit expenses	$4.30	'	'
Increase trend rate by 1%, increase the benefit obligation	0.3	'	'
Decrease trend rate by 1%, decrease the benefit expenses	3.7	'	'
Decrease trend rate by 1%, decrease the benefit obligation	0.2	'	'
Defined benefit plans, annual average Medicare part D subsidy	0.2	'	'
Defined contribution plans, costs	12.1	10.1	10.2
Equity Securities	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Target allocation percentage of securities	45.00%	'	'
Fixed Income Securities	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Target allocation percentage of securities	35.00%	'	'
Other Securities	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Target allocation percentage of securities	20.00%	'	'
United States Pension Plans of US Entity, Defined Benefit	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Discount rate	5.09%	'	'
United States Postretirement Benefit Plans of US Entity, Defined Benefit	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Discount rate	4.70%	'	'
U.S. And Foreign Defined Benefit Pension Plans	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Accumulated benefit obligation	367.3	396.7	'
Expected employer contribution for year 2011	9.4	'	'
Postretirement Health Care Plans	'	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Expected employer contribution for year 2011	$3.40	'	'

Future_Minimum_Lease_Payments_

Future Minimum Lease Payments under Noncancelable Operating Leases (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Leases Future Minimum Payments [Line Items]	'
2014	$21,700
2015	17,000
2016	13,700
2017	11,800
2018 and thereafter	$46,200

Recovered_Sheet4

Commitments and Contingent Liabilities - Additional Information (Detail) (USD $)

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Aug. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Discontinued Operations

Minimum

Maximum

Accrued Liabilities

Accrued Liabilities

Other Liability

Other Liability

Property, Plant and Equipment

Property, Plant and Equipment

Property, Plant and Equipment

Property, Plant and Equipment

Build To Suit Lease

Build To Suit Lease

Build To Suit Lease

Corporate Headquarters

Loss Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated fair value of the costs to construct buildings

$55,092,000

$41,424,000

'

'

'

'

'

'

'

'

$13,600,000

$23,000,000

$11,200,000

$9,600,000

Expected construction completion year

'

'

'

'

'

'

'

'

'

'

'

'2014-10

'

'2014-02

Lease commencement date

'

'

'

'

'

'

'

'

'

'

'

'

'

1-Feb-14

Operating leases, rental expense

26,400,000

24,000,000

26,300,000

'

'

'

'

'

'

'

'

'

'

'

Waste disposed accrued liability

'

'

'

'

'

'

2,500,000

1,900,000

5,800,000

6,900,000

'

'

'

'

Time-frame over which the accrued amounts may be paid out, in years

'

'

'

'

'15 years

'20 years

'

'

'

'

'

'

'

'

Contingency reserve for litigation

$6,800,000

$2,300,000

'

$1,400,000

'

'

'

'

'

'

'

'

'

'

Segment_Result_Detail

Segment Result (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

$450,539

$413,796

$420,059

$411,877

[1]

$419,056

[2]

$368,054

[2]

$383,332

[2]

$380,567

[1],[2]

$1,696,271

$1,551,009

$1,492,528

Segment assets

4,209,007

'

'

'

3,733,687

'

'

'

4,209,007

3,733,687

3,924,103

Segment expenditures for property, plant and equipment

'

'

'

'

'

'

'

'

63,580

65,394

44,582

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

38,452

3,037

6,005

Operating Segments

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

1,696,271

1,551,009

1,492,528

Segment depreciation and amortization

'

'

'

'

'

'

'

'

107,935

94,884

96,496

Segment operating profit

'

'

'

'

'

'

'

'

271,713

[3]

237,458

[3]

236,157

[3]

Segment assets

3,577,768

'

'

'

3,211,466

'

'

'

3,577,768

3,211,466

3,095,752

Segment expenditures for property, plant and equipment

'

'

'

'

'

'

'

'

62,420

58,042

41,415

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

38,452

3,037

6,005

Operating Segments | Americas Segment

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

800,464

726,810

688,036

Segment depreciation and amortization

'

'

'

'

'

'

'

'

69,653

64,174

65,580

Segment operating profit

'

'

'

'

'

'

'

'

97,386

[3]

91,627

[3]

90,046

[3]

Segment assets

2,266,161

'

'

'

1,947,583

'

'

'

2,266,161

1,947,583

2,078,850

Segment expenditures for property, plant and equipment

'

'

'

'

'

'

'

'

47,554

32,023

23,203

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

18,265

743

4,626

Operating Segments | EMEA Segment

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

557,427

510,248

525,277

Segment depreciation and amortization

'

'

'

'

'

'

'

'

28,938

22,974

23,419

Segment operating profit

'

'

'

'

'

'

'

'

76,199

[3]

54,746

[3]

74,311

[3]

Segment assets

1,008,329

'

'

'

985,069

'

'

'

1,008,329

985,069

789,978

Segment expenditures for property, plant and equipment

'

'

'

'

'

'

'

'

11,487

14,717

11,843

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

19,007

2,294

1,379

Operating Segments | Asia Segment

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

207,207

173,721

149,585

Segment depreciation and amortization

'

'

'

'

'

'

'

'

4,774

3,653

3,848

Segment operating profit

'

'

'

'

'

'

'

'

70,800

[3]

59,421

[3]

47,101

[3]

Segment assets

240,535

'

'

'

245,578

'

'

'

240,535

245,578

199,684

Segment expenditures for property, plant and equipment

'

'

'

'

'

'

'

'

754

472

804

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

592

'

'

Operating Segments | OEM

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

131,173

140,230

129,630

Segment depreciation and amortization

'

'

'

'

'

'

'

'

4,570

4,083

3,649

Segment operating profit

'

'

'

'

'

'

'

'

27,328

[3]

31,664

[3]

24,699

[3]

Segment assets

62,743

'

'

'

33,236

'

'

'

62,743

33,236

27,240

Segment expenditures for property, plant and equipment

'

'

'

'

'

'

'

'

2,625

10,830

5,565

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

588

'

'

Intersegment Eliminations

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intersegment revenues

'

'

'

'

'

'

'

'

'

'

'

Intersegment Eliminations | Americas Segment

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intersegment revenues

'

'

'

'

'

'

'

'

128,512

135,499

137,499

Intersegment Eliminations | EMEA Segment

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intersegment revenues

'

'

'

'

'

'

'

'

153,951

76,967

67,199

Intersegment Eliminations | Asia Segment

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intersegment revenues

'

'

'

'

'

'

'

'

40,579

4,660

1

Intersegment Eliminations | OEM

'

'

'

'

'

'

'

'

'

'

'

Revenues From External Customers And Long Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Intersegment revenues

'

'

'

'

'

'

'

'

$519

$422

$464

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

[3]

Segment operating profit includes a segment’s net revenues from external customers reduced by its cost of goods sold, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Segment operating profit excludes goodwill impairment charges, restructuring and impairment charges, net (gain) loss on sales of businesses and assets, interest income and expense, loss on extinguishment of debt and taxes on income.

Reconciliation_of_Segment_Oper

Reconciliation of Segment Operating Profit to Income (Loss) from Continuing Operations before Interest, Loss on Extinguishment of Debt and Taxes (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Segment Reporting Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Operating profit

$54,064

$66,042

$63,751

$49,404

[1]

$58,440

[2]

$49,841

[2]

$64,722

[2]

($270,378)

[1],[2]

$233,261

($97,375)

$229,570

Goodwill impairment charges

'

'

'

'

'

'

'

-332,100

'

-332,128

'

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

-38,452

-3,037

-6,005

Net gain (loss) on sales of businesses and assets

'

'

'

'

'

'

'

'

'

332

-582

Operating Segments

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Operating profit

'

'

'

'

'

'

'

'

271,713

237,458

236,157

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

($38,452)

($3,037)

($6,005)

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

Reconciliation_of_Segment_Asse

Reconciliation of Segment Assets to Consolidated Total Assets (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total assets	$4,209,007	$3,733,687	$3,924,103
Operating Segments	'	'	'
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total assets	3,577,768	3,211,466	3,095,752
Corporate, Non-Segment	'	'	'
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total assets	620,811	514,258	767,231
Assets of Businesses Divested	'	'	'
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total assets	'	'	53,218
Assets Held-for-sale	'	'	'
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total assets	$10,428	$7,963	$7,902

Schedule_of_Reconciliation_of_

Schedule of Reconciliation of Segment Expenditures for Property, Plant and Equipment to Condensed Consolidated Total Expenditures for Property, Plant, and Equipment (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total expenditures for property, plant and equipment	$63,580	$65,394	$44,582
Operating Segments	'	'	'
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total expenditures for property, plant and equipment	62,420	58,042	41,415
Corporate, Non-Segment	'	'	'
Segment Reporting Asset Reconciling Item [Line Items]	'	'	'
Total expenditures for property, plant and equipment	$1,160	$7,352	$3,167

Total_Net_Revenues_and_Total_N

Total Net Revenues and Total Net Property, Plant and Equipment by Geographic Region (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

$450,539

$413,796

$420,059

$411,877

[1]

$419,056

[2]

$368,054

[2]

$383,332

[2]

$380,567

[1],[2]

$1,696,271

$1,551,009

$1,492,528

Property, plant and equipment, net

325,900

'

'

'

297,945

'

'

'

325,900

297,945

251,912

United States

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

844,884

789,771

762,957

Property, plant and equipment, net

203,985

'

'

'

180,833

'

'

'

203,985

180,833

159,042

Other Americas

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

57,656

53,665

55,228

Property, plant and equipment, net

12,350

'

'

'

12,828

'

'

'

12,350

12,828

12,492

Germany

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

133,598

123,355

128,072

Property, plant and equipment, net

12,135

'

'

'

12,197

'

'

'

12,135

12,197

8,549

Other Europe

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

438,567

393,627

403,274

Property, plant and equipment, net

61,891

'

'

'

58,843

'

'

'

61,891

58,843

53,775

All Other

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

221,566

190,591

142,997

Property, plant and equipment, net

$35,539

'

'

'

$33,244

'

'

'

$35,539

$33,244

$18,054

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

Condensed_Consolidating_Guaran2

Condensed Consolidating Guarantor Financial Information - Additional Information (Detail) (USD $)	Dec. 31, 2013	Jun. 26, 2011
In Thousands, unless otherwise specified		6.875% Senior Subordinated Notes Due 2019
Condensed Financial Statements Captions [Line Items]	'	'
Senior subordinated notes	'	$250,000
Interest rate	3.88%	6.88%
Ownership percentage of subsidiaries	100.00%	'

Adjustments_to_Condensed_Conso

Adjustments to Condensed Consolidating Balance Sheet included within Guarantor Financial Information (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Thousands, unless otherwise specified
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	$295,290	$297,976	'	'
Investments in affiliates	1,715	2,066	'	'
Other assets	70,095	61,863	'	'
Total assets	4,209,007	3,733,687	3,924,103	'
Accounts payable	71,967	75,165	'	'
Other liabilities	48,506	59,771	'	'
Total liabilities	2,292,991	1,952,150	'	'
Total common shareholders’ equity	1,913,527	1,778,950	'	'
Total equity	1,916,016	1,781,537	1,982,783	1,787,278
Total liabilities and equity	4,209,007	3,733,687	'	'
Consolidation, Eliminations	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	3,472	3,164	'	'
Accounts receivable from consolidated subsidiaries	-2,880,648	-3,135,161	'	'
Investments in affiliates	-6,987,772	-6,614,936	'	'
Note receivable and other amounts due from consolidated subsidiaries	-1,936,618	-1,334,833	'	'
Total assets	-11,856,688	-11,164,385	'	'
Accounts payable to consolidated subsidiaries	-2,880,648	-3,135,161	'	'
Notes payable and other amounts due to consolidated subsidiaries	-1,940,100	-1,337,563	'	'
Total liabilities	-4,860,161	-4,539,449	'	'
Total common shareholders’ equity	-6,996,527	-6,624,936	'	'
Total equity	-6,996,527	-6,624,936	'	'
Total liabilities and equity	-11,856,688	-11,164,385	'	'
Scenario, Adjustment | Consolidation, Eliminations	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	'	993,224	'	'
Accounts receivable from consolidated subsidiaries	'	-3,135,161	'	'
Investments in affiliates	'	-87,855	'	'
Note receivable and other amounts due from consolidated subsidiaries	'	-1,334,833	'	'
Other assets	'	3,399,522	'	'
Total assets	'	-165,103	'	'
Accounts payable	'	993,224	'	'
Accounts payable to consolidated subsidiaries	'	-3,135,161	'	'
Notes payable and other amounts due to consolidated subsidiaries	'	-1,337,563	'	'
Other liabilities	'	3,402,252	'	'
Total liabilities	'	-77,248	'	'
Total common shareholders’ equity	'	-87,855	'	'
Total equity	'	-87,855	'	'
Total liabilities and equity	'	-165,103	'	'
Parent Company	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	1,822	2,147	'	'
Accounts receivable from consolidated subsidiaries	42,865	422,058	'	'
Investments in affiliates	5,489,676	5,226,567	'	'
Note receivable and other amounts due from consolidated subsidiaries	1,049,344	529,913	'	'
Other assets	24,574	33,937	'	'
Total assets	6,765,670	6,385,219	'	'
Accounts payable	2,194	3,366	'	'
Accounts payable to consolidated subsidiaries	2,644,296	2,563,602	'	'
Notes payable and other amounts due to consolidated subsidiaries	785,476	878,148	'	'
Other liabilities	19,884	22,503	'	'
Total liabilities	4,852,143	4,606,269	'	'
Total common shareholders’ equity	1,913,527	1,778,950	'	'
Total equity	1,913,527	1,778,950	'	'
Total liabilities and equity	6,765,670	6,385,219	'	'
Parent Company | Scenario, Adjustment	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable from consolidated subsidiaries	'	422,058	'	'
Note receivable and other amounts due from consolidated subsidiaries	'	529,913	'	'
Total assets	'	951,971	'	'
Accounts payable	'	-77,129	'	'
Accounts payable to consolidated subsidiaries	'	2,563,602	'	'
Notes payable and other amounts due to consolidated subsidiaries	'	878,148	'	'
Other liabilities	'	-2,412,650	'	'
Total liabilities	'	951,971	'	'
Total liabilities and equity	'	951,971	'	'
Guarantor Subsidiaries	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	10,948	10,523	'	'
Accounts receivable from consolidated subsidiaries	2,623,314	2,520,933	'	'
Investments in affiliates	1,478,429	1,369,056	'	'
Note receivable and other amounts due from consolidated subsidiaries	873,105	804,843	'	'
Other assets	7,447	8,096	'	'
Total assets	7,200,122	6,601,573	'	'
Accounts payable	45,802	44,468	'	'
Accounts payable to consolidated subsidiaries	147,957	512,145	'	'
Notes payable and other amounts due to consolidated subsidiaries	957,451	275,674	'	'
Other liabilities	16,221	27,720	'	'
Total liabilities	1,769,263	1,409,568	'	'
Total common shareholders’ equity	5,430,859	5,192,005	'	'
Total equity	5,430,859	5,192,005	'	'
Total liabilities and equity	7,200,122	6,601,573	'	'
Guarantor Subsidiaries | Scenario, Adjustment	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	'	-763,757	'	'
Accounts receivable from consolidated subsidiaries	'	2,520,933	'	'
Investments in affiliates	'	87,855	'	'
Note receivable and other amounts due from consolidated subsidiaries	'	804,843	'	'
Other assets	'	-2,699,168	'	'
Total assets	'	-49,294	'	'
Accounts payable	'	-829,286	'	'
Accounts payable to consolidated subsidiaries	'	512,145	'	'
Notes payable and other amounts due to consolidated subsidiaries	'	275,674	'	'
Other liabilities	'	-7,827	'	'
Total liabilities	'	-49,294	'	'
Total liabilities and equity	'	-49,294	'	'
Non-Guarantor Subsidiaries	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	279,048	282,142	'	'
Accounts receivable from consolidated subsidiaries	214,469	192,170	'	'
Investments in affiliates	21,382	21,379	'	'
Note receivable and other amounts due from consolidated subsidiaries	14,169	77	'	'
Other assets	38,074	19,830	'	'
Total assets	2,099,903	1,911,280	'	'
Accounts payable	23,971	27,331	'	'
Accounts payable to consolidated subsidiaries	88,395	59,414	'	'
Notes payable and other amounts due to consolidated subsidiaries	197,173	183,741	'	'
Other liabilities	12,401	9,548	'	'
Total liabilities	531,746	475,762	'	'
Total common shareholders’ equity	1,565,668	1,432,931	'	'
Total equity	1,568,157	1,435,518	'	'
Total liabilities and equity	2,099,903	1,911,280	'	'
Non-Guarantor Subsidiaries | Scenario, Adjustment	'	'	'	'
Condensed Balance Sheet Statements Captions [Line Items]	'	'	'	'
Accounts receivable, net	'	-229,467	'	'
Accounts receivable from consolidated subsidiaries	'	192,170	'	'
Note receivable and other amounts due from consolidated subsidiaries	'	77	'	'
Other assets	'	-700,354	'	'
Total assets	'	-737,574	'	'
Accounts payable	'	-86,809	'	'
Accounts payable to consolidated subsidiaries	'	59,414	'	'
Notes payable and other amounts due to consolidated subsidiaries	'	183,741	'	'
Other liabilities	'	-981,775	'	'
Total liabilities	'	-825,429	'	'
Total common shareholders’ equity	'	87,855	'	'
Total equity	'	87,855	'	'
Total liabilities and equity	'	($737,574)	'	'

Adjustments_to_Condensed_Conso1

Adjustments to Condensed Consolidating Statements of Cash Flows within Guarantor Financial Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	$229,871	$193,853	$94,357
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Cash Flows from Financing Activities of Continuing Operations	232,598	-64,888	-11,106
Scenario, Adjustment | Consolidation, Eliminations	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	'	-98,903	-103,624
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany dividends paid	'	98,903	103,624
Cash Flows from Financing Activities of Continuing Operations	'	98,903	103,624
Parent Company	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	-132,459	-178,782	-107,279
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany transactions	-141,614	196,850	220,302
Cash Flows from Financing Activities of Continuing Operations	108,678	150,264	214,857
Parent Company | Scenario, Adjustment	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	'	1,077	1,450
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany transactions	'	-1,077	-1,450
Cash Flows from Financing Activities of Continuing Operations	'	-1,077	-1,450
Guarantor Subsidiaries	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	205,954	310,736	234,145
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany transactions	137,304	-177,900	-227,222
Intercompany dividends paid	-17,400	-16,900	-18,300
Cash Flows from Financing Activities of Continuing Operations	105,102	-211,510	-251,469
Guarantor Subsidiaries | Scenario, Adjustment	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	'	71,965	86,896
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany transactions	'	-55,065	-68,596
Intercompany dividends paid	'	-16,900	-18,300
Cash Flows from Financing Activities of Continuing Operations	'	-71,965	-86,896
Non-Guarantor Subsidiaries	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	304,278	160,802	71,115
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany transactions	4,310	-18,950	6,920
Intercompany dividends paid	-130,502	-82,003	-85,324
Cash Flows from Financing Activities of Continuing Operations	-129,084	-102,545	-78,118
Non-Guarantor Subsidiaries | Scenario, Adjustment	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Cash Flows from Operating Activities of Continuing Operations	'	25,861	15,278
Cash Flows from Financing Activities of Continuing Operations:	'	'	'
Intercompany transactions	'	56,142	70,046
Intercompany dividends paid	'	-82,003	-85,324
Cash Flows from Financing Activities of Continuing Operations	'	($25,861)	($15,278)

Condensed_Consolidating_Statem

Condensed Consolidating Statements of Income (Loss) and Comprehensive Income (Loss) (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Schedule Of Condensed Consolidating Statement Of Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

$450,539

$413,796

$420,059

$411,877

[1]

$419,056

[2]

$368,054

[2]

$383,332

[2]

$380,567

[1],[2]

$1,696,271

$1,551,009

$1,492,528

Cost of goods sold

'

'

'

'

'

'

'

'

857,326

802,784

783,750

Gross profit

224,943

203,992

209,490

200,520

[1]

199,180

[2]

180,567

[2]

184,364

[2]

184,114

[1],[2]

838,945

748,225

708,778

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

502,187

454,489

423,909

Research and development expenses

'

'

'

'

'

'

'

'

65,045

56,278

48,712

Goodwill impairment

'

'

'

'

'

'

'

332,100

'

332,128

'

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

38,452

3,037

6,005

Net (gain) loss on sales of businesses and assets

'

'

'

'

'

'

'

'

'

-332

582

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes

54,064

66,042

63,751

49,404

[1]

58,440

[2]

49,841

[2]

64,722

[2]

-270,378

[1],[2]

233,261

-97,375

229,570

Interest expense

'

'

'

'

'

'

'

'

56,905

69,565

70,317

Interest income

'

'

'

'

'

'

'

'

-624

-1,571

-1,260

Loss on extinguishments of debt

'

'

'

'

'

'

'

'

1,250

'

15,413

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

175,730

-165,369

145,100

Taxes (benefit) on income (loss) from continuing operations

'

'

'

'

'

'

'

'

23,547

16,413

25,778

Income (loss) from continuing operations

35,302

45,779

43,401

27,701

[1]

30,614

[2]

24,451

[2]

47,266

[2]

-284,113

[1],[2]

152,183

-181,782

119,322

Operating income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-2,205

-9,207

292,683

Taxes (benefit) on income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-1,770

-1,887

87,038

Income (loss) from discontinued operations

-236

1,029

-766

-462

[1]

-1,037

[2]

-2,521

[2]

-4,367

[2]

605

[1],[2]

-435

-7,320

205,645

Net income (loss)

35,066

46,808

42,635

27,239

[1]

29,577

[2]

21,930

[2]

42,899

[2]

-283,508

[1],[2]

151,748

-189,102

324,967

Less: Income from continuing operations attributable to noncontrolling interest

238

234

194

201

[1]

254

[2]

188

[2]

286

[2]

227

[1],[2]

867

955

1,021

Income from discontinued operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

'

'

617

Net income (loss) attributable to common shareholders

34,828

46,574

42,441

27,038

[1]

29,323

[2]

21,742

[2]

42,613

[2]

-283,735

[1],[2]

150,881

-190,057

323,329

Other comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

21,193

27,305

-107,473

Comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

172,074

-162,752

215,856

Consolidation, Eliminations

'

'

'

'

'

'

'

'

'

'

'

Schedule Of Condensed Consolidating Statement Of Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

-268,317

-233,782

-235,339

Cost of goods sold

'

'

'

'

'

'

'

'

-268,501

-232,823

-236,567

Gross profit

'

'

'

'

'

'

'

'

184

-959

1,228

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

-307

267

232

Net (gain) loss on sales of businesses and assets

'

'

'

'

'

'

'

'

'

265,433

'

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes

'

'

'

'

'

'

'

'

491

-266,659

996

Loss on extinguishments of debt

'

'

'

'

'

'

'

'

'

'

'

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

491

-266,659

996

Taxes (benefit) on income (loss) from continuing operations

'

'

'

'

'

'

'

'

-754

-519

-325

Equity in net income (loss) of consolidated subsidiaries

'

'

'

'

'

'

'

'

-405,530

65,824

-870,442

Income (loss) from continuing operations

'

'

'

'

'

'

'

'

-404,285

-200,316

-869,121

Net income (loss)

'

'

'

'

'

'

'

'

-404,285

-200,316

-869,121

Income from discontinued operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

'

'

'

Net income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

-404,285

-200,316

-869,121

Other comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

-7,402

-19,382

151,665

Comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

-411,687

-219,698

-717,456

Parent Company

'

'

'

'

'

'

'

'

'

'

'

Schedule Of Condensed Consolidating Statement Of Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

39,176

34,657

39,614

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

935

'

11

Net (gain) loss on sales of businesses and assets

'

'

'

'

'

'

'

'

'

-116,193

'

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes

'

'

'

'

'

'

'

'

-40,111

81,536

-39,625

Interest expense

'

'

'

'

'

'

'

'

134,879

143,653

138,460

Interest income

'

'

'

'

'

'

'

'

-15

-372

-384

Loss on extinguishments of debt

'

'

'

'

'

'

'

'

1,250

'

15,413

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

-176,225

-61,745

-193,114

Taxes (benefit) on income (loss) from continuing operations

'

'

'

'

'

'

'

'

-63,857

-63,806

-73,608

Equity in net income (loss) of consolidated subsidiaries

'

'

'

'

'

'

'

'

263,469

-190,742

473,311

Income (loss) from continuing operations

'

'

'

'

'

'

'

'

151,101

-188,681

353,805

Operating income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-1,947

-2,647

-55,872

Taxes (benefit) on income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-1,727

-1,271

-25,396

Income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-220

-1,376

-30,476

Net income (loss)

'

'

'

'

'

'

'

'

150,881

-190,057

323,329

Income from discontinued operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

'

'

'

Net income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

150,881

-190,057

323,329

Other comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

21,193

27,305

-107,473

Comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

172,074

-162,752

215,856

Guarantor Subsidiaries

'

'

'

'

'

'

'

'

'

'

'

Schedule Of Condensed Consolidating Statement Of Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

1,001,404

950,888

923,000

Cost of goods sold

'

'

'

'

'

'

'

'

582,110

552,726

552,606

Gross profit

'

'

'

'

'

'

'

'

419,294

398,162

370,394

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

284,960

259,476

231,490

Research and development expenses

'

'

'

'

'

'

'

'

55,694

48,649

41,648

Goodwill impairment

'

'

'

'

'

'

'

'

'

331,779

'

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

15,288

598

4,615

Net (gain) loss on sales of businesses and assets

'

'

'

'

'

'

'

'

'

-149,240

'

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes

'

'

'

'

'

'

'

'

63,352

-93,100

92,641

Interest expense

'

'

'

'

'

'

'

'

-85,058

-81,328

-68,926

Interest income

'

'

'

'

'

'

'

'

-5

-23

-67

Loss on extinguishments of debt

'

'

'

'

'

'

'

'

'

'

'

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

148,415

-11,749

161,634

Taxes (benefit) on income (loss) from continuing operations

'

'

'

'

'

'

'

'

42,804

45,068

52,667

Equity in net income (loss) of consolidated subsidiaries

'

'

'

'

'

'

'

'

141,773

124,918

397,131

Income (loss) from continuing operations

'

'

'

'

'

'

'

'

247,384

68,101

506,098

Operating income (loss) from discontinued operations

'

'

'

'

'

'

'

'

'

-9,179

40,287

Taxes (benefit) on income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-170

-129

88,582

Income (loss) from discontinued operations

'

'

'

'

'

'

'

'

170

-9,050

-48,295

Net income (loss)

'

'

'

'

'

'

'

'

247,554

59,051

457,803

Income from discontinued operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

'

'

'

Net income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

247,554

59,051

457,803

Other comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

1,960

10,475

-75,928

Comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

249,514

69,526

381,875

Non-Guarantor Subsidiaries

'

'

'

'

'

'

'

'

'

'

'

Schedule Of Condensed Consolidating Statement Of Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

963,184

833,903

804,867

Cost of goods sold

'

'

'

'

'

'

'

'

543,717

482,881

467,711

Gross profit

'

'

'

'

'

'

'

'

419,467

351,022

337,156

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

178,358

160,089

152,573

Research and development expenses

'

'

'

'

'

'

'

'

9,351

7,629

7,064

Goodwill impairment

'

'

'

'

'

'

'

'

'

349

'

Restructuring and other impairment charges

'

'

'

'

'

'

'

'

22,229

2,439

1,379

Net (gain) loss on sales of businesses and assets

'

'

'

'

'

'

'

'

'

-332

582

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes

'

'

'

'

'

'

'

'

209,529

180,848

175,558

Interest expense

'

'

'

'

'

'

'

'

7,084

7,240

783

Interest income

'

'

'

'

'

'

'

'

-604

-1,176

-809

Loss on extinguishments of debt

'

'

'

'

'

'

'

'

'

'

'

Income (loss) from continuing operations before taxes

'

'

'

'

'

'

'

'

203,049

174,784

175,584

Taxes (benefit) on income (loss) from continuing operations

'

'

'

'

'

'

'

'

45,354

35,670

47,044

Equity in net income (loss) of consolidated subsidiaries

'

'

'

'

'

'

'

'

288

'

'

Income (loss) from continuing operations

'

'

'

'

'

'

'

'

157,983

139,114

128,540

Operating income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-258

2,619

308,268

Taxes (benefit) on income (loss) from discontinued operations

'

'

'

'

'

'

'

'

127

-487

23,852

Income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-385

3,106

284,416

Net income (loss)

'

'

'

'

'

'

'

'

157,598

142,220

412,956

Less: Income from continuing operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

867

955

1,021

Income from discontinued operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

'

'

617

Net income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

156,731

141,265

411,318

Other comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

5,442

8,907

-75,737

Comprehensive income (loss) attributable to common shareholders

'

'

'

'

'

'

'

'

$162,173

$150,172

$335,581

[1]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[2]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

Condensed_Consolidating_Balanc

Condensed Consolidating Balance Sheets (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Thousands, unless otherwise specified
Current assets	'	'	'	'
Cash and cash equivalents	$431,984	$337,039	$584,088	$208,452
Accounts receivable, net	295,290	297,976	'	'
Inventories, net	333,621	323,347	'	'
Prepaid expenses and other current assets	39,810	28,712	'	'
Prepaid taxes	36,504	27,160	'	'
Deferred tax assets	52,917	51,025	'	'
Assets held for sale	10,428	7,963	'	'
Total current assets	1,200,554	1,073,222	'	'
Property, plant and equipment, net	325,900	297,945	251,912	'
Goodwill	1,354,203	1,238,452	'	'
Intangibles assets, net	1,255,597	1,058,792	'	'
Investments in affiliates	1,715	2,066	'	'
Deferred tax assets	943	1,347	'	'
Other assets	70,095	61,863	'	'
Total assets	4,209,007	3,733,687	3,924,103	'
Current liabilities	'	'	'	'
Notes payable	356,287	4,700	'	'
Accounts payable	71,967	75,165	'	'
Accrued expenses	74,868	65,064	'	'
Current portion of contingent consideration	4,131	23,693	'	'
Payroll and benefit-related liabilities	73,090	74,586	'	'
Accrued interest	8,725	9,418	'	'
Income taxes payable	23,821	16,895	'	'
Other current liabilities	22,231	5,779	'	'
Total current liabilities	635,120	275,300	'	'
Total long-term debt	930,000	965,280	'	'
Deferred tax liabilities	514,715	418,874	'	'
Pension and other postretirement benefit liabilities	109,498	170,946	'	'
Noncurrent liability for uncertain tax positions	55,152	61,979	'	'
Other liabilities	48,506	59,771	'	'
Total liabilities	2,292,991	1,952,150	'	'
Total common shareholders’ equity	1,913,527	1,778,950	'	'
Noncontrolling interest	2,489	2,587	'	'
Total equity	1,916,016	1,781,537	1,982,783	1,787,278
Total liabilities and equity	4,209,007	3,733,687	'	'
Consolidation, Eliminations	'	'	'	'
Current assets	'	'	'	'
Accounts receivable, net	3,472	3,164	'	'
Accounts receivable from consolidated subsidiaries	-2,880,648	-3,135,161	'	'
Inventories, net	-15,709	-15,893	'	'
Prepaid taxes	'	-3,136	'	'
Deferred tax assets	-3	-1,045	'	'
Total current assets	-2,892,888	-3,152,071	'	'
Investments in affiliates	-6,987,772	-6,614,936	'	'
Deferred tax assets	-39,410	-62,545	'	'
Note receivable and other amounts due from consolidated subsidiaries	-1,936,618	-1,334,833	'	'
Total assets	-11,856,688	-11,164,385	'	'
Current liabilities	'	'	'	'
Accounts payable to consolidated subsidiaries	-2,880,648	-3,135,161	'	'
Income taxes payable	'	-3,136	'	'
Other current liabilities	-4	-1,045	'	'
Total current liabilities	-2,880,652	-3,139,342	'	'
Deferred tax liabilities	-39,409	-62,544	'	'
Notes payable and other amounts due to consolidated subsidiaries	-1,940,100	-1,337,563	'	'
Total liabilities	-4,860,161	-4,539,449	'	'
Total common shareholders’ equity	-6,996,527	-6,624,936	'	'
Total equity	-6,996,527	-6,624,936	'	'
Total liabilities and equity	-11,856,688	-11,164,385	'	'
Parent Company	'	'	'	'
Current assets	'	'	'	'
Cash and cash equivalents	42,749	70,860	114,531	22,632
Accounts receivable, net	1,822	2,147	'	'
Accounts receivable from consolidated subsidiaries	42,865	422,058	'	'
Prepaid expenses and other current assets	15,200	7,769	'	'
Prepaid taxes	27,487	11,079	'	'
Deferred tax assets	20,218	13,987	'	'
Assets held for sale	1,669	'	'	'
Total current assets	152,010	527,900	'	'
Property, plant and equipment, net	14,189	7,258	'	'
Investments in affiliates	5,489,676	5,226,567	'	'
Deferred tax assets	35,877	59,644	'	'
Note receivable and other amounts due from consolidated subsidiaries	1,049,344	529,913	'	'
Other assets	24,574	33,937	'	'
Total assets	6,765,670	6,385,219	'	'
Current liabilities	'	'	'	'
Notes payable	351,587	'	'	'
Accounts payable	2,194	3,366	'	'
Accounts payable to consolidated subsidiaries	2,644,296	2,563,602	'	'
Accrued expenses	15,569	11,338	'	'
Payroll and benefit-related liabilities	15,976	24,633	'	'
Accrued interest	8,720	9,413	'	'
Other current liabilities	9,646	598	'	'
Total current liabilities	3,047,988	2,612,950	'	'
Total long-term debt	930,000	965,280	'	'
Pension and other postretirement benefit liabilities	57,406	114,257	'	'
Noncurrent liability for uncertain tax positions	11,389	13,131	'	'
Notes payable and other amounts due to consolidated subsidiaries	785,476	878,148	'	'
Other liabilities	19,884	22,503	'	'
Total liabilities	4,852,143	4,606,269	'	'
Total common shareholders’ equity	1,913,527	1,778,950	'	'
Total equity	1,913,527	1,778,950	'	'
Total liabilities and equity	6,765,670	6,385,219	'	'
Guarantor Subsidiaries	'	'	'	'
Current assets	'	'	'	'
Cash and cash equivalents	14,500	1,989	'	'
Accounts receivable, net	10,948	10,523	'	'
Accounts receivable from consolidated subsidiaries	2,623,314	2,520,933	'	'
Inventories, net	211,165	202,748	'	'
Prepaid expenses and other current assets	6,870	5,294	'	'
Deferred tax assets	22,472	30,201	'	'
Assets held for sale	3,503	2,738	'	'
Total current assets	2,892,772	2,774,426	'	'
Property, plant and equipment, net	188,455	168,451	'	'
Goodwill	797,671	694,070	'	'
Intangibles assets, net	962,243	782,631	'	'
Investments in affiliates	1,478,429	1,369,056	'	'
Note receivable and other amounts due from consolidated subsidiaries	873,105	804,843	'	'
Other assets	7,447	8,096	'	'
Total assets	7,200,122	6,601,573	'	'
Current liabilities	'	'	'	'
Accounts payable	45,802	44,468	'	'
Accounts payable to consolidated subsidiaries	147,957	512,145	'	'
Accrued expenses	21,120	20,471	'	'
Current portion of contingent consideration	4,131	21,115	'	'
Payroll and benefit-related liabilities	21,818	19,799	'	'
Income taxes payable	'	1,322	'	'
Other current liabilities	7,517	704	'	'
Total current liabilities	248,345	620,024	'	'
Deferred tax liabilities	496,228	426,754	'	'
Pension and other postretirement benefit liabilities	33,777	37,269	'	'
Noncurrent liability for uncertain tax positions	17,241	22,127	'	'
Notes payable and other amounts due to consolidated subsidiaries	957,451	275,674	'	'
Other liabilities	16,221	27,720	'	'
Total liabilities	1,769,263	1,409,568	'	'
Total common shareholders’ equity	5,430,859	5,192,005	'	'
Total equity	5,430,859	5,192,005	'	'
Total liabilities and equity	7,200,122	6,601,573	'	'
Non-Guarantor Subsidiaries	'	'	'	'
Current assets	'	'	'	'
Cash and cash equivalents	374,735	264,190	469,557	185,820
Accounts receivable, net	279,048	282,142	'	'
Accounts receivable from consolidated subsidiaries	214,469	192,170	'	'
Inventories, net	138,165	136,492	'	'
Prepaid expenses and other current assets	17,740	15,649	'	'
Prepaid taxes	9,017	19,217	'	'
Deferred tax assets	10,230	7,882	'	'
Assets held for sale	5,256	5,225	'	'
Total current assets	1,048,660	922,967	'	'
Property, plant and equipment, net	123,256	122,236	'	'
Goodwill	556,532	544,382	'	'
Intangibles assets, net	293,354	276,161	'	'
Investments in affiliates	21,382	21,379	'	'
Deferred tax assets	4,476	4,248	'	'
Note receivable and other amounts due from consolidated subsidiaries	14,169	77	'	'
Other assets	38,074	19,830	'	'
Total assets	2,099,903	1,911,280	'	'
Current liabilities	'	'	'	'
Notes payable	4,700	4,700	'	'
Accounts payable	23,971	27,331	'	'
Accounts payable to consolidated subsidiaries	88,395	59,414	'	'
Accrued expenses	38,179	33,255	'	'
Current portion of contingent consideration	'	2,578	'	'
Payroll and benefit-related liabilities	35,296	30,154	'	'
Accrued interest	5	5	'	'
Income taxes payable	23,821	18,709	'	'
Other current liabilities	5,072	5,522	'	'
Total current liabilities	219,439	181,668	'	'
Deferred tax liabilities	57,896	54,664	'	'
Pension and other postretirement benefit liabilities	18,315	19,420	'	'
Noncurrent liability for uncertain tax positions	26,522	26,721	'	'
Notes payable and other amounts due to consolidated subsidiaries	197,173	183,741	'	'
Other liabilities	12,401	9,548	'	'
Total liabilities	531,746	475,762	'	'
Total common shareholders’ equity	1,565,668	1,432,931	'	'
Noncontrolling interest	2,489	2,587	'	'
Total equity	1,568,157	1,435,518	'	'
Total liabilities and equity	$2,099,903	$1,911,280	'	'

Condensed_Consolidating_Statem1

Condensed Consolidating Statements of Cash Flows (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Net cash (used in) provided by operating activities from continuing operations	$229,871	$193,853	$94,357
Expenditures for property, plant and equipment	-63,580	-65,394	-44,582
Proceeds from sales of businesses and assets, net of cash sold	'	66,660	376,025
Payments for businesses and intangibles acquired, net of cash acquired	-309,008	-369,444	-24,623
Investments in affiliates	-50	-80	-150
Net cash used in investing activities from continuing operations	-372,638	-368,258	306,670
Proceeds from long-term borrowings	680,000	'	515,000
Repayment of long-term borrowings	-375,000	'	-455,800
Debt extinguishment, issuance and amendment fees	-6,400	'	-18,518
Decrease in notes payable and current borrowings	'	-706	-24,714
Proceeds from stock compensation plans	7,609	9,003	34,009
Dividends	-55,917	-55,589	-55,136
Payments to noncontrolling interest shareholders	-736	'	'
Payments for contingent consideration	-16,958	-17,596	-5,947
Net cash provided by (used in) financing activities from continuing operations	232,598	-64,888	-11,106
Net cash (used in) provided by operating activities	-3,327	-7,799	121
Net cash used in investing activities	'	-2,351	-2,875
Net cash (used in) provided by discontinued operations	-3,327	-10,150	-2,754
Effect of exchange rate changes on cash and cash equivalents	8,441	2,394	-11,531
Net (decrease) increase in cash and cash equivalents	94,945	-247,049	375,636
Cash and cash equivalents at the beginning of the year	337,039	584,088	208,452
Cash and cash equivalents at the end of the year	431,984	337,039	584,088
Parent Company	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Net cash (used in) provided by operating activities from continuing operations	-132,459	-178,782	-107,279
Expenditures for property, plant and equipment	-1,553	-7,352	-3,167
Proceeds from sales of businesses and assets, net of cash sold	'	4,301	'
Investments in affiliates	-50	-80	-150
Net cash used in investing activities from continuing operations	-1,603	-3,131	-3,317
Proceeds from long-term borrowings	680,000	'	515,000
Repayment of long-term borrowings	-375,000	'	-455,800
Debt extinguishment, issuance and amendment fees	-6,400	'	-18,518
Decrease in notes payable and current borrowings	'	'	-25,000
Proceeds from stock compensation plans	7,609	9,003	34,009
Dividends	-55,917	-55,589	-55,136
Intercompany transactions	-141,614	196,850	220,302
Net cash provided by (used in) financing activities from continuing operations	108,678	150,264	214,857
Net cash (used in) provided by operating activities	-2,727	-12,022	-12,359
Net cash used in investing activities	'	'	-3
Net cash (used in) provided by discontinued operations	-2,727	-12,022	-12,362
Net (decrease) increase in cash and cash equivalents	-28,111	-43,671	91,899
Cash and cash equivalents at the beginning of the year	70,860	114,531	22,632
Cash and cash equivalents at the end of the year	42,749	70,860	114,531
Guarantor Subsidiaries	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Net cash (used in) provided by operating activities from continuing operations	205,954	310,736	234,145
Expenditures for property, plant and equipment	-47,633	-39,118	-25,840
Proceeds from sales of businesses and assets, net of cash sold	'	45,204	58,986
Payments for businesses and intangibles acquired, net of cash acquired	-250,912	-105,195	-24,623
Net cash used in investing activities from continuing operations	-298,545	-99,109	8,523
Decrease in notes payable and current borrowings	'	-421	'
Payments for contingent consideration	-14,802	-16,289	-5,947
Intercompany transactions	137,304	-177,900	-227,222
Intercompany dividends paid	-17,400	-16,900	-18,300
Net cash provided by (used in) financing activities from continuing operations	105,102	-211,510	-251,469
Net cash (used in) provided by operating activities	'	4,223	9,306
Net cash used in investing activities	'	-2,351	-505
Net cash (used in) provided by discontinued operations	'	1,872	8,801
Net (decrease) increase in cash and cash equivalents	12,511	1,989	'
Cash and cash equivalents at the beginning of the year	1,989	'	'
Cash and cash equivalents at the end of the year	14,500	1,989	'
Non-Guarantor Subsidiaries	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Net cash (used in) provided by operating activities from continuing operations	304,278	160,802	71,115
Expenditures for property, plant and equipment	-14,394	-18,924	-15,575
Proceeds from sales of businesses and assets, net of cash sold	'	17,155	317,039
Payments for businesses and intangibles acquired, net of cash acquired	-58,096	-264,249	'
Net cash used in investing activities from continuing operations	-72,490	-266,018	301,464
Decrease in notes payable and current borrowings	'	-285	286
Payments to noncontrolling interest shareholders	-736	'	'
Payments for contingent consideration	-2,156	-1,307	'
Intercompany transactions	4,310	-18,950	6,920
Intercompany dividends paid	-130,502	-82,003	-85,324
Net cash provided by (used in) financing activities from continuing operations	-129,084	-102,545	-78,118
Net cash (used in) provided by operating activities	-600	'	3,174
Net cash used in investing activities	'	'	-2,367
Net cash (used in) provided by discontinued operations	-600	'	807
Effect of exchange rate changes on cash and cash equivalents	8,441	2,394	-11,531
Net (decrease) increase in cash and cash equivalents	110,545	-205,367	283,737
Cash and cash equivalents at the beginning of the year	264,190	469,557	185,820
Cash and cash equivalents at the end of the year	374,735	264,190	469,557
Consolidation, Eliminations	'	'	'
Condensed Cash Flow Statements Captions [Line Items]	'	'	'
Net cash (used in) provided by operating activities from continuing operations	-147,902	-98,903	-103,624
Intercompany dividends paid	147,902	98,903	103,624
Net cash provided by (used in) financing activities from continuing operations	$147,902	$98,903	$103,624

Asset_Held_for_Sale_Detail

Asset Held for Sale (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Long Lived Assets Held For Sale [Line Items]	'	'
Property, plant and equipment	$10,428	$7,963
Total assets held for sale	$10,428	$7,963

Schedule_of_Operating_Results_

Schedule of Operating Results of Operations Treated as Discontinued Operations (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net revenues

'

'

'

'

'

'

'

'

'

$16,616

$277,972

Costs and other expenses

'

'

'

'

'

'

'

'

2,205

18,328

255,919

Goodwill impairment

'

'

'

'

'

'

'

'

'

9,700

[1]

'

Gain on disposition

'

'

'

'

'

'

'

'

'

2,205

[2]

270,630

[2]

Income (loss) from discontinued operations before income taxes

'

'

'

'

'

'

'

'

-2,205

-9,207

292,683

Taxes (benefit) on income (loss) from discontinued operations

'

'

'

'

'

'

'

'

-1,770

-1,887

87,038

Income (loss) from discontinued operations

-236

1,029

-766

-462

[3]

-1,037

[4]

-2,521

[4]

-4,367

[4]

605

[3],[4]

-435

-7,320

205,645

Less: Income from discontinued operations attributable to noncontrolling interest

'

'

'

'

'

'

'

'

'

'

617

Income (loss) from discontinued operations attributable to common shareholders

'

'

'

'

'

'

'

'

($435)

($7,320)

$205,028

[1]

During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of the orthopedic business to its estimated fair value

[2]

The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the cargo systems and cargo container businesses.

[3]

Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.

[4]

Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.

Schedule_of_Operating_Results_1

Schedule of Operating Results of Operations Treated as Discontinued Operations (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012		Dec. 31, 2011
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]	'		'
Goodwill impairment	$9,700	[1]	'
Gain on disposition	$2,205	[2]	$270,630	[2]
[1]	During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of the orthopedic business to its estimated fair value
[2]	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the cargo systems and cargo container businesses.

DivestitureRelated_Activities_1

Divestiture-Related Activities - Additional Information (Detail) (USD $)	1 Months Ended		3 Months Ended	12 Months Ended			1 Months Ended	12 Months Ended
	Aug. 26, 2012	Dec. 02, 2011	Sep. 25, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Mar. 22, 2011	Dec. 31, 2012	Jun. 26, 2011
							Marine Business	Marine Business	Product Recall
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]	'	'	'	'	'	'	'	'	'
Retained liability expenses on divested business	'	'	'	($2,200,000)	($2,700,000)	($17,100,000)	'	'	'
Additional litigation reserves associated with retained liability related to divested business	'	'	'	'	'	'	'	'	7,500,000
Amount paid as part of the settlement related to the recall costs	'	'	7,600,000	'	'	'	'	'	'
Proceeds from sale of business	45,200,000	280,000,000	'	'	'	'	123,100,000	'	'
Gain from sale of business	39,000	'	'	'	'	'	'	'	'
Gains or losses resulting from sale of businesses or assets	'	126,800,000	'	'	'	'	57,300,000	'	'
Working capital adjustment	'	'	'	'	16,800,000	'	'	'	'
Additional gain on sale of discontinued operations	'	'	'	'	2,200,000	'	'	'	'
Cash proceeds from sale of asset held for sale	'	'	'	'	'	'	103,100,000	'	'
Subordinated promissory note	'	'	'	'	'	'	4,500,000	'	'
Liabilities assumed	'	'	'	'	'	'	15,500,000	'	'
Cash included as part of net assets sold	'	'	'	'	'	'	1,500,000	'	'
Net cash proceeds	'	'	'	'	'	'	101,600,000	'	'
Accumulated loss realized from pension and postretirement obligations	'	'	'	'	'	'	8,400,000	'	'
Cumulative translation gains	'	'	'	'	'	'	33,400,000	'	'
Accumulated other comprehensive income	'	'	'	-110,855,000	-132,048,000	-159,353,000	25,000,000	'	'
Accrued interest paid	'	'	'	'	'	'	'	$700,000	'

Quarterly_Data_Detail

Quarterly Data (Detail) (USD $)	3 Months Ended																12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Sep. 30, 2013		Jun. 30, 2013		Mar. 31, 2013		Dec. 31, 2012		Sep. 30, 2012		Jun. 30, 2012		Mar. 31, 2012		Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule Of Quarterly Financial Information [Line Items]	'		'		'		'		'		'		'		'		'	'	'
Net revenues	$450,539		$413,796		$420,059		$411,877	[1]	$419,056	[2]	$368,054	[2]	$383,332	[2]	$380,567	[1],[2]	$1,696,271	$1,551,009	$1,492,528
Gross profit	224,943		203,992		209,490		200,520	[1]	199,180	[2]	180,567	[2]	184,364	[2]	184,114	[1],[2]	838,945	748,225	708,778
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	54,064		66,042		63,751		49,404	[1]	58,440	[2]	49,841	[2]	64,722	[2]	-270,378	[1],[2]	233,261	-97,375	229,570
Income (loss) from continuing operations	35,302		45,779		43,401		27,701	[1]	30,614	[2]	24,451	[2]	47,266	[2]	-284,113	[1],[2]	152,183	-181,782	119,322
Income (loss) from discontinued operations	-236		1,029		-766		-462	[1]	-1,037	[2]	-2,521	[2]	-4,367	[2]	605	[1],[2]	-435	-7,320	205,645
Net income (loss)	35,066		46,808		42,635		27,239	[1]	29,577	[2]	21,930	[2]	42,899	[2]	-283,508	[1],[2]	151,748	-189,102	324,967
Less: Income from continuing operations attributable to noncontrolling interest	238		234		194		201	[1]	254	[2]	188	[2]	286	[2]	227	[1],[2]	867	955	1,021
Net income (loss) attributable to common shareholders	$34,828		$46,574		$42,441		$27,038	[1]	$29,323	[2]	$21,742	[2]	$42,613	[2]	($283,735)	[1],[2]	$150,881	($190,057)	$323,329
Basic:	'		'		'		'		'		'		'		'		'	'	'
Income (loss) from continuing operations	$0.85	[3]	$1.11	[3]	$1.05	[3]	$0.67	[1],[3]	$0.74	[2],[3]	$0.59	[2],[3]	$1.15	[2],[3]	($6.97)	[1],[2],[3]	$3.68	($4.47)	$2.92
Income (loss) from discontinued operations	'		$0.02	[3]	($0.02)	[3]	($0.01)	[1],[3]	($0.02)	[2],[3]	($0.06)	[2],[3]	($0.11)	[2],[3]	$0.01	[1],[2],[3]	($0.01)	($0.18)	$5.06
Net income	$0.85	[3]	$1.13	[3]	$1.03	[3]	$0.66	[1],[3]	$0.72	[2],[3]	$0.53	[2],[3]	$1.04	[2],[3]	($6.96)	[1],[2],[3]	$3.67	($4.65)	$7.98
Diluted:	'		'		'		'		'		'		'		'		'	'	'
Income (loss) from continuing operations	$0.78	[3]	$1.05	[3]	$0.99	[3]	$0.64	[1],[3]	$0.72	[2],[3]	$0.58	[2],[3]	$1.14	[2],[3]	($6.97)	[1],[2],[3]	$3.46	($4.47)	$2.90
Income (loss) from discontinued operations	($0.01)	[3]	$0.03	[3]	($0.01)	[3]	($0.01)	[1],[3]	($0.02)	[2],[3]	($0.06)	[2],[3]	($0.10)	[2],[3]	$0.01	[1],[2],[3]	($0.01)	($0.18)	$5.02
Net income	$0.77	[3]	$1.08	[3]	$0.98	[3]	$0.63	[1],[3]	$0.70	[2],[3]	$0.52	[2],[3]	$1.04	[2],[3]	($6.96)	[1],[2],[3]	$3.45	($4.65)	$7.92
[1]	Amounts for the first quarter 2012 include a pretax goodwill impairment charge of $332.1 million, or $315.1 million net of tax. See Note 7 to the consolidated financial statements.
[2]	Amounts reflect the retrospective impact of reporting the orthopedic business as discontinued operations. See Note 18 to the consolidated financial statements.
[3]	Each quarter is calculated as a discrete period; the sum of the four quarters may not equal the calculated full year amount.

Quarterly_Data_Parenthetical_D

Quarterly Data (Parenthetical) (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Quarterly Financial Information [Line Items]	'	'	'
Goodwill impairment charges	$332,100	'	$332,128
Net of Tax	'	'	'
Schedule Of Quarterly Financial Information [Line Items]	'	'	'
Goodwill impairment charges	$315,100	'	'

Schedule_II_Valuation_and_Qual1

Schedule II - Valuation and Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at End of Year	$86,510	$69,527	'
Allowance for Doubtful Accounts	'	'	'
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at Beginning of Year	7,818	6,452	4,138
Dispositions	'	'	-497
Additions Charged to Income (Expense)	4,414	1,730	3,245
Accounts Receivable Write-offs	-1,446	-483	-884
Translation and Other	-64	119	450
Balance at End of Year	10,722	7,818	6,452
Inventory Valuation Reserve	'	'	'
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at Beginning of Year	31,703	32,919	38,284
Dispositions	'	-504	-7,941
Additions Charged to Income (Expense)	14,226	19,488	16,863
Accounts Receivable Write-offs	-17,777	-18,733	-15,496
Translation and Other	4,221	-1,467	1,209
Balance at End of Year	32,373	31,703	32,919
Inventory Valuation Reserve | Raw Material	'	'	'
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at Beginning of Year	9,394	9,095	15,717
Dispositions	'	-504	-5,064
Additions Charged to Income (Expense)	1,931	5,206	877
Accounts Receivable Write-offs	-5,774	-4,346	-715
Translation and Other	136	-57	-1,720
Balance at End of Year	5,687	9,394	9,095
Inventory Valuation Reserve | Work-In-Process	'	'	'
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at Beginning of Year	1,646	2,742	5,908
Dispositions	'	'	-478
Additions Charged to Income (Expense)	855	1,107	382
Accounts Receivable Write-offs	-340	-2,204	-355
Translation and Other	-432	1	-2,715
Balance at End of Year	1,729	1,646	2,742
Inventory Valuation Reserve | Finished Goods	'	'	'
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at Beginning of Year	20,663	21,082	16,659
Dispositions	'	'	-2,399
Additions Charged to Income (Expense)	11,440	13,175	15,604
Accounts Receivable Write-offs	-11,663	-12,183	-14,426
Translation and Other	4,517	-1,411	5,644
Balance at End of Year	24,957	20,663	21,082
Valuation Allowance of Deferred Tax Assets	'	'	'
Valuation And Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at Beginning of Year	69,527	66,305	49,522
Additions Charged to Income (Expense)	21,118	6,103	26,743
Accounts Receivable Write-offs	-1,553	-4,888	-2,206
Translation and Other	-2,582	2,007	-7,754
Balance at End of Year	$86,510	$69,527	$66,305